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CHARACTERIZATION OF LOW DENSITY INTRACRANIAL LESIONS USING DUAL-
ENERGY COMPUTED TOMOGRAPHY 
 
Jessica Nute, M.S. 
Supervisory Professor: Dianna Cody, Ph.D. 
Abstract 
Calcific and hemorrhagic foci of susceptibility are frequently encountered on routine 
brain MR studies.  Both etiologies cause variations in local magnetic field strength, leading 
to dark regions on the MR images that cannot be classified.  Single-energy CT (SECT) can 
be used to identify lesions with attenuation over 100 HU as calcific, however lesions with 
lower attenuation cannot be reliably identified.  While calcific lesions are unlikely to cause 
harm, hemorrhagic lesions carry a risk of subsequent intracranial bleeding; as such, 
identification of hemorrhage is vital in preventing the inappropriate use of anticoagulant 
medications in patients with hemorrhagic lesions.   
Given there currently exists no clinically available means of differentiating between 
these two lesions over their full biological attenuation ranges, there is a clear need for a 
reliable imaging method to differentiate low intensity calcification and hemorrhage.  
Recently, several vendors have released new computed tomography (CT) scanner models 
with dual-energy capabilities, which may be successfully applied to this issue.  By acquiring 
data at two different energies, dual-energy CT (DECT) collects information about the 
energy-dependent attenuation changes in a material and may help distinguish between two 
materials with similar linear attenuation measurements which would be impossible to 
differentiate using SECT. 
This work applies the unique capabilities of DECT to the characterization of 
intracranial hemorrhage and calcification using biologically-relevant and spectrally-
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equivalent models.  Lesion and acquisition parameters were varied to elucidate their impact 
on DECT’s ability to differentiate and subsequently classify intracranial lesions.  DECT’s 
characterization ability was shown to improve with increasing CTDIvol, image thickness and 
lesion size.  Using an optimized protocol, intracranial lesions were correctly classified with 
over 90% confidence down to a minimum attenuation of 56 HU, representing a significant 
improvement beyond the 100 HU limit imposed by the current standard.  Since this data 
collection spanned several years, a dual-energy quality control program was designed to 
validate the comparison of collected data.  The added characterization ability of DECT will 
assist physicians in the correct prescription of anticoagulant medications, hopefully sparing 
hemorrhagic patients from prophylaxis that might cause them harm. 
  
ix 
 
Table of Contents 
 
Acknowledgements ............................................................................................................. iv 
Abstract .............................................................................................................................. vii 
Table of Contents ................................................................................................................ ix 
List of Figures ................................................................................................................... xiv 
List of Tables .................................................................................................................. xxvii 
List of Equations ........................................................................................................... xxxvii 
List of Abbreviations ...................................................................................................... xxxix 
1 Introduction ................................................................................................................... 1 
1.1 Objectives and Hypothesis ............................................................................. 2 
1.2 Specific Aims ................................................................................................. 2 
1.3 Dissertation Organization ............................................................................... 4 
2 Background ................................................................................................................... 5 
2.1 Basics of DECT ............................................................................................. 9 
2.2 DECT Implementations .................................................................................10 
2.3 Dual-Energy Image Reconstruction...............................................................12 
2.4 Tissue Differentiation using Dual-Energy CT .................................................17 
2.5 MR for the Differentiation of Calcification and Hemorrhage ...........................17 
3 Lesion Differentiation using an Agar-Gel Based Phantom ........................................... 19 
3.1 Introduction ...................................................................................................19 
x 
 
3.2 Materials and Methods ..................................................................................21 
3.2.1 Calcification and Hemorrhage Phantom Models ..............................21 
3.2.2 Imaging and Region-of-Interest Analysis .........................................23 
3.2.3 Fabrication of Matched Hemorrhage and Calcification Gel Models ..24 
3.2.4 Dual-Energy Data Processing .........................................................25 
3.2.5 Matched Model Pair Data Analysis ..................................................26 
3.3 Results ..........................................................................................................29 
3.3.1 Calcification and Hemorrhage Phantom Models ..............................29 
3.3.2 Fabrication of Matched Hemorrhage and Calcification Gel Models ..29 
3.3.3 Matched Model Pair Data Analysis ..................................................30 
3.4 Discussion ....................................................................................................35 
4 Lesion Differentiation using a Biologically-Relevant Phantom ..................................... 39 
4.1 Materials and Methods ..................................................................................39 
4.1.1 Phantom Preparation .......................................................................39 
4.1.2 Spectrally Equivalent Brain Material ................................................41 
4.1.3 Lesion Models .................................................................................42 
4.1.4 Selection of optimal keV level for simulated SECT scanning ...........44 
4.1.5 Collection of Lesion Differentiation Data ..........................................46 
4.1.6 Data Organization and Structure .....................................................48 
4.1.7 Determination of Differentiation Accuracy ........................................53 
4.1.8 Inter-Scanner and Intra-Scanner Correlation ...................................57 
4.1.9 Validation of Lesion Attenuation ......................................................57 
4.2 Results ..........................................................................................................58 
4.2.1 Spectrally Equivalent Brain Material ................................................58 
xi 
 
4.2.2 Lesion Models .................................................................................62 
4.2.3 Selection of Optimal keV Level for Simulated SECT Scanning ........65 
4.2.4 Validation of Lesion Attenuation ......................................................66 
4.2.5 Determination of Differentiation Accuracy ........................................70 
4.2.6 Inter-Scanner and Intra-Scanner Correlation ................................. 106 
4.3 Discussion .................................................................................................. 118 
4.3.1 Gaussian Mixture Model (GMM) Analysis ...................................... 118 
4.3.2 Support Vector Machine and Geometric Bisector Analyses ........... 118 
4.3.3 Inter- and Intra-Scanner Correlation .............................................. 120 
4.3.4 Validation of Optimal keV Level for Simulated SECT Scanning ..... 122 
4.3.5 Power Fits for 90% Differentiation Accuracy .................................. 123 
4.3.6 Limitations ..................................................................................... 124 
5 Lesion Classification using Unknown Lesion Models ................................................. 125 
5.1 Materials and Methods ................................................................................ 125 
5.1.1 Fabrication and Evaluation of Unknown Lesion Models ................. 125 
5.1.2 Unknown Lesion Data Acquisition ................................................. 127 
5.1.3 Unknown Lesion Classification Methods ........................................ 128 
5.1.4 Inter-Method correlation ................................................................ 132 
5.2 Results ........................................................................................................ 133 
5.2.1 Fabrication and Evaluation of Unknown Lesion Models ................. 133 
5.2.2 Probability Distribution Definition ................................................... 133 
5.2.3 Classification of Unknown Lesions ................................................ 137 
5.2.4 Inter-Method Correlations .............................................................. 149 
5.3 Discussion .................................................................................................. 154 
xii 
 
5.3.1 Effect of Lesion Parameters on Classification Confidence ............. 154 
5.3.2 Effect of CTDIvol on Classification Confidence ............................... 159 
5.3.3 Generalizability of the Geometric Bisector Plane Solution ............. 160 
5.3.4 Protocol Recommendations for Optimal Classification Confidence 162 
5.3.5 Limitations ..................................................................................... 163 
6 Dual-Energy CT Quality Control Program Development ............................................ 165 
6.1 Introduction ................................................................................................. 165 
6.2 Materials and Methods ................................................................................ 168 
6.2.1 Phantom Design ............................................................................ 168 
6.2.2 Test Metrics ................................................................................... 173 
6.2.3 Protocol Development ................................................................... 176 
6.2.4 Data Collection .............................................................................. 181 
6.3 Results ........................................................................................................ 184 
6.3.1 Determination of Relevant Acquisition Parameters ........................ 184 
6.3.2 DECT Response by Test Metric .................................................... 185 
6.3.3 Recommendations on Clinical Implementation of DEQC Program . 211 
6.4 Discussion .................................................................................................. 212 
6.4.1 Iodine Accuracy ............................................................................. 213 
6.4.2 Uniformity ...................................................................................... 213 
6.4.3 Monoenergetic HU Stability ........................................................... 215 
6.4.4 Noise ............................................................................................. 216 
6.4.5 Differences in DEQC Body and DEQC Head Phantom Results ..... 216 
6.4.6 Impact of Results on Intracranial Lesion Characterization ............. 217 
6.4.7 Limitations ..................................................................................... 220 
xiii 
 
6.4.8 Future Work................................................................................... 221 
7 Conclusions ............................................................................................................... 222 
7.1 Summary of Major Findings ........................................................................ 222 
7.2 Comments on Clinical Implementation ........................................................ 225 
7.3 Limitations and Future Directions ................................................................ 226 
8 Appendix ................................................................................................................... 228 
8.1 Gaussian Mixture Model Formulation .......................................................... 228 
8.2 GMM Fitting and Analysis ........................................................................... 229 
References ..................................................................................................................... 232 
Vita ................................................................................................................................. 243 
 
  
xiv 
 
List of Figures 
 
 
Figure 2.1: Increase in DECT publications from January 1, 2000 to December 31, 2014 
based on occurrence of “Dual-Energy CT” or “Spectral CT” using the Web of Science 
database tool (34). .............................................................................................................. 8 
Figure 3.1:  Anthropomorphic head phantom. ....................................................................22 
Figure 3.2: (a) Custom water-filled insert for the anthropomorphic head phantom. The 
lateral view (top), the axial view (bottom left), and the relative position of the insert in the 
head phantom (bottom right) are shown. The orientation of the imaging volume is 
represented by the yellow shaded region. (b) A lateral scout image of the anthropomorphic 
head phantom with custom water-filled insert and gel models in place. ..............................23 
Figure 3.3: 3D plot of voxel data from all calcification and hemorrhage gel models used in 
this study, rotated to show the full distribution of the data (a) or the planar nature of these 
data in the 3D coordinate space (b). Hemorrhage gel model voxel data are shown in red; 
calcification gel model voxel data are shown in blue. .........................................................28 
Figure 3.4: SECT attenuation (HU) for the concentration of iron oxide in the hemorrhage gel 
models and the hydroxyapatite in the calcification gel models. Linear regression equations 
and correlation coefficients are shown for each data set. ...................................................29 
Figure 3.5:  GMM assignment results for the 62-HU matched gel model pair (1 of 16 pairs).  
Each point represents a voxel within the 6,032-voxel volume of interest in one of the two gel 
models. ..............................................................................................................................32 
Figure 3.6:  Accuracy of hemorrhage and calcification differentiation using the GMM and 
threshold plane analysis method for all attenuation-matched model pairs. For the GMM 
xv 
 
series, each point represents 1,000 iteratively filtered runs of the analysis.  A third-order 
polynomial (Poly.) was fit to each series to facilitate visual interpretation of the data. .........33 
Figure 3.7:  3D plot of all voxel data (n = 193,024) from all 16 hemorrhage/calcification 
matched model pairs. Hemorrhage gel model voxel data are shown in red; calcification gel 
model voxel data are shown in blue. (a) Threshold plane viewed edge on as black line 
[equation: -0.93x + 0.31y - 0.20z = -929.20].  (b) Voxel data viewed from an angle showing 
hemorrhage and calcification data falling on the hemorrhage side of the threshold plane. 
Bright blue calcification data would be incorrectly identified as belonging to the hemorrhage 
population, with greyed-out blue data being correctly classified. (c) Voxel data viewed from 
an angle showing hemorrhage and calcification data falling on the calcification side of the 
threshold plane. Bright red hemorrhage data would be incorrectly identified as belonging to 
the calcification population, with greyed-out red data being correctly classified. .................35 
Figure 4.1:  Interior of anthropomorphic nuclear medicine phantom. ..................................39 
Figure 4.2:  Intracranial lesion phantom plan showing brain slabs in tan, hemorrhage lesion 
models in red and calcification lesion models in blue.  (a) sagittal view showing position of 
cerebrum and skull base brain slabs.  (b) axial view of cerebrum brain slab showing position 
of hemorrhage and calcification lesion models.  (c) axial view of skull base slab showing 
position calcification and hemorrhage model. .....................................................................40 
Figure 4.3:  Gammex validation phantom.  Water balloons are positioned in insert holes 
covered by tape.  Target lesion was positioned at 12 o’clock. ............................................43 
Figure 4.4: Artifact caused by phantom discontinuity. .........................................................50 
Figure 4.5: Support vector machine plane (gray) based on identified support vectors (green) 
for the hemorrhage (red) and calcification (blue) distributions. ...........................................54 
Figure 4.6:  Geometric bisector plane (gray) shown separating the hemorrhage (red) and 
calcification (blue) distributions.  Three dimensional linear regressions of the two 
distributions and the resulting bisector are shown in as color-matched lines. .....................55 
xvi 
 
Figure 4.7:  Results of dual-energy analysis for potential spectrally equivalent brain 
materials.  Spectral data from a clinical brain study (GE, Waukesha, WI; personal contact) 
is shown in black. ...............................................................................................................59 
Figure 4.8:  Sagittal reformat of intracranial lesion phantom showing potential positioning of 
cerebrum and skull base slabs.  Red lines show the relative thickness of the cerebrum vs 
the skull base brain slabs while the blue dotted line represents the upper bound of the 
imaging area affected by the bony anatomy of the skull base. ...........................................60 
Figure 4.9:  Simplified structure of cerebrum slab based on upper and lower curvatures with 
arrow showing mismatch between phantom base and crown interiors. ..............................61 
Figure 4.10: Error in attenuation (HU) measurement between SECT and 68 keV 
reconstructions for both calcification and hemorrhage models.  Error bars represent one 
standard deviation (SD) of the distribution accounting for all image thickness, CTDIvol and 
reconstruction filter protocol variations. ..............................................................................67 
Figure 4.11: Bland-Altman and Correlation graphs for the correlation of SECT attenuation 
(HU) to 68 keV HU.  Data includes all protocol variations and lesion models. ....................67 
Figure 4.12:  Lesion matching results based on SECT and 68 keV attenuation evaluation.  
Values represent mean difference in calcification and hemorrhage models across all 
available protocol variations.  Error bars represent one SD of this distribution. ..................69 
Figure 4.13:  Accuracy of 3D GMM differentiation for intracranial lesion pairs based on 
lesion model size and location. Displayed values represent mean of accuracy across the 
three studies and all protocol variations: CTDIvol, image thickness and reconstruction filter. 
Error bars represent one SD of the distribution. .................................................................71 
Figure 4.14: Differentiation Accuracy using Gaussian Mixture Model (GMM) method 
analyzed by CTDIvol.  Displayed values represent mean of accuracy across the three 
studies and additional protocol variations: image thickness and reconstruction filter. Error 
bars represent one SD for each distribution. ......................................................................72 
xvii 
 
Figure 4.15: Differentiation Accuracy using Gaussian Mixture Model (GMM) method 
analyzed by image thickness.  Displayed values represent mean of accuracy across the 
three studies and additional protocol variations: CTDIvol and reconstruction filter. Error bars 
represent one SD for each distribution. ..............................................................................73 
Figure 4.16: Differentiation Accuracy using Gaussian Mixture Model (GMM) method 
analyzed by reconstruction filter.  Displayed values represent mean of accuracy across the 
three studies and additional protocol variations: CTDIvol and image thickness. Error bars 
represent one SD for each distribution ...............................................................................74 
Figure 4.17:  Distribution of differentiation accuracy results from 7,000 GMMs (1,000 per 
lesion pair) graphed versus the attenuation of lesion pair.  Data represents 67 mGy CTDIvol, 
3.75 mm image thickness, standard filter acquisition of 1 cm cerebrum matched lesion 
pairs. ..................................................................................................................................75 
Figure 4.18:  Differentiation accuracy results for calcification model, hemorrhage model and 
combined matched model pair.  Error bars represent standard deviation in accuracy value 
over the 1,000 GMM repetitions.  Data represents 67 mGy CTDIvol, 3.75 mm image 
thickness, standard filter acquisition of 1 cm cerebrum matched lesion pairs. ....................76 
Figure 4.19:  Top: Raw voxel data from a CTDIvol, 3.75 mm image thickness, standard filter 
acquisition of 1 cm cerebrum matched lesion pairs at 80 HU.  Lower Left: GMM solution 
resulting in high calcification model and overall matched model pair accuracies.  Lower 
Right: GMM solution resulting in low calcification model and overall matched model pair 
accuracies. .........................................................................................................................77 
Figure 4.20:  Differentiation accuracy using support vector machine method.  Displayed 
values represent mean of accuracy across the three studies and all protocol variations: 
CTDIvol, image thickness and reconstruction filter. Error bars represent one SD of the 
distribution. ........................................................................................................................79 
xviii 
 
Figure 4.21:  Differentiation accuracy using support vector machine method analyzed by 
CTDIvol.  Displayed values represent mean of accuracy across the three studies and 
additional protocol variations: image thickness and reconstruction filter. Error bars represent 
one SD for each distribution. ..............................................................................................80 
Figure 4.22:  Differentiation accuracy using support vector machine method analyzed by 
image thickness.  Displayed values represent mean of accuracy across the three studies 
and additional protocol variations: CTDIvol and reconstruction filter. Error bars represent one 
SD for each distribution. .....................................................................................................81 
Figure 4.23:  Differentiation accuracy using support vector machine method analyzed by 
reconstruction filter.  Displayed values represent mean of accuracy across the three studies 
and additional protocol variations: CTDIvol and image thickness. Error bars represent one 
SD for each distribution. .....................................................................................................82 
Figure 4.24: Surface plots for SVM differentiation accuracy (z-axis) for 0.5 cm and 1.0 cm 
cerebrum matched model pairs based on the attenuation (HU) of the lesion pair (x-axis, 
right) and the CTDIvol of the acquisition (y-axis, left) for all image thicknesses.  Standard 
filter used for all visualizations.  Color bar provided to assist in visualization of higher 
accuracy results (warmer colors correspond with higher accuracies).  The gray plane is 
fixed at 90% differentiation accuracy. .................................................................................83 
Figure 4.25: Surface plots for SVM differentiation accuracy (z-axis) for 1.5 cm cerebrum 
and 1.5 cm skull base matched model pairs based on the attenuation (HU) of the lesion pair 
(x-axis, right) and the CTDIvol of the acquisition (y-axis, left) for all image thicknesses.  
Standard filter used for all visualizations.  Color bar provided to assist in visualization of 
higher accuracy results (warmer colors correspond with higher accuracies).  The gray plane 
is fixed at 90% differentiation accuracy. .............................................................................84 
Figure 4.26:  Graphical representation of lesion attenuation (HU) necessary for 90% SVM 
differentiation accuracy by acquisition parameters (Table 4.13).  The un-shaded region 
xix 
 
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the 
current clinical limit of 100 HU imposed by SECT. .............................................................89 
Figure 4.27:  Differentiation accuracy using geometric bisector method.  Displayed values 
represent mean of accuracy across the three studies and all protocol variations: CTDIvol, 
image thickness and reconstruction filter. Error bars represent one SD of the distribution..90 
Figure 4.28:  Differentiation accuracy using geometric bisector method analyzed by CTDIvol.  
Displayed values represent mean of accuracy across the three studies and additional 
protocol variations: image thickness and reconstruction filter. Error bars represent one SD 
for each distribution. ...........................................................................................................91 
Figure 4.29:  Differentiation accuracy using geometric bisector method analyzed by image 
thickness.  Displayed values represent mean of accuracy across the three studies and 
additional protocol variations: CTDIvol and reconstruction filter. Error bars represent one SD 
for each distribution. ...........................................................................................................92 
Figure 4.30:  Differentiation accuracy using geometric bisector method analyzed by 
reconstruction filter.  Displayed values represent mean of accuracy across the three studies 
and additional protocol variations: CTDIvol and image thickness. Error bars represent one 
SD for each distribution. .....................................................................................................93 
Figure 4.31:  Surface plots for GB differentiation accuracy (z-axis) for 0.5 cm and 1.0 cm 
cerebrum matched model pairs based on the attenuation (HU) of the lesion pair (x-axis, 
right) and the CTDIvol of the acquisition (y-axis, left) for all image thicknesses.  Standard 
filter used for all visualizations.  Color bar provided to assist in visualization of higher 
accuracy results (warmer colors correspond with higher accuracies).  The gray plane is 
fixed at 90% differentiation accuracy. .................................................................................94 
Figure 4.32: Surface plots for GB differentiation accuracy (z-axis) for 1.5 cm cerebrum and 
1.5 cm skull base matched model pairs based on the attenuation (HU) of the lesion pair (x-
axis, right) and the CTDIvol of the acquisition (y-axis, left) for all image thicknesses.  
xx 
 
Standard filter used for all visualizations.  Color bar provided to assist in visualization of 
higher accuracy results (warmer colors correspond with higher accuracies).  The gray plane 
is fixed at 90% differentiation accuracy. .............................................................................95 
Figure 4.33: Graphical representation of lesion attenuation (HU) necessary for 90% GB 
differentiation accuracy by acquisition parameters (Table 4.15).  The un-shaded region 
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the 
current clinical limit of 100 HU imposed by SECT. ........................................................... 100 
Figure 4.34: Bland-Altman and Correlation graphs for inter-method correlation between 
SVM and GB methods.  Top: Full data results including all protocol variations and lesion 
models.  Middle: Results for 0.5 cm cerebrum matched model pair, identified as a major 
source of variability in Table 4.18.  Bottom: Results for full data excluding 0.5 cm cerebrum 
matched model pair values. ............................................................................................. 105 
Figure 4.35: Bland-Altman and correlation graphs for SVM inter-scanner correlation.  Upper 
Left: Analysis of full data.  Right: Analysis of major sources of variability based on results in 
Table 4.19.  Lower Left: Analysis of full data with the data associated with these major 
sources of variability removed. ......................................................................................... 108 
Figure 4.36: Bland-Altman and correlation graphs for GB inter-scanner correlation.  Upper 
Left: Analysis of full data.  Right: Analysis of major sources of variability based on both CV 
and R2 cutoff criteria (Table 4.20). Sources of variability identified solely by R2 criteria were 
excluded for simplicity of visualization.  Lower Left: Analysis of full data with the data 
associated with these major sources of variability removed ............................................. 111 
Figure 4.37:  Bland-Altman and correlation graphs for SVM intra-scanner correlation.  
Upper Left: Analysis of full data.  Right: Analysis of major sources of variability based on 
results in Table 4.21.  Lower Left: Analysis of full data with the data associated with these 
major sources of variability removed. ............................................................................... 114 
xxi 
 
Figure 4.38: Bland-Altman and correlation graphs for GB intra-scanner correlation.  Upper 
Left: Analysis of full data.  Right: Analysis of major sources of variability based on results in 
Table 4.22.  Lower Left: Analysis of full data with the data associated with these major 
sources of variability removed .......................................................................................... 117 
Figure 5.1:  Application of lesion and acquisition specific geometric bisector plane (gray) to 
an example unknown lesion model.  The lesion model mean is shown as a black diamond 
to the left of the plane.  The voxel data also on the left of the plane (and thus contributing to 
the classification confidence) is shown in red, while the voxel data on the right side of the 
plane (and thus counting against the classification confidence) is shown in blue. ............ 129 
Figure 5.2:  Classification confidence results for all unknown lesion models using the 
geometric bisector method.  Calcification lesion models are shown in blue while 
hemorrhage models are shown in red. ............................................................................. 137 
Figure 5.3: Classification confidence results for all unknown lesion models using the 
generalized geometric bisector method.  Calcification lesion models are shown in blue while 
hemorrhage models are shown in red. ............................................................................. 138 
Figure 5.4: Classification confidence results for all unknown lesion models using the 
probability distribution method.  Calcification lesion models are shown in blue while 
hemorrhage models are shown in red. ............................................................................. 140 
Figure 5.5: Geometric bisector confidence in classification of hemorrhage unknown lesions.  
Darker shades of red indicate higher CTDIvol levels. ......................................................... 141 
Figure 5.6: Geometric bisector confidence in classification of calcification unknown lesions.  
Darker shades of blue indicate higher CTDIvol levels. ....................................................... 141 
Figure 5.7: Generalized geometric bisector confidence in classification of hemorrhage 
unknown lesions.  Darker shades of red indicate higher CTDIvol levels. ............................ 144 
Figure 5.8: Generalized geometric bisector confidence in classification of calcification 
unknown lesions.  Darker shades of red indicate higher CTDIvol levels. ............................ 144 
xxii 
 
Figure 5.9: Probability distribution confidence in classification of hemorrhage unknown 
lesions.  Darker shades of red indicate higher CTDIvol levels. ........................................... 147 
Figure 5.10: Probability distribution confidence in classification of calcification unknown 
lesions.  Darker shades of blue indicate higher CTDIvol levels. ......................................... 147 
Figure 5.11: Bland-Altman and Correlation graphs for inter-method correlation between GB 
and PD methods.  Top: Full data results including all lesion/acquisition combinations.  
Middle: Results for hemorrhage lesion models, identified as a major source of variability in 
Table 5.11.  Bottom: Results for full data excluding hemorrhage lesion model values. ..... 151 
Figure 5.12: Bland-Altman and Correlation graphs for inter-method correlation between GB 
and GGB methods.  Top: Full data results including all lesion/acquisition combinations.  
Middle: Results for 0.5 cm cerebrum lesion models, identified as a major source of 
variability in Table 5.12.  Bottom: Results for full data excluding 0.5 cm cerebrum lesion 
model values. ................................................................................................................... 153 
Figure 5.13:  Summary of GB (solid lines) and PD (dashed lines) classification confidence 
based on lesion size and location.  Error bars represent one SD of the CTDIvol levels 
investigated.  Hemorrhage data is shown in red while calcification data is shown in blue. 155 
Figure 5.14: Distance between unknown lesion mean value and parameter-specific GB 
plane.  Error bars represent one SD of the CTDIvol levels investigated.  Hemorrhage model 
data is shown in red while calcification model data is shown in blue. ............................... 156 
Figure 5.15:  Visualization of unknown lesion and prior differentiation lesion mean values for 
a 1.0 cm cerebrum lesion imaged using 105.6 mGy, 3.75 mm image thickness, and 
Standard reconstruction filter.  Acquisition matched GB plane and hemorrhage and 
calcification line fits shown. .............................................................................................. 157 
Figure 5.16: Visualization of unknown lesion and prior differentiation lesion mean values for 
a 0.5 cm cerebrum lesion imaged using 105.6 mGy, 3.75 mm image thickness, and 
xxiii 
 
Standard reconstruction filter.  Acquisition matched GB plane and hemorrhage and 
calcification line fits shown. .............................................................................................. 157 
Figure 5.17: Summary of geometric bisector results for hemorrhage lesions by availability of 
prior knowledge.  GB (dotted line) is lesion and acquisition parameter-specific and thus 
requires prior knowledge of the lesion size and location and acquisition to be used.  GGB 
(dashed line) requires knowledge of only the lesion size and location.  SGGB (solid line) 
assumes no prior knowledge of either the lesion or acquisition. ....................................... 161 
Figure 5.18: Summary of geometric bisector results for calcification lesions by availability of 
prior knowledge.  GB (dotted line) is lesion and acquisition parameter-specific and thus 
requires prior knowledge of the lesion size and location and acquisition to be used.  GGB 
(dashed line) requires knowledge of only the lesion size and location.  SGGB (solid line) 
assumes no prior knowledge of either the lesion or acquisition. ....................................... 162 
Figure 6.1: Basic structure and measurements of DEQC phantom.  Solid water components 
are shown in dark brown, HDPE components in tan and PVC in light gray. ..................... 169 
Figure 6.2:  DEQC insert layout with average 120kVp HU level of inserts labeled. ........... 170 
Figure 6.3: a) Polycarbonate plate attached to back of phantom with solid water bolts visible 
at the bottom and side periphery of the phantom (white arrows).  b) Detail of lower solid 
water bolt as well as the orientation plug (red arrow) used to ensure proper alignment of the 
head phantom within the body phantom. .......................................................................... 171 
Figure 6.4: DEQC body phantom results for iodine accuracy.  Left: Iodine accuracy trends 
sorted primarily by mAs and secondarily by CTDIvol for 2 mg/mL, 5 mg/mL, and 15 mg/mL 
iodine rods displayed by scanner.  Right: Iodine accuracy inter- and intra-scanner variance 
trends sorted primarily by CTDIvol and secondarily by mAs for 2 mg/mL, 5 mg/mL, and 15 
mg/mL iodine rods............................................................................................................ 187 
Figure 6.5: DEQC head phantom results for iodine accuracy.  Left: Iodine accuracy trends 
sorted primarily by mAs and secondarily by CTDIvol for 2 mg/mL and 5 mg/mL iodine rods 
xxiv 
 
displayed by scanner.  Right: Iodine accuracy inter- and intra-scanner variance trends 
sorted primarily by mAs and secondarily by CTDIvol for 2 mg/mL and 5 mg/mL iodine rods.
......................................................................................................................................... 189 
Figure 6.6:  DEQC body phantom results for uniformity.  Left: Uniformity trends sorted 
primarily by rotation time and secondarily by CTDIvol for 50, 70, 110 and 140 keV 
monoenergetic reconstructions and displayed by scanner.  Right: Uniformity inter- and intra-
scanner variance trends sorted primarily by CTDIvol and secondarily by mAs for 50, 70, 110, 
and 140 keV monoenergetic reconstructions. ................................................................... 192 
Figure 6.7: DEQC body phantom results for uniformity.  Left: Uniformity trends sorted 
primarily by rotation time and secondarily by CTDIvol for Water(Iodine) and Iodine(Water) 
material density reconstructions and displayed by scanner.  Right: Uniformity inter- and 
intra-scanner variance trends sorted primarily by CTDIvol and secondarily by mAs for 
Water(Iodine) and Iodine(Water) material density reconstructions. .................................. 193 
Figure 6.8:  DEQC body phantom results for uniformity sorted primarily by rotation time and 
secondarily by mAs for 50, 70, 110 and 140 keV monoenergetic reconstructions. ........... 195 
Figure 6.9: DEQC head phantom results for uniformity.  Left: Uniformity trends sorted 
primarily by mAs and secondarily by CTDIvol for 50, 70, 110 and 140 keV monoenergetic 
reconstructions and displayed by scanner.  Right: Uniformity inter- and intra-scanner 
variance trends sorted primarily by CTDIvol and secondarily by mA for 50, 70, 110, and 140 
keV monoenergetic reconstructions. ................................................................................ 197 
Figure 6.10: DEQC head phantom results for uniformity.  Left: Uniformity trends sorted 
primarily by mAs and secondarily by CTDIvol for Water(Iodine) and Iodine(Water) material 
density reconstructions and displayed by scanner.  Right: Uniformity inter- and intra-
scanner variance trends sorted primarily by CTDIvol and secondarily by mA for 
Water(Iodine) and Iodine(Water) material density reconstructions. .................................. 198 
xxv 
 
Figure 6.11: DEQC head phantom results for uniformity sorted primarily by mAs and 
secondarily by rotation time for 50, 70, 110 and 140 keV monoenergetic reconstructions.
......................................................................................................................................... 199 
Figure 6.12:  DEQC body phantom results for monoenergetic HU stability.  Left: 
Monoenergetic HU stability trends sorted primarily by mAs and secondarily by CTDIvol for 
50, 70, 110 and 140 keV monoenergetic reconstructions and displayed by scanner.  
Calculated attenuations (using NIST values) based on vendor-provided elemental 
composition and true monoenergetic acquisition are shown in black.  Right: Monoenergetic 
HU stability inter- and intra-scanner variance trends sorted primarily by CTDIvol and 
secondarily by mAs for 50, 70, 110, and 140 keV monoenergetic reconstructions. .......... 202 
Figure 6.13:  DEQC body phantom results for monoenergetic HU stability trends sorted 
primarily by mAs and secondarily by CTDIvol for 50, 70, 110 and 140 keV monoenergetic 
reconstructions.  The dashed red line indicates a potential mAs cutoff for optimum efficiency 
of monoenergetic visualizations. ...................................................................................... 203 
Figure 6.14: DEQC head phantom results for monoenergetic HU stability.  Left: 
Monoenergetic HU stability trends sorted primarily by mA and secondarily by CTDIvol for 50, 
70, 110 and 140 keV monoenergetic reconstructions and displayed by scanner.  Calculated 
attenuations (using NIST values) based on vendor-provided elemental composition and true 
monoenergetic acquisition are shown in black.  Right: Monoenergetic HU stability inter- and 
intra-scanner variance trends sorted primarily by mA and secondarily by CTDIvol for 50, 70, 
110, and 140 keV monoenergetic reconstructions. ........................................................... 206 
Figure 6.15: DEQC head phantom results for monoenergetic HU stability trends sorted 
primarily by mA and secondarily by CTDIvol for 50, 70, 110 and 140 keV monoenergetic 
reconstructions. ................................................................................................................ 207 
Figure 6.16: DEQC body phantom results for noise trends sorted by CTDIvol for 50, 70, 110 
and 140 keV monoenergetic reconstructions. ................................................................... 208 
xxvi 
 
Figure 6.17: DEQC body phantom results for noise trends sorted by CTDIvol for 
Water(Iodine) and Iodine(Water) material density reconstructions. .................................. 208 
Figure 6.18: DEQC head phantom results for noise trends sorted by CTDIvol for 50, 70, 110 
and 140 keV monoenergetic reconstructions. ................................................................... 210 
Figure 6.19: DEQC head phantom results for noise trends sorted by CTDIvol for 
Water(Iodine) and Iodine(Water) material density reconstructions. .................................. 210 
Figure 7.1: Graphical representation of lesion attenuation (HU) necessary for 90% GB 
differentiation accuracy by acquisition parameters (Table 4.15).  The un-shaded region 
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the 
current clinical limit of 100 HU imposed by SECT. ........................................................... 223 
Figure 7.2: Accuracy of intracranial lesion differentiation using geometric bisector method 
with 132.6 mGy CTDIvol, 5 mm image thickness and standard filter.  Error bars represent 
one SD of the variation over the three studies collected. .................................................. 224 
Figure 8.1:  Posterior probabilities for the calcification cluster based on the GMM results of 
the 50 HU matched model pair. Red indicates a very high probability the voxel is 
calcification, while blue indicates a very low probability. ................................................... 231 
 
  
xxvii 
 
List of Tables 
 
 
Table 3.1:  Imaging parameters for the single- and dual-energy CT protocols used in the 
study.  For both protocols: Image thickness: 3.75 mm, Table Speed: 10.62 mm/rotation, 
Pitch: 0.531, Interval: 3 mm, Scan Field of View (SFOV): Head, Display Field of View 
(DFOV): 12 cm, Reconstruction Algorithm: Soft. ................................................................24 
Table 3.2:  Concentrations and weights of iron oxide and hydroxyapatite needed to create 
hemorrhage and calcification models of specific SECT attenuation (HU). ..........................30 
Table 3.3:  Average SECT attenuation (HU) of each matched pair and mean SECT 
attenuations (HU) for the hemorrhage gel model and the calcification gel model in each 
pair. ....................................................................................................................................31 
Table 4.1:  Imaging Technique for basic single-energy and matched dual-energy data 
collection. ...........................................................................................................................41 
Table 4.2:  Imaging technique for validation of lesion model inserts.  Bold line indicates 
break in protocol where insert was repositioned to allow imaging of second half of insert 
extent.  Series 2 and 4 were not repeated since their relation to series 3 was already 
evaluated in the first imaging setting. For all series: SFOV: Head, DFOV: 25 cm, Filter: 
Standard. ...........................................................................................................................43 
Table 4.3:  Imaging technique for intracranial lesion phantom scanning.  For all series and 
groups (except series 1): SFOV: Head, DFOV: 25 cm, Scan Type: Helical, Beam Width: 20 
mm. ....................................................................................................................................46 
Table 4.4:  Dual-energy reconstructions for intracranial lesion phantom protocol (detailed in 
Table 4.3).  Prospective recons are listed first and labeled with a P, followed by 
retrospective recons labeled with an R. ..............................................................................47 
xxviii 
 
Table 4.5: ROI diameters and associated number of voxels based on lesion model size and 
location. .............................................................................................................................49 
Table 4.6: Number of images and extent analyzed for both the cerebrum and skull base 
brain slabs. ........................................................................................................................51 
Table 4.7:  Total number of voxels included in analysis for both cerebrum and skull base 
brain slabs based on image thickness and lesion diameter.  Note: This total includes 
multiple image locations as defined by Table 4.6. ..............................................................52 
Table 4.8:  Results of lesion rod imaging and ROI analysis using a SECT acquisition.  
Green fields represent a matched model pair with < 1 HU difference between the 
calcification and hemorrhage model while orange represents a difference > 1 HU but < 2 
HU. Gray regions represent data that is not applicable given the skull base contained only 
1.5 cm lesion models. ........................................................................................................63 
Table 4.9:  Initial SECT attenuation (HU) matching of milled lesion model pairs (calcification 
and hemorrhage).  Green denotes matching < 2 HU, orange denotes matching < 3 HU and 
red denotes matching out of tolerance > 3 HU. ..................................................................64 
Table 4.10:  Final SECT attenuation (HU) matching of lesion model pairs (calcification and 
hemorrhage).  Green denotes matching < 2 HU, orange denotes matching < 3 HU and red 
denotes matching out of tolerance > 3 HU.  Note the improved lesion matching of the 50 
HU, 0.5 cm cerebrum and 100 HU, 1.5 cm skull base lesion pairs. ....................................65 
Table 4.11: Sorted results of Bland-Altman analysis of the correlation of attenuation (HU) 
from 68 keV and SECT acquisitions organized for subsets of the data based on available 
protocol and lesion parameters.  Parameters and values above the double line indicate 
worse correlation or linearity than the analysis of the full data set while those below the 
double line indicate improved correlation or linearity. .........................................................68 
Table 4.12: CTDIvol (mGy) necessary for 90% SVM differentiation accuracy by HU of 
matched model pair based on a second order power fit of available data from studies 1-3.  
xxix 
 
Areas in gray indicate 90% SVM differentiation accuracy was not possible at any dose level 
investigated.  Areas in green indicate 90% SVM differentiation accuracy was achieved at all 
dose levels investigated (minimum dose investigated shown).  Remaining areas in white 
indicate 90% SVM differentiation accuracy was reached within the investigated dose range 
and show the minimum CTDIvol required for this level of accuracy.  Values in red indicate a 
fit with an R2 value of less than 0.8. ....................................................................................87 
Table 4.13:  Lesion attenuation (HU) necessary for 90% SVM differentiation accuracy by 
acquisition parameters based on a second order power fit of available data from studies 1-
3.  Areas in gray indicate 90% SVM differentiation accuracy was not possible under 100 
HU.  Attenuation (HU) values in red indicate a fit with an R2 values less than 0.8. .............88 
Table 4.14:  CTDIvol (mGy) necessary for 90% GB differentiation accuracy by HU of 
matched model pair based on a second order power fit of available data from studies 1-3.  
Areas in gray indicate 90% GB differentiation accuracy was not possible at any dose level 
investigated.  Areas in green indicate 90% GB differentiation accuracy was achieved at all 
dose levels investigated (minimum dose investigated shown).  Remaining areas in white 
indicate 90% GB differentiation accuracy was reached within the investigated dose range 
and show the minimum CTDIvol required for this level of accuracy.  Values in red indicate a 
fit with an R2 value of less than 0.8. ....................................................................................98 
Table 4.15: Lesion attenuation (HU) necessary for 90% GB differentiation accuracy by 
acquisition parameters based on a second order power fit of available data from studies 1-
3.  Areas in gray indicate 90% GB differentiation accuracy was not possible under 100 HU.  
Attenuation (HU) values in red indicate a fit with an R2 values less than 0.8. .....................99 
Table 4.16:  Results of parameter-specific geometric bisector plane calculations.  Both raw 
accuracy and accuracy difference (relative to all data solution) are shown.  Plane 
coefficients follow the equation form Ax+By+Cz+D = 0, where x is water density, y is 
calcium density and z is measured attenuation (HU) at 68 keV.  Those parameters 
xxx 
 
identified as major sources of variability based on their accuracy difference are shown in 
red.  Note: Location (Skull Base) and Lesion Model (1.5 cm Skull Base) represent identical 
analysis because only 1.5 cm lesions were evaluated in the skull base. .......................... 101 
Table 4.17: Generalized geometric bisector plane results assuming prior knowledge of 
lesion location and size. Plane coefficients follow the equation form Ax+By+Cz+D = 0, 
where x is water density, y is calcium density and z is measured attenuation (HU) at 68 
keV. ................................................................................................................................. 103 
Table 4.18:  Sorted results of Bland-Altman analysis for inter-method correlation between 
SVM and GB methods for subsets of data based on available protocol and lesion 
parameters.  Parameters and values above the double line indicate worse correlation or 
linearity than the full data set while those below the double line indicate improved 
correlation or linearity.  Text in red indicates a major source of variability based on CV or R2 
cutoff criteria. ................................................................................................................... 104 
Table 4.19: Sorted results of Bland-Altman analysis of SVM inter-scanner correlation for 
subsets of data based on available protocol and lesion parameters.  Parameters and values 
above the double line indicate worse correlation or linearity than the full data set while those 
below the double line indicate improved correlation or linearity.  Text in red indicates a 
major source of variability based on CV or R2 cutoff criteria. ............................................ 107 
Table 4.20: Sorted results of Bland-Altman analysis of GB inter-scanner correlation for 
subsets of data based on available protocol and lesion parameters.  Parameters and values 
above the double line indicate worse correlation or linearity than the full data set while those 
below the double line indicate improved correlation or linearity.  Text in red indicates a 
major source of variability based on CV or R2 cutoff criteria. ............................................ 110 
Table 4.21: Sorted results of Bland-Altman analysis of SVM intra-scanner correlation for 
subsets of data based on available protocol and lesion parameters.  Parameters and values 
above the double line indicate worse correlation or linearity than the full data set while those 
xxxi 
 
below the double line indicate improved correlation or linearity.  Text in red indicates a 
major source of variability based on CV or R2 cutoff criteria. ............................................ 113 
Table 4.22: Sorted results of Bland-Altman analysis of GB intra-scanner correlation for 
subsets of data based on available protocol and lesion parameters.  Parameters and values 
above the double line indicate worse correlation or linearity than the full data set while those 
below the double line indicate improved correlation or linearity.  Text in red indicates a 
major source of variability based on CV or R2 cutoff criteria. ............................................ 116 
Table 4.23: Summary of inter-scanner (Study 1 versus Study 3) and intra-scanner (Study 1 
versus Study 2) correlations based on both SVM and GB methods.  Parameters identified 
as major sources of variability are listed along with the initial CV and R2 for the full data, as 
well as, the final CV and R2 with the sources of variability removed from analysis. .......... 121 
Table 5.1: Unknown lesion material verification and evaluation protocol.  Both series were 
acquired in helical mode, using a 20 mm beam width, 25 cm DFOV and Head SFOV.  
Images were evaluated visually to confirm the lesion models were homogeneous and free 
of defects. ........................................................................................................................ 126 
Table 5.2: Unknown lesion validation protocol.  For all acquisitions: helical, 20 mm beam 
width, 25 cm DFOV, Head SFOV. .................................................................................... 128 
Table 5.3: Summary of multivariate logistic regression model results correlating water, 
calcium, and 68 keV measurements with probability of the unknown lesion being 
calcification. Odds ratio is for each unit increase in the measurement. Odds ratio greater 
than 1 means an increased probability of being calcification. LCL and UCL refer to the lower 
and upper confidence limits, respectively. ........................................................................ 135 
Table 5.4:  Summary of logistic regression model coefficients based on analysis of Study 1 
differentiation data (Chapter 4).  These coefficients work with Equations 12-14 to calculate 
the probability of being calcification based on an unknown lesion’s mean 3D-DECT 
measurement. .................................................................................................................. 136 
xxxii 
 
Table 5.5: SECT attenuation (HU) necessary for 90% classification confidence using the 
GB method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 90% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 90% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 90% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. ........................ 142 
Table 5.6: SECT attenuation (HU) necessary for 80% classification confidence using the 
GB method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 80% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 80% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 80% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. ........................ 143 
Table 5.7: SECT attenuation (HU) necessary for 90% classification confidence using the 
GGB method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 90% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 90% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 90% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. ........................ 145 
Table 5.8: SECT attenuation (HU) necessary for 80% classification confidence using the 
GGB method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 90% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 90% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
xxxiii 
 
combinations that would be classified with 90% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. ........................ 146 
Table 5.9: SECT attenuation (HU) necessary for 90% classification confidence using the 
PD method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 90% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 90% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 90% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. ........................ 148 
Table 5.10: SECT attenuation (HU) necessary for 80% classification confidence using the 
PD method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 80% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 80% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 80% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. ........................ 149 
Table 5.11: Sorted results of GB vs PD inter-method Bland-Altman analysis for subsets of 
data based on available protocol and lesion parameters.  Parameters and values above the 
double line indicate worse correlation or linearity than the full data set while those below the 
double line indicate improved correlation or linearity.  Text in red indicates a major source of 
variability based on CV or R2 cutoff criteria. ..................................................................... 150 
Table 5.12: Sorted results of GB vs GGB inter-method Bland-Altman analysis for subsets of 
data based on available protocol and lesion parameters.  Parameters and values above the 
double line indicate worse correlation or linearity than the full data set while those below the 
double line indicate improved correlation or linearity.  Text in red indicates a major source of 
variability based on CV or R2 cutoff criteria. ...................................................................... 152 
xxxiv 
 
Table 6.1:  List of DEQC phantom insert types. ................................................................ 170 
Table 6.2:  DEQC insert validation protocol. For all series: SFOV: Head, DFOV: 25 cm, 
Filter: Standard. ............................................................................................................... 172 
Table 6.3: Reconstructions created from DEQC validation data and quantitative data 
acquired. .......................................................................................................................... 173 
Table 6.4:  List of test metrics included in DEQC program and their application to various 
image reconstruction types, as well as the composition and position of the rods used to 
evaluate the metric. .......................................................................................................... 176 
Table 6.5: Head Phantom DEQC Protocol Version 1. All acquisitions used helical 
acquisition mode, beam width of 20 mm, Head SFOV, DFOV of 25 cm, and Standard 
reconstruction algorithm. A total of 5 images were acquired per group. ............................ 177 
Table 6.6:  Body Phantom DEQC Protocol Version 1. All acquisitions used helical 
acquisition mode, beam width of 40 mm, Large Body SFOV, 42 cm DFOV, and Standard 
reconstruction algorithm.  A total of 5 images were acquired per group. ........................... 178 
Table 6.7:  Dual-energy reconstructions applied to all dual-energy acquisitions in both the 
version 1 DEQC Body and Head protocols. The number of images reconstructed was 
based on the minimum setting for each reconstruction type: five for monoenergetic and one 
for material density. .......................................................................................................... 179 
Table 6.8:  DEQC Head Phantom Protocol Version 2. All acquisitions used helical scan 
mode, 20 mm beam width, Head SFOV, 25 cm DFOV, and Standard reconstruction 
algorithm. ......................................................................................................................... 180 
Table 6.9: DEQC Body Phantom Protocol Version 2. All acquisitions used helical scan 
mode, 40 mm beam width, Large Body SFOV, 42 cm DFOV, and Standard reconstruction 
algorithm. ......................................................................................................................... 180 
Table 6.10: Dual-energy reconstructions applied to all dual-energy acquisitions in both the 
version 2 DEQC body and head protocols. The number of images reconstructed was based 
xxxv 
 
on the minimum setting for each reconstruction type: five for monoenergetic and one for 
material density. ............................................................................................................... 181 
Table 6.11: Results of DEQC protocol 1 for the DEQC Body phantom showing which 
factors were found to influence the test metrics investigated.  Marked cells indicate that the 
acquisition parameter was found to have an effect on the test metric.  Empty cells indicate 
no effect was identified. .................................................................................................... 185 
Table 6.12:  Results of DEQC protocol 1 for the DEQC head phantom showing which 
factors were found to influence the test metrics investigated.  Marked cells indicate that the 
acquisition parameter was found to have an effect on the test metric.  Empty cells indicate 
no effect was identified. .................................................................................................... 185 
Table 6.13:DEQC body phantom results for the effect of mAs on iodine accuracy based on 
linear mixed model analysis. ............................................................................................ 188 
Table 6.14: DEQC head phantom results for the effect of mAs on iodine accuracy based on 
linear mixed model analysis. ............................................................................................ 190 
Table 6.15: DEQC body phantom results for the effect of rotation time on uniformity based 
on linear mixed model analysis. ....................................................................................... 194 
Table 6.16:  DEQC head phantom results for the effect of mAs on Uniformity based on 
linear mixed model analysis. ............................................................................................ 199 
Table 6.17: DEQC body phantom results for the effect of mAs on monoenergetic HU 
stability based on linear mixed model analysis. ................................................................ 202 
Table 6.18: DEQC head phantom results for the effect of mA on monoenergetic HU stability 
based on linear mixed model analysis. ............................................................................. 206 
Table 6.19:  DEQC body phantom results for the effect of CTDIvol on noise based on linear 
mixed model analysis. ...................................................................................................... 209 
Table 6.20: DEQC head phantom results for the effect of CTDIvol on noise based on linear 
mixed model analysis. ...................................................................................................... 211 
xxxvi 
 
Table 6.21: Final recommendations for the clinically implementable dual-energy quality 
control protocol.  All acquisitions performed in helical mode, using a 40 mm beam width, 
Large Body SFOV, 42 cm DFOV and standard reconstruction filter. ................................ 212 
 
  
xxxvii 
 
List of Equations 
 
Equation 1    ???? ? ???????? ? ???????  ...........................................................13 
Equation 2  ????? ?????????? ?????????  ..........................................................13 
Equation 3  ????? ?????????? ?????????  ............................................................13 
Equation 4  ??? ??? ? ?
??????? ? ???????
???? ? ????   ...........................................................14 
Equation 5  ????? ? ?
??????? ? ???????
???? ? ????   .............................................................14 
Equation 6  ?????? ??? ? ?????? ??? ? ????????  ........................................................14 
Equation 7 ?????? ??? ? ?? ??
??????? ? ???????
???? ? ???? ? ? ?? ?
??????? ? ???????
???? ? ???? ?  .........14 
Equation 8 ?????? ??? ? ? ?
??? ? ???
???? ? ?????????? ???
??? ? ???
???? ? ????? ?????  ...14 
Equation 9  ?????? ??? ? ???????? ??????????????? ?????
?? ? ? ?
??? ? ????
???? ??????? ??????????? ? ? ?
??? ? ????
???? ??????? 
 .........................15 
Equation 10 ?????? ??????? ? ???????????? ?????????????  ......................................15 
Equation 11 ?????? ????? ? ? ?????????? ? ??????????? ?  ...........................................15 
Equation 12 ???????????????????????????????????? ??
??? ??????????????????? ????????????????????????????????? ?? 
 . 131 
xxxviii 
 
Equation 13  ?????????????????????????? ?? ? ?
???
?? ? ???? ?  .............................................. 131 
Equation 14 ??????????????????????? ? ? ? ??????????????????????????  ................. 131 
Equation 15  ???? ? ? ??
?
???
???? ? ???  .................................................................. 229 
Equation 16 ? ? ???????????????????? ? ????????????????????????????????  ..... 230 
 
  
xxxix 
 
List of Abbreviations 
 
3D   Three Dimensional 
AW   Advantage Workstation 
CNR  Contrast-To-Noise Ratio 
CT   Computed Tomography 
CTDIvol  Computed Tomography Dose Index Volumetric 
CV   Coefficient of Variation 
DECT  Dual-Energy CT 
DEQC  Dual-Energy Quality Control 
DFOV  Display Field of View 
DICOM  Digital Imaging and Communications in Medicine 
EM   Expectation Maximization 
GB   Geometric Bisector 
GE   General Electric 
GGB  Generalized Geometric Bisector 
GMM  Gaussian Mixture Model 
GRE  Gradient Echo 
GSI   Gemstone Spectral Imaging 
HDPE  High Density Polyethylene 
HU   Hounsfield Unit 
keV   Kilo-Electron Volt 
kVp   Kilo-Voltage Peak 
LCL   Lower Confidence Limit 
mA   Milliamperes 
xl 
 
mAs  Milliampere-Second 
MR   Magnetic Resonance 
NPS  Noise Power Spectrum 
PD   Probability Distribution 
PVC  Polyvinyl Chloride 
QC   Quality Control 
QSM  Quantitative Susceptibility Mapping 
R2   Squared Pearson R-Value 
ROI   Region of Interest 
SD   Standard Deviation 
SECT  Single-Energy CT 
SFOV  Scan Field of View 
SGGB  Super Generalized Geometric Bisector 
SVM  Support Vector Machine 
SWI  Susceptibility Weighted Imaging 
UCL  Upper Confidence Limit 
VMS  Virtual Monoenergetic Spectral
1 
 
Chapter 1 
1 Introduction 
 
Calcific and hemorrhagic foci of susceptibility are frequently encountered in routine 
brain Magnetic Resonance (MR) studies.  Both etiologies cause variations in magnetic field 
strength leading to dark regions on the MR images that cannot be classified (1).  Single-
energy computed tomography (SECT) can be used to identify lesions with attenuation over 
100 Hounsfield Units (HU) as calcific (2), however lesions with lower attenuation cannot be 
reliably identified.  While calcific lesions are unlikely to cause harm (3), hemorrhagic lesions 
carry a risk of subsequent intracranial bleeding (4,5); as such, identification of hemorrhage 
is vital in preventing the inappropriate use of anticoagulant medications in patients with 
hemorrhagic lesions.  The relatively high incidence of deep vein thrombosis and pulmonary 
embolism in cancer patients (6–10) has led many practitioners to treat prophylactically for 
these conditions.  The proper differentiation of calcification and hemorrhage will allow 
physicians to guide therapy for patients with hemorrhagic lesions away from therapy or 
prophylaxis that might cause them harm (11,12). Given that there currently exists no 
clinically available means of differentiating between these two lesion types over their full 
biological attenuation ranges, there is a clear need for a reliable imaging method to 
differentiate low intensity calcification and hemorrhage.  A novel computed tomography 
(CT) modality has been developed which collects temporally and anatomically registered 
CT scans at two different tube voltages.  By collecting data at two different energies, dual-
energy CT (DECT) identifies energy-dependent attenuation changes which can be used to 
gain information about the material characteristics within a specific voxel.  The rationale 
behind this research is that the difference in the energy-dependent attenuation 
characteristics of calcium, found in calcification, and iron, found in hemorrhage should 
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result in unique signatures using DECT, permitting the differentiation of the two lesion 
types. 
 
1.1 Objectives and Hypothesis 
Therefore, the objective of this project is to model intracranial calcification and 
hemorrhage over a wide range of biological conditions and image using DECT in order to 
determine if material characteristic information derived from DECT images can be used to 
differentiate between calcification and hemorrhage.  The central hypothesis is that DECT 
can be used to differentiate between intracranial calcium associated with 
calcification and iron associated with hemorrhage below the attenuation level 
possible using traditional SECT.   
 
1.2 Specific Aims 
To test this central hypothesis, four specific aims were constructed: 
Specific Aim 1: Determine the SECT attenuation (HU) level at which hemorrhage and 
calcification models can be differentiated on DECT images to within 90% accuracy using an 
agar gel-based phantom. 
Specific Aim 2:  
A:  Design and create a biologically relevant phantom that more realistically replicates 
the attenuation characteristics of the human brain, and includes various intracranial 
lesion sizes and locations. 
B:  Determine the DECT technique that provides optimal differentiation of calcification 
and hemorrhage models based on the lesion pair’s size and location within the 
biologically relevant phantom (Specific Aim 2A). 
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Specific Aim 3: Assess the ability of DECT to classify unknown intracranial lesions with 
SECT attenuation levels under 100 HU as either calcific or hemorrhagic using the 
biologically relevant phantom model described in Specific Aim 2. 
Specific Aim 4: Develop a dual-energy CT quality control phantom and program to provide 
inter- and intra-scanner quality assurance data for long term clinical DECT applications. 
To achieve these specific aims, models of calcification and hemorrhage will be 
designed and fabricated.  The models will be imaged in anthropomorphic phantoms using 
both single-energy and dual-energy techniques.  Calcification and hemorrhage models will 
be organized into pairs consisting of a calcification model and a hemorrhage model that 
display equivalent single-energy attenuation.  The material characteristic information for all 
matched attenuation pairs will be derived from the dual-energy images.  The accuracy of 
the differentiation between calcification and hemorrhage model will be calculated for each 
matched model pair and the SECT attenuation (HU) level at which the accuracy exceeds 
90% will be determined.  In specific aim 2, the models of calcification and hemorrhage will 
be improved to better mimic the typical biology as well as to simulate a range of lesion 
sizes, intracranial locations and imaging parameters.  The resulting material characteristic 
information from the dual-energy images will be compared to the results in specific aim 1 
and used to determine the imaging technique, patient population constraints and analysis 
methods for a prospective human trial.  These conclusions will be verified using unknown 
lesion models of varying attenuation, size and intracranial location in the biologically 
relevant phantom system designed in Specific Aim 2.  Given that this work will span several 
years, verification that the results are intercomparable is necessary.  Unfortunately, since 
DECT is a novel and emerging modality, a true quality control standard has yet to be 
determined. Specific Aim 4 will strive to develop a quality control phantom and program 
designed specifically to verify the dual-energy capabilities of the scanners used in this 
study.  Through the completion of Specific Aims 1-4 we propose to develop a clinically 
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feasible method for the differentiation, and hopefully correct classification, of intracranial 
hemorrhage and calcification. 
 
1.3 Dissertation Organization 
The remaining chapters of this dissertation are organized as follows:  Chapter 2 
introduces background concepts specific to DECT as well as competing modalities.  
Chapter 3 addresses Specific Aim 1 and presents the results of a simple agar-gel based 
phantom for the differentiation of calcification and hemorrhage.  Chapter 4 addresses 
Specific Aim 2 and covers the development of the biologically relevant phantom model and 
the determination of optimal DECT techniques based on lesion size and location within the 
phantom.  Chapter 5 addresses Specific Aim 3 and includes preliminary results on unknown 
lesion characterization.  Chapter 6 addresses Specific Aim 4 and covers the design and 
development of the DECT quality control phantom and protocol as well as preliminary 
results and clinical insights.  Finally, Chapter 7 summarizes the dissertation and comments 
on future work. 
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Chapter 2 
2 Background 
 
Intracranial hemorrhagic and calcific lesions are associated with very different 
outcomes and may require different management strategies. Intracranial calcifications are 
relatively common but in general are benign and have little clinical importance (3).  They 
can be caused by a number of conditions and treatments including radiation therapy and 
chemotherapy (13) and are typically found in the pineal gland, choroid plexus, habenula, 
and blood vessels. Their size and structure can range from small and punctuate to large 
and more laminar (2) and typically consist of a combination of calcium phosphorus, silicon, 
potassium, magnesium and zinc (14). 
 Intracranial hemorrhagic lesions due to cavernomata, however, carry a risk of 
subsequent intracranial bleeding, with rehemorrhage rates as high as 4-10% per lesion per 
year (4,5). The lesions range in size from 1 mm up to several centimeters (4) and can be 
found throughout the nervous system, but are most commonly found in the cerebrum (15).  
They present in approximately 0.1 to 0.5% of the population and comprise roughly 5-13% of 
all vascular lesions (4).   
Due to the risk of brain hemorrhage, the use of anticoagulants in patients with 
intracranial cavernomata or hemorrhagic lesions is contraindicated (11,12). However, 
driven by the high incidence of deep vein thrombosis and pulmonary embolism in cancer 
patients (6–10) and other high risk populations, many practitioners are prescribing 
prophylactic anticoagulants (16).  Cohen et al. investigated the risk for venous 
thromboembolism (VTE) and the application of anticoagulant prophylaxis based on all 
hospital impatients over the age of 40 admitted to the medical ward, or over the age of 18 
admitted to the surgical ward over 358 hospitals spanning 32 countries (17).  They found 
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that of the 68,183 patients admitted, 64% of surgical patients and 42% of medical patients 
were at risk of VTE.  Of the at risk population, 59% of at risk surgical patients and 40% of at 
risk medical patients were administered anticoagulants.  Zwicker et al. investigated cancer 
patients specifically and found that of the 775 patients at risk of VTE, 68% had no 
contraindication for prophylaxis and of those a full 75% were administered anticoagulants 
(18). Beyond inpatients, a recent study has shown that approximately 5% of people 
between the ages of 65 and 74, and 10% of people over the age of 75 have been 
prescribed prophylactic anticoagulants (19).  Based on these facts it is evident that accurate 
differentiation of intracranial calcification and hemorrhage would benefit a large patient 
population by allowing physicians to steer patients with hemorrhagic lesions away from 
common anticoagulant prophylaxis that might harm them. 
Accurate differentiation of intracranial calcification and hemorrhage would allow 
physicians to steer patients with hemorrhagic lesions away from anticoagulation that might 
harm them.  
Currently there exists no clinically available means of differentiating calcification and 
hemorrhage over their full biological ranges.  Traditional SECT is considered the gold 
standard modality for the identification of calcification. Generally, any lesion with SECT 
attenuation levels >100 HU is classified as a calcification (2). However, lesions with SECT 
attenuation levels <100 HU present a clinical problem, since hemorrhage and calcifications 
overlap in this attenuation range, making classification difficult.   
Magnetic Resonance (MR) has long been the gold standard for hemorrhage 
detection where the characteristic appearance is a ring of hypo-intensity due to 
susceptibility artifacts caused by the iron-rich hemosiderin deposits in the lesion (15). 
However, calcifications also induce this susceptibility artifact which leads to a similar hypo-
intense region within the image.  
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Susceptibility artifacts occur due to variations in magnetic field strength which are 
caused by paramagnetic materials, diamagnetic materials or interfaces between regions of 
very different magnetic susceptibility.  These intra-voxel variations in the magnetic field 
strength result in variations in the protons’ precession frequency and thus phase shifts.  
Secondly, intra-voxel variations create spin incoherence resulting in a hypo-intense or 
signal void region on the image (20,21).  Since foci of susceptibility can be caused by either 
calcification or hemorrhage, conventional MR is of little help in differentiating these two 
lesion types. 
Given that at this time there are no clinically available means of differentiating 
between these two lesions over their full biological attenuation ranges, there is a clear need 
for a reliable imaging method to differentiate low intensity calcification and hemorrhage.  
Recently, several vendors have released new CT scanner models with dual-energy 
capabilities, which may be successfully applied to this issue.  By collecting data at two 
different energies, DECT provides information about energy-dependent changes in linear 
attenuation which can be used to derive information about the material characteristics 
within a specific voxel.  This information may help distinguish between two materials with 
similar linear attenuation measurements which would be impossible to differentiate using 
SECT (22).   
Although the technique of dual-energy Computed Tomography (DECT) has been 
known since the 1970s (23–25), the application of the technique has been hampered by a 
range of issues including high image noise, motion misregistration and long acquisition 
times resulting in excessive patient dose (26).  Only recently have advances in scanner 
hardware helped overcome these issues and allowed DECT to enter the realm of clinical 
applications.  With the release of the first clinical DECT scanner by Siemens (SOMATOM 
Flash) in 2005 (27), and the subsequent release of the General Electric (GE) Discovery 
750HD and Siemens SOMATOM Definition Flash in 2008 (28,29), dual-energy CT (or 
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spectral CT) research and applications have grown at an increasing rate (Figure 2.1).  
Given the recent release of the Siemens SOMATOM Force, as well as the scheduled 
release of the dual-energy package on the GE Revolution CT within the next year, it can be 
expected that this trend will continue as new hardware and software advance the 
capabilities of material decomposition.  The Siemens SOMATOM Force x-ray tube is 
capable a generating peak kilovoltage (kVp) beams from 70kVp to 150kVp and has higher 
milliampere (mA) limits, both hopefully leading to better characterized material 
decomposition (30–32).  The GE Revolution CT, once equipped with dual-energy software, 
will provide a much larger beam width of 16 cm (33), opening up a wealth of applications in 
cardiac imaging and perfusion measurements.  These advances in dual-energy data 
collection are sure to lead to further research into the expanding clinical applications of 
dual-energy CT. 
 
Figure 2.1: Increase in DECT publications from January 1, 2000 to December 31, 2014 based 
on occurrence of “Dual-Energy CT” or “Spectral CT” using the Web of Science database tool 
(34).   
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2.1 Basics of DECT 
In traditional single-energy CT (SECT), the x-ray absorption through the patient is 
expressed as an attenuation value normalized to the linear attenuation of water.  The 
resulting CT numbers, measured in Hounsfield units (HU), are displayed in shades of gray 
on the CT image.  While intuitive to view, these Hounsfield units do not accurately represent 
material composition within the voxel.  First, linear attenuation is dependent on the effective 
energy of the X-ray beam.  Since the effective energy of the beam varies with location due 
to X-ray beam hardening and scatter, the same material could have different CT numbers 
at two different locations within the scan field of view.  Second, two very different materials 
could have the same CT number by having the same linear attenuation coefficient even 
though they possess very different elemental composition, mass attenuation coefficient and 
density. 
Dual-energy CT is based on the premise that by measuring the attenuation of a 
voxel at two different energies, energy-dependent attenuation characteristics can be 
derived allowing for material-specific information to be deduced.  This information would 
then help distinguish between two materials with similar linear attenuation measurements 
which would be impossible to differentiate using single energy CT (22,35,36).  The energy-
dependent changes in attenuation are relatively specific for every material.  Materials with 
high atomic number, such as iodine, display much larger changes in attenuation over 
diagnostic CT energies than low atomic number materials, such as water, due to the higher 
relative dominance of the photoelectric effect.  By obtaining attenuation information at two 
different energies, material specific information can be deduced and images can be created 
that highlight the distribution of selected materials within the body.  Useful dual-energy 
attenuation data relies on an adequate separation between the high and low energy, 
accurate temporal registration and accurate spatial registration (22). 
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2.2 DECT Implementations 
Three vendors have developed dual-energy CT systems which use different 
methods for obtaining dual-energy attenuation data.  Siemens has implemented a dual-
source dual-energy CT design (SOMATOM FLASH®, Siemens AG, Forchheim, Germany) 
that employs two X-ray tubes mounted 90 to 95 degrees apart, operating at two different 
tube potentials (27,35).  Generally, 80 and 140 peak kilovoltage (kVp) are used; however, 
100 and 140 kVp may be employed for larger patients to help with X-ray penetration (35).  
The two separate tubes allow for the tube current associated with each energy in dual-
energy mode to be modified based on the patient size and anatomy to be imaged.  It also 
allows for an additional filter to be inserted to constrain the energy spread of the X-ray 
spectra and achieve better spectral separation between the two energies (37).  While using 
two tubes can improve the spectral separation, it can also lead to registration issues as the 
data is collected at slightly different times.  Siemens has resolved this issue by minimizing 
the temporal related offset by using two sets of 64-row detectors in conjunction with a 
moving focal spot which can collect 128 isotropic 0.6-mm slices in 0.4ms (38).  The use of 
two tubes can also lead to cross scatter from tube A into the detector associated with tube 
B.  The effect of the cross scatter is reduced through the use measurement based scatter 
correction using scatter sensors positioned close to the detectors but outside the fan beam 
penumbra (39).  Additionally, in order to fit two x-ray tubes and two sets of detectors in the 
scanner, one of the detectors had to be reduced in size.  Due to this, the dual-energy 
capabilities of the system are currently limited to a 33 cm field of view (26). 
General Electric has designed a fast kilovoltage switching dual-energy CT scanner 
(Discovery CT 750HD, GE Healthcare, Milwaukee, USA) that uses a single X-ray tube that 
quickly switches between 80 and 140 kVp every 0.5ms as it rotates around the patient (40).  
To capture the alternating high and low energy projections individually, the scanner is 
equipped with a garnet crystal scintillator detector.  The detector has a 100 times faster 
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response time than the typical gadolinium oxysulfide scintillator detector and four times less 
afterglow.  The data acquisition system is also enhanced with fast sampling capabilities 
which enables 2.5 times the data sampling possible in a conventional 64-channel CT 
scanner (40–42). 
Unlike the Siemens system where the current for each X-ray tube can be adjusted, 
the single tube on the GE system is forced to maintain a constant tube current since it is not 
possible to alternate the mA as rapidly as the tube voltage (37).  The exposure time ratio is 
adjusted to 60% at 80 kVp and 40% at 140kVp to help account for the higher tube output at 
the higher energy (43).  A number of preset protocols are available on the scanner with 
varying bowtie filters, beam widths, rotation times and dose levels depending on the 
anatomy to be imaged and the patient size.  By utilizing a single fast switching X-ray tube, 
both axial and helical scanning are possible, and dual-energy analysis is available over the 
full 50 cm field of view.  The close timing of the alternating high- and low-kVp projections 
provides excellent temporal resolution (40,41). 
Similar to the GE fast-kilovoltage switching system, Toshiba offers a single-source 
dual-energy scanner based on kV switching (Aquilion ONE; Toshiba Medical Systems, 
Otawara, Japan).  The system contains 320 detector rows covering 160 mm in the z-
direction allowing volumetric data collection (44,45).  The system switches from 80 to 
135kV between rotations rather than between projections like the GE variant (44,45).  This 
rotation-based kV switching allows for different tube currents to be used for the high and 
low kV rotations, as well as the application of tube current modulation (46).  It also allows 
for perfect spatial matching between the initial high-kV tube rotation and the subsequent 
low-kV tube rotation.  However, the time difference between the high and low kV data 
collection results in spatial misregistration of the two data sets which may adversely affect 
the dual-energy processing (45).  The extent of spatial misregistration will depend on 
patient motion, the rotation time, and the time interval between the high and low kV data 
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collection (44,45).  This interval subsequently depends on the difference in the tube 
currents in the two rotations and can vary from 180 to 800 milliseconds (45). 
The last vendor to develop a dual-energy CT system, Phillips, has designed a 
scanner (Brilliance CT, Phillips Healthcare) that uses a single X-ray tube and a modified 
detector with two scintillation layers.  The top layer of the detector captures low energy 
data, while the bottom layer captures high energy data.  The low and high energy data are 
then reconstructed to allow for dual-energy analysis.  While anticipated for multiple years, 
the scanner was just officially released at the Radiologic Society of North America 2015 
conference in Chicago.  At the time of this publication however, no publications can be 
found based on clinical use of this system. 
 
2.3 Dual-Energy Image Reconstruction 
Given the prevalence of the Siemens and GE scanners over the Toshiba and 
Phillips variants, discussion of image reconstruction processes will be limited to the two 
major vendors, Siemens and GE.  
Processing of the dual-energy data from the Siemens SOMATOM FLASH® system 
is performed in the imaging domain after the independent reconstruction of the high and low 
energy images.  Three data sets are automatically produced: a pure 140 kVp image, a pure 
80 kVp image and a “blended” set combining partial contributions of the 140 and 80 kVp 
images.  The percent contribution of the two energies can be customized for the desired 
application.  The combination can be linear, where the intensity of each pixel is weighed 
equally, or non-linear sigmoidal, where the intensity of each pixel is weighed by its CT 
number.  Non-linear sigmoidal blending is particularly useful for iodine signal enhancement 
(35,47).  Material specific information is generated using a “three-material decomposition 
algorithm” which is based on the fixed attenuation values of two fixed materials, soft tissue 
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and fat, at both the high and low energy as well as a third varied material (35,36).  This third 
material, usually iodine, can be selectively mapped or removed from the images (37). 
Unlike Siemens systems, the GE Discovery CT 750HD system processes dual-
energy data in the projection domain before the images are reconstructed.  This allows for 
greater flexibility in material decomposition as well as the reduction of beam hardening 
artifacts (48–51).  Reducing beam hardening can provide images with improved CT 
attenuation linearity, lower image noise and improved contrast-to-noise ratio (CNR) 
compared to their single-energy counterparts (35,52).  Because the processing of the dual-
energy data takes time to complete, the 140 kVp projections are reconstructed and 
immediately displayed to allow for a quick anatomic coverage check.  These images should 
not be used for analysis, however, since they are not fully corrected for scanner calibration 
(52). 
Material specific information is generated using a “basis material decomposition 
algorithm” which proposes that the attenuation coefficients of a material can be 
characterized as a weighted sum of the attenuation coefficients of two basis materials 
(35,36).  This idea is based on the concept that any material can be characterized as the 
linear combination of its photoelectric and Compton scatter properties (Equation 1) (22,51) 
.   
Equation 1    ???? ? ???????? ? ???????     
 
Equation 2  ????? ?????????? ?????????      
Equation 3  ????? ?????????? ?????????     
   
Applying the concept described in Equation 1 to two materials (Equation 2, Equation 
3), one can derive equations that express the photoelectric and Compton components of 
attenuation in terms of the two basis materials (Equation 4, Equation 5).   
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Equation 4  ??? ??? ? ?
??????? ? ???????
???? ? ????    
 
Equation 5  ????? ? ?
??????? ? ???????
???? ? ????     
 
The algorithm then selects a target voxel of unknown composition.  This voxel can 
also be expressed as a linear combination of photoelectric and Compton scatter properties 
(Equation 6).   
 
Equation 6  ?????? ??? ? ?????? ??? ? ????????   
 
Equations 4 and 5, which express photoelectric and Compton scatter properties in 
terms of the two basis materials, can then be substituted into Equation 6 resulting in 
Equation 7.   
 
Equation 7 ?????? ??? ? ?? ??
??????? ? ???????
???? ? ???? ? ? ?? ?
??????? ? ???????
???? ? ???? ?               
 
 
This equation can be further rearranged (Equation 8) and simplified into an 
expression that characterizes the attenuation of the target voxel in terms of the weighted 
sum of the attenuation coefficients of the two basis materials (Equation 9).   
 
Equation 8 ?????? ??? ? ? ?
??? ? ???
???? ? ?????????? ???
??? ? ???
???? ? ????? ?????  
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Equation 9  ?????? ??? ? ???????? ??????????????? ?????
?? ? ? ?
??? ? ????
???? ??????? ??????????? ? ? ?
??? ? ????
???? ??????? 
         
  
 
Since the attenuation coefficients of the two basis materials would be known, the 
equation contains two unknown factors: the weighting factor of basis material 1 and the 
weighting factor of basis material 2.  By collecting attenuation data on the target voxel at 
two separate energies, two equations can be written (Equation 10, Equation 11).  This 
system of equations can then be solved for the factors for the two material basis pairs 
(22,51).  These factors, expressed in material density, are then displayed in shades of gray 
to produce two material density images of the object. 
 
 
Equation 10 ?????? ??????? ? ???????????? ?????????????   
Equation 11 ?????? ????? ? ? ?????????? ? ??????????? ?                   
 
The two materials used as the basis material pair can be selected by the user.  A 
range of materials are included in the GE Discovery CT 750HD software package; however, 
additional materials may be added to the software database by the user using published 
attenuation coefficients.  Care should be taken in the selection of the basis material pair, as 
the two materials must have sufficiently different atomic numbers and thus sufficiently 
different attenuation properties (22,51).  Water and Iodine are currently the most common 
pair in use. The atomic numbers of the materials adequately frame the range of atomic 
numbers of materials commonly found in medical imaging thus allowing for optimal 
separation of tissues, bone and iodinated contrast (53).  Measurements of iodine density 
from the material density image can also be used to detect iodinated contrast enhancement 
(54).  Iodine material density images have proven to be semi-quantitative and thus may be 
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used to measure relative iodine concentrations in the body (53,55).  The water material 
density image produced from a water/Iodine material decomposition of a contrast scan has 
its own unique use as a virtual non-contrast image.  This approach reduces patient dose by 
eliminating the need for a true non-contrast image and can improve image quality of the 
non-contrast image due to the inherent reductions in beam hardening from a dual-energy 
scan (56–59).   
In addition to the material density images, the GE system also supports a virtual 
monoenergetic spectral (VMS) image output.  The VMS images depict an object as if it 
were imaged not by a polychromatic kVp beam but by a single monoenergetic kilo-electron 
volt (keV) beam (50,60).  VMS images are derived from the material density images by 
applying the known energy-specific attenuation of each basis material to the image, 
converting the material density values into attenuation values.  The resulting attenuation 
images, one for each basis material, are then summed to create the final VMS image. 
Using this method, VMS images can be created at any specific energy level 
between 40 and 140 keV (61).  Low-energy VMS images have been shown to provide 
excellent contrast for iodinated structures due to higher attenuation closer to Iodine’s k-
edge, allowing for a 50% reduction in the required amount of iodinated contrast delivered to 
the patient (54,62).  Several studies have also shown that VMS images in the range of 65-
70 keV have less noise, decreased beam hardening artifact and higher contrast-to-noise 
ratio (CNR) than traditional 120 kVp single-energy CT images acquired using the same 
dose (41,48,63)(41),(48) (63).  In fact, both the “blended” images produced by Siemens 
systems and the VMS images produced by GE have been shown to “provide equivalent 
structural information” as compared to single-energy scans using the same dose over a 
wide range of patient sizes (41,64).   
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2.4 Tissue Differentiation using Dual-Energy CT 
Although no other studies to our knowledge have explored the potential of applying 
dual-energy CT to differentiate calcific and hemorrhagic lesions, the differentiating power of 
dual-energy CT has been shown in many previously published studies. Dual-energy CT has 
been used to distinguish between non-enhancing and enhancing renal lesions (54) as well 
as benign and malignant tumors in the liver, thyroid and adrenal glands (53,55,65).  It has 
also been shown useful in the detection and characterization of endoleaks, pulmonary 
embolism, liver metastases, urinary stones, myocardial ischemia and renal corticomedullary 
sodium gradients(57,58,63,66–71).  In two studies using Siemens dual-source dual-energy 
CT scanners and a three-material decomposition algorithm, hemorrhage was distinguished 
from iodinated contrast on the basis of the pattern of hyper-attenuation on the virtual 
unenhanced image relative to the iodine overlay image (72,73).  
 
2.5 MR for the Differentiation of Calcification and Hemorrhage 
Data derived from the phase component of magnetic resonance imaging has been 
investigated in the differentiation of intracranial calcification from hemorrhage for several 
years.    Corrected gradient echo (GRE) phase imaging (20,74,75), susceptibility-weighted 
imaging (SWI) (21,76,77), and quantitative susceptibility mapping (QSM) (78–81), have 
each been proposed, however none has found wide clinical acceptance at this point in time.  
GRE-based approaches are prone to errors due to either low T2* decay signal or low 
proton density, noise, lesion orientation, the influence of non-local susceptibility effects and 
differences in vendor phase sign conventions  (74,75,82–87).  However, techniques such 
as SWI have been found to improve calcification and hemorrhage detection and 
characterization compared to these earlier techniques (88–90).  Although these phase 
based methods have provided positive results in the differentiation of these two lesion 
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types, SECT was employed as the criterion standard for calcification detection.  As such, 
the usefulness of these methods can only be applied to intracranial hemorrhage and 
calcification above 100 HU.  Preliminary work by Berberat, et al suggests that calcification 
and hemorrhage in glioma could be differentiable under 100 HU using SWI (77), however 
further work is needed to confirm these results for low density lesions.  While these 
methods for the differentiation of calcification and hemorrhage are of note, the transition of 
phase dependent MR techniques from research to clinical use has traditionally proved 
difficult due the sensitivity of these techniques to commonly encountered magnetic field 
inhomogeneities (83,91). 
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Chapter 3 
3 Lesion Differentiation using an Agar-Gel Based Phantom 
 
This chapter investigates the differentiation of calcium, present in calcification, and 
iron, present in hemorrhage, using dual-energy CT.  A simplified physics approach based 
on agar get models was developed.  SECT attenuation (HU) matched model pairs, 
consisting of a hemorrhage and a calcification model, were evaluated using an 
anthropomorphic phantom and the SECT attenuation (HU) necessary for 90% 
differentiation accuracy were determined.  
 
This chapter is taken from: 
JL Nute, LG Le Roux, AG Chandler, V Baladandayuthapani, D Schellingerhout, DD Cody.  
Differentiation of low-attenuation intracranial hemorrhage and calcification using dual-
energy computed tomography in a phantom system. Invest Radiol. 2015; 50(1): 9-16.  doi: 
10.1097/RLI.0000000000000089 
Written permission has been obtained from the journal for use of these materials in 
this dissertation.  Wolters Kluwer Health Lippincott Williams & Wilkins © No modifications 
will be permitted. 
 
3.1 Introduction 
The ability to characterize cerebral lesions in terms of material composition, 
especially at low Hounsfield values, has many important clinical applications, such as the 
distinction of hemorrhagic from calcific lesions.  There is overlap in the Hounsfield densities 
of blood and calcium on conventional CT, particularly below 100 Hounsfield Units (HU).  
This difference is clinically important, for example in differentiating benign cerebral 
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calcifications, which require no treatment (3), from cavernous angiomata which carry a risk 
of bleeding and are a contra-indication for anticoagulant therapy (4,5).  Oligodendrogliomas 
are commonly calcified, and need to be distinguished from glioblastomas, which commonly 
contain intratumoral hemorrhages.  The treatment strategies for these tumors are 
completely different, and would be better informed if calcification and hemorrhage could be 
reliably separated.   
Currently, conventional single-energy computed tomography (SECT) is considered 
the gold standard modality for the identification of calcification. In general, any lesion with 
SECT attenuation levels >100 HU is classified as a calcification (2). However, this gold 
standard fails for lesions with SECT attenuation levels <100 HU, where blood and 
calcifications overlap in attenuation.   
In clinical practice, MR is often used as a characterizing modality to add to the 
information derived from CT.  However, conventional MR is of little help in distinguishing 
hemorrhagic from calcific lesions.  Both types of lesion manifest as signal voids on Gradient 
Echo images, with little characterizing information available without the use of specialized 
experimental phase contrast MR techniques (1).  There is a significant clinical need for an 
imaging technology to distinguish hemorrhage from calcification at low Hounsfield values, 
and dual-energy CT is a strong candidate to fill this gap in our imaging armamentarium. 
Dual-energy CT is based on the knowledge that the relationship between 
attenuation and x-ray energy is material dependent.  By collecting attenuation information at 
two distinct energies, assumptions can be made about the shape of the energy-dependent 
attenuation curve for a given tissue, and thus about its material characteristics. This 
represents a significant advance from SECT, where only a single attenuation value is 
derived, with no further information available on the material characteristics of the 
tissue(35,36,51). 
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Dual-energy CT has already been used with success in distinguishing blood from 
iodinated contrast staining in patients after intra-arterial stroke therapies (72,73,92), in 
distinguishing iodine enhancement from calcification in artificial pulmonary nodules (93), 
and in distinguishing complimentary contrast media (iodine and tungsten, or iodine and 
bismuth subsalicylate) (94). All are clinically significant problems where the attenuations of 
the two main differential diagnostic possibilities have significant overlap on conventional 
SECT.  Dual-energy CT’s success has also been shown in the characterization of renal 
calculi (26,95,96), distinguishing non-enhancing and enhancing renal lesions(54), 
distinguishing benign and malignant tumors in the liver (53), thyroid (53) and adrenal glands 
(55,97,98).  It has also been shown useful in the detection and characterization of 
endoleaks, pulmonary embolism, liver metastases, urinary stones, myocardial ischemia and 
renal corticomedullary sodium gradients (57,58,63,66–69,71).     
In this study, we apply dual-energy CT to the more subtle problem of distinguishing 
calcification and hemorrhage.  We provide a phantom-based proof-of-concept that the 
differentiation of these two intracranial lesion types below 100 HU is both possible and 
clinically feasible using dual-energy CT.  
 
3.2 Materials and Methods 
3.2.1 Calcification and Hemorrhage Phantom Models 
Powdered ferric oxide (#529311; Sigma-Aldrich, St. Louis, MO) and hydroxyapatite 
(#289396; Sigma-Aldrich) were used to model hemorrhage and calcification, respectively. 
Ferric oxide and hydroxyapatite were added to separate sets of 1.8-mL cryo-vials 
(#375418; Thermo Scientific, Waltham, MA), and 500 μL of 0.01% Tween-20 (#P9416; 
Sigma-Aldrich) solution was added to each vial as an emulsificant to promote a uniform 
mixture. The hydroxyapatite vials were agitated for 24 hours using a Max Q2000 shaker 
(#4314; Thermo Scientific). The iron oxide particles used to model hemorrhage were not 
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adequately emulsified by Tween alone, and required the addition of small 7 mm × 2 mm 
magnetic stir bars (#14-513-63; Fisher Scientific, Waltham, MA) to provide mechanical 
agitation.  Iron oxide vials were agitated for 24 hours using a PC-220 stirrer plate (Corning, 
Corning, NY).  
The stirrer bars were removed from the iron oxide vials using a strong magnet, and 
both sets of vials were moved to a water bath, where they were heated to 75°C.  Heated 
1% agar gel solution (2 mL) (#0710; Amresco, Solon, OH) was added to both sets, and the 
vials were tightly capped. The warm vials were then manually agitated by vigorous shaking 
for approximately 10 minutes until the solution cooled into a gel with uniform compound 
distribution. These gel models were stored at 4°C prior to scanning.  
An anthropomorphic head phantom (The Phantom Laboratory, Salem, NY) (Figure 
3.1) consisting of a human skull cast in tissue-equivalent Alderson material with anatomical 
airways was obtained from the Radiological Physics Center (Houston, TX). A cylindrical 
insert was placed in the cranium, and a custom insert was fabricated that allowed for 
simultaneous imaging of six agar gels (Figure 3.2).   
 
 
Figure 3.1:  Anthropomorphic head phantom. 
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Figure 3.2: (a) Custom water-filled insert for the anthropomorphic head phantom. The lateral 
view (top), the axial view (bottom left), and the relative position of the insert in the head 
phantom (bottom right) are shown. The orientation of the imaging volume is represented by 
the yellow shaded region. (b) A lateral scout image of the anthropomorphic head phantom 
with custom water-filled insert and gel models in place. 
 
3.2.2 Imaging and Region-of-Interest Analysis 
The calcification and hemorrhage gel model were scanned in the phantom on a 
Discovery CT750 HD CT scanner (GE Healthcare, Waukesha, WI) using two protocols: a) a 
single-energy in-house routine brain protocol and b) a dual-energy protocol designed to 
match the imaging parameters and dose of the single-energy protocol (Table 3.1). To 
improve the spatial resolution of the gel images, the display field of view was reduced to the 
minimum of 12 cm.  Images were viewed with Gemstone Spectral Imaging (GSI) viewer 
software (version 2; GE Healthcare), and data were collected on eight consecutive images 
using a circular 39-mm2 (7 mm diameter) region of interest covering approximately two-
thirds of the vial diameter. The total number of voxels per region of interest was 754, for a 
total of 6,032 voxels in a volume of interest per vial.  The 6,032-voxel volume of interest 
covered 952 mm3 and constituted 37% of the total gel volume of approximately 2.5 mL.  For 
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each voxel in the volume of interest, the following data were recorded: a) SECT attenuation 
(HU), b) calcium density from a water/calcium material decomposition based on the dual-
energy CT data (see ‘Dual-Energy Data Processing’ below), c) water density from a 
water/calcium material decomposition based on the dual-energy CT data (see ‘Dual-Energy 
Data Processing’ below), and d) material composition of the gel model (iron oxide-based 
hemorrhage model or hydroxyapatite-based calcification model).  
 
Table 3.1:  Imaging parameters for the single- and dual-energy CT protocols used in the 
study.  For both protocols: Image thickness: 3.75 mm, Table Speed: 10.62 mm/rotation, Pitch: 
0.531, Interval: 3 mm, Scan Field of View (SFOV): Head, Display Field of View (DFOV): 12 cm, 
Reconstruction Algorithm: Soft. 
Protocol Scan type Rot time [s] kVp mA CTDIvol* [mGy] 
Single-energy Helical 0.8 140 440 66 
Dual-energy GSI-26 0.7 80/140 375 67 
*Computed Tomography Dose Index Volumetric (CTDIvol) 
 
3.2.3 Fabrication of Matched Hemorrhage and Calcification Gel Models 
Iron oxide and hydroxyapatite gels were created at concentrations between 1 
mg/mL and 100 mg/mL and scanned in the phantom using the single-energy CT protocol 
(Table 3.1). Images were viewed as described above. Each gel model’s mean SECT 
attenuation (HU) was calculated and plotted against the gel model’s concentration. The 
SECT attenuation (HU) was fitted to a linear function of the known concentration of each 
material and the concentration required to achieve a given SECT attenuation (HU) was then 
calculated from the fit.  
Pairs of agar gels were fabricated with similar SECT attenuation (HU) levels and 
differed only in their composition (iron oxide-based hemorrhage model or hydroxyapatite-
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based calcification model). These matched gel models were fabricated at SECT attenuation 
levels ranging from 0 to 100 HU, in roughly 10-HU intervals. Paired vials of similar 
attenuation (within 2 HU) were then scanned in the anthropomorphic head phantom and 
scanned using a) the single-energy in-house routine brain protocol, to verify the SECT 
attenuation (HU) level of each gel model, and b) the dual-energy protocol, to collect 
material density information.  
 
3.2.4 Dual-Energy Data Processing 
To extract the dual-energy signature of a material from the high- and low-kilovolt-
peak data gathered in the dual-energy CT scan, GE Healthcare (Waukesha, WI) uses a 
process called material decomposition. This process is based on the concept that the 
energy-dependent attenuation of any material can be characterized as the linear 
combination of the energy-dependent attenuations of two basis materials (35,36).  One of 
the unique capabilities of this approach is allowing the user to independently choose the 
basis materials. Theoretically, any two materials could be chosen, but biologically relevant 
pairs such as water and iodine give more meaningful results (26,40).  Materials with k-
edges within the relevant x-ray energy range of 40-140 keV should also be avoided as 
these discontinuities can give rise to erroneous material decomposition results. The 
materials chosen should also have sufficiently different atomic numbers and thus 
sufficiently different attenuation properties to produce meaningful material separation, thus 
generating clinically useful data (22,99).  We chose calcium and water as our working pair 
because of their biological relevance and dissimilar attenuation properties.  Iron-water and 
iodine –water material basis pairs were also investigated, however, preliminary data 
indicated the calcium-water material density pair as yielding separation plots that were 
more meaningful and convenient for our application. (Data not shown) 
26 
 
Data from the dual-energy images were collected using the GE Gemstone Spectral 
Imaging viewer in material density mode with a water/calcium material density pair. These 
images express the density of water and the density of calcium in each voxel needed to 
produce the observed linear attenuation coefficient.  
 
3.2.5 Matched Model Pair Data Analysis 
For each SECT attenuation (HU)-matched model pair, single-energy and dual-
energy voxel data (6,032 voxels/gel model) for both the hemorrhage model and the 
calcification model were loaded into MATLAB software (R2012a; MathWorks, Natick, MA).  
The single-energy and dual-energy voxel data were registered based on the image number 
and voxel location data included in the region of interest data file. 
A Gaussian mixture model (GMM) was performed to group the voxels into two 
populations: calcification and hemorrhage.  Using the measured SECT attenuation (HU), 
water density and calcium density values for each voxel as input, a probability of belonging 
to either the calcification or the hemorrhage population was calculated for each voxel (see 
Chapter 8: Appendix), with a posterior probability of ≥0.5 as the criterion for population 
assignment (100,101).The analysis was performed using a 50% training set, 50% validation 
set approach to ensure that the data used to build the model (randomly assigned training 
set) was distinct from the data the model was used to evaluate (randomly assigned 
validation set) and was performed 1,000 times to ensure convergence in light of the non-
stochastic nature of the GMM analysis. 
The probabilistic assignments for the two populations (calcification and hemorrhage) 
were tested against the gold standard of actual gel composition, and an overall model 
accuracy was calculated as a function of the SECT attenuation (HU) of the matched model 
pair.  
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While Gaussian mixture model analysis can be quite powerful, its potential for 
application in a clinical setting is low due to the time and processing power needed to apply 
the technique.  To provide a more clinically implementable test metric, a threshold plane 
was derived from the GMM data.  For all matched model pairs included in the study, voxels 
receiving an assignment probability of 50 ± 1% (equal probabilities of being assigned to the 
hemorrhage or calcification cluster) were isolated, and a line of best fit was determined 
using regression analysis in three dimensions.  Due to the correlated nature of the SECT 
attenuation (HU) and dual-energy material density data, gel model voxel data were found to 
be concentrated in a single plane in three-dimensional (3D) space (Figure 3.3).  Using 
principle component analysis, the centroid and inertia axes of the plane were calculated 
and the equation for the plane of the data was determined.  A second plane was then 
calculated which included the line fit of the equal-probability points and was orthogonal to 
the plane of the data, effectively bisected the voxel data into two groups.  Based on the 
equation of this threshold plane, voxels were sorted into either a hemorrhage group or a 
calcification group according to their position relative to the threshold plane.  For each 
matched model pair, the predicted material composition for each voxel was compared with 
actual composition, and the accuracy of the threshold plane’s differentiation was calculated 
and plotted against the SECT attenuation (HU) of the matched model pair. 
Statistical details describing the Gaussian mixture model formulation, fitting and 
analysis are included in the Appendix (Chapter 8). 
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Figure 3.3: 3D plot of voxel data from all calcification and hemorrhage gel models used in this 
study, rotated to show the full distribution of the data (a) or the planar nature of these data in 
the 3D coordinate space (b). Hemorrhage gel model voxel data are shown in red; calcification 
gel model voxel data are shown in blue.  
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3.3 Results 
3.3.1 Calcification and Hemorrhage Phantom Models 
The results of the SECT attenuation (HU) calculation for all iron oxide and 
hydroxyapatite gels are shown in Figure 3.4, and indicate the concentration of the 
compounds in each of gel types needed to produce gel models of a specific SECT 
attenuation. 
 
Figure 3.4: SECT attenuation (HU) for the concentration of iron oxide in the hemorrhage gel 
models and the hydroxyapatite in the calcification gel models. Linear regression equations 
and correlation coefficients are shown for each data set. 
 
3.3.2 Fabrication of Matched Hemorrhage and Calcification Gel Models 
The target concentration of iron oxide and of hydroxyapatite required to produce 
each desired SECT attenuation (HU) is presented in Table 3.2.  The exact weight of each 
compound added to each gel vial is also presented and was calculated based on the 
concentration and the known volume of the gel vials used in the study. 
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Table 3.2:  Concentrations and weights of iron oxide and hydroxyapatite needed to create 
hemorrhage and calcification models of specific SECT attenuation (HU). 
Target 
attenuation 
[HU] 
Concentration [mg/mL]* Weight [mg]† 
Hydroxyapatite Iron Oxide Hydroxyapatite Iron oxide 
10 6.32 3.41 16.11 8.69 
20 14.98 7.19 38.20 18.34 
30 23.64 10.97 60.29 27.98 
40 32.31 14.76 82.38 37.63 
50 40.97 18.54 104.47 47.28 
60 49.63 22.32 126.55 56.92 
70 58.29 26.11 148.64 66.57 
80 66.95 29.89 170.73 76.22 
90 75.62 33.67 192.82 85.86 
100 84.28 37.46 214.91 95.51 
*Derived from the linear-fit equation in Figure 4. †Weights required to achieve the concentrations 
listed were calculated based on the volume of specific gel vial used in the study. 
 
3.3.3 Matched Model Pair Data Analysis 
A total of 16 hemorrhage and calcification model pairs were matched. The average 
SECT attenuation (HU) of each pair, as well as the mean and standard deviation of the 
SECT attenuation (HU) for each gel model in the pair, is shown in Table 3.3.   
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Table 3.3:  Average SECT attenuation (HU) of each matched pair and mean SECT attenuations 
(HU) for the hemorrhage gel model and the calcification gel model in each pair. 
Average SECT attenuation of 
matched model pair [HU]* 
Mean SE attenuation [HU] ± SD 
Hemorrhage model  
(iron oxide) 
Calcification model 
(hydroxyapatite) 
12 11.4 ± 8.5 12.7 ± 3.4 
14 13.9 ± 3.2 14.2 ± 3.4 
17 17.1 ± 3.8 16.9 ± 3.3 
20 20.8 ± 3.4 19.7 ± 3.2 
30 30.4 ± 4.6 30.6 ± 3.5 
32 31.3 ± 3.4 31.8 ± 3.3 
39 39.2 ± 5.3 38.8 ± 3.5 
50 49.4 ± 3.2 51.3 ± 3.9 
60 59.7 ± 4.8 60.6 ± 3.6 
62 62.3 ± 4.0 62.3 ± 4.4 
71 70.7 ± 4.0 71.1 ± 5.0 
75 75.7 ± 4.0 74.7 ± 9.5 
82 82.4 ± 6.2 82.3 ± 4.4 
88 88.7 ± 6.6 87.5 ± 4.2 
89 88.7 ± 6.6 89.6 ± 7.6 
90 90.1 ± 6.6 89.6 ± 7.6 
*Hemorrhage and calcification gel models with attenuation levels within 2 HU of each other 
were organized into matched model pairs, and the average attenuation of each pair was the 
rounded average of the hemorrhage model attenuation and the calcification model 
attenuation. 
 
 
As an example for the purposes of illustration, the voxel data for the 62-HU matched 
model pair along with the GMM predicted and actual gel model compositions are shown in 
Figure 3.5.  For the GMM analysis (Figure 3.5), the accuracies for the calcification and 
hemorrhage models were 99.7% and 97.7%, respectively.  
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Figure 3.5:  GMM assignment results for the 62-HU matched gel model pair (1 of 16 pairs).  
Each point represents a voxel within the 6,032-voxel volume of interest in one of the two gel 
models. 
 
Matched calcification and hemorrhage gel model pairs were differentiated with 
>90% accuracy using GMM analysis starting at 50HU (Figure 3.6).  A slight drop to just 
below the 90% threshold was seen at 60HU however, all subsequent matched model pairs 
exceeded 90% accuracy.  All matched model pairs over 50HU, with the exception of the 
60HU pair, possessed very narrow accuracy distributions, with standard deviations of <1%. 
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Figure 3.6:  Accuracy of hemorrhage and calcification differentiation using the GMM and 
threshold plane analysis method for all attenuation-matched model pairs. For the GMM 
series, each point represents 1,000 iteratively filtered runs of the analysis.  A third-order 
polynomial (Poly.) was fit to each series to facilitate visual interpretation of the data. 
 
In order to derive the threshold plane, eight hundred thirty-six voxels with posterior 
probabilities of 50 ± 1% were isolated from the total 193,024 voxels on the basis of the 32 
gel models included in this study. A coordinate system was established with the x-axis 
defined as the dual-energy CT water density, the y-axis defined as the dual-energy CT 
calcium density, and the z-axis defined as the SECT attenuation (HU). The line fit to the 
equal probability points had the vector equation <x,y,z> =  <998.17, 11.88, 23.18> + t<0.06, 
-0.41, -0.91> where t is any real number. The 3D threshold plane had the equation -0.93x + 
0.31y - 0.20z = -929.20 and clearly bisected the hemorrhage and calcification model voxel 
data (Figure 3.7). Matched model pairs with SECT attenuation levels ≥50 HU were 
differentiated with >90% accuracy for both the GMM analysis as well as its more clinically 
implementable threshold plane metric (Figure 3.6).   
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Figure 3.7:  3D plot of all voxel data (n = 193,024) from all 16 hemorrhage/calcification 
matched model pairs. Hemorrhage gel model voxel data are shown in red; calcification gel 
model voxel data are shown in blue. (a) Threshold plane viewed edge on as black line 
[equation: -0.93x + 0.31y - 0.20z = -929.20].  (b) Voxel data viewed from an angle showing 
hemorrhage and calcification data falling on the hemorrhage side of the threshold plane. 
Bright blue calcification data would be incorrectly identified as belonging to the hemorrhage 
population, with greyed-out blue data being correctly classified. (c) Voxel data viewed from 
an angle showing hemorrhage and calcification data falling on the calcification side of the 
threshold plane. Bright red hemorrhage data would be incorrectly identified as belonging to 
the calcification population, with greyed-out red data being correctly classified.  
 
3.4 Discussion 
This study provides proof-of-concept in a phantom system that dual-energy CT can 
distinguish intracranial calcification from hemorrhage below the 100 HU limit imposed by 
currently available clinical modalities. Intracranial lesions over 100 HU are identifiable as 
calcification using SECT, however lesions under this attenuation are impossible to classify. 
Using conventional MR, both hemorrhage and calcification manifest as signal voids in 
Gradient Echo images.  Without additional information, the cause of the signal voids, be it 
calcification or hemorrhage, cannot be determined. 
The use of phase information in MR for the differentiation of diamagnetic materials, 
such as calcification, and paramagnetic materials, such as hemorrhage, has been under 
investigation for several years (79).  Corrected gradient echo phase imaging (20), 
susceptibility-weighted imaging (21), and quantitative susceptibility mapping (78) have all 
been proposed to distinguish calcification from hemorrhage, however these methods have 
not yet found wide clinical acceptance.  In each of these studies, SECT was used as the 
gold standard for presence of calcification, and thus the usefulness of these methods can 
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be reported only for hemorrhage and calcification above 100 HU. Preliminary work 
suggests that calcification and hemorrhage in glioma may be differentiable under the 100 
HU limit using phase data derived from susceptibility-weighted imaging (77). However, the 
transition from research to clinical use of phase-dependent MR techniques has been 
difficult due to the sensitivity of the technique to magnetic field inhomogeneity, which is the 
rule, rather than the exception in clinical applications.  
In this study, dual-energy CT in combination with Gaussian mixture model analysis 
was shown to be capable of differentiating intracranial calcification and hemorrhage models 
far below the level possible using currently available clinical modalities.  Overall, the 
accuracy of the GMM differentiation of the hemorrhage and calcification model voxel data 
increased with the matched model pair’s SECT attenuation (HU). Put simply, the denser the 
lesion model, the easier it was to differentiate hemorrhage from calcification. Strong 
differentiation with >90% accuracy can be seen starting at 50 HU. The dip in accuracy and 
associated increase in accuracy distribution at 60 HU in the GMM analysis (Figure 3.6) may 
be due to a higher heterogeneity in the SECT attenuation (HU) dimension from either the 
calcification or the hemorrhage gel model due to variability in gel model fabrication. 
Nevertheless, the overall trends in both the GMM and threshold plane accuracy results 
support the use of 50 HU as a threshold for highly accurate differentiation.  
Gaussian mixture model analysis was chosen as the statistical analytic method for 
this study due to its ease of interpretation and to take advantage of the three dimensional 
and potentially overlapping nature of the data collected.  The Gaussian assumption of the 
analysis was appropriate given the large amount of voxel data collected from each gel 
model. Traditional t-test analysis was contraindicated by both the vast amount of data and 
the differences in the manufacturing methods for the calcification and hemorrhage gel 
model. (Because of the large numbers of data points, slight differences in heterogeneity 
between the calcification and hemorrhage models resulted in statistically significant 
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differences when in fact the model’s voxel data overlapped to a considerable extent. This 
observation indicated that t-test analysis was inappropriate.) Additionally, the ability to 
perform training/validation data set analysis using GMM allowed for a more robust test of 
differentiation as well as lending itself to the development of a model-based threshold for 
classification of unknown lesions.   
For practical implementation of the GMM statistical separation procedure, we 
derived a simple threshold plane to divide the voxels into calcification and hemorrhage 
population.  The discrimination performance of this plane was similar to the original GMM 
analysis (Figure 3.6) and actually outperformed the GMM analysis at low densities, likely by 
linearly extrapolating from higher densities to lower where the GMM itself became noise-
limited.   
To establish the use of dual-energy CT to discriminate calcification and hemorrhage 
clinically, an initial phantom study is necessary to allow essential variables to be 
interrogated and analysis tools and methods to be designed, trained, and optimized in a 
controlled fashion.  However, due to the inherent constraints requisite to use of a phantom 
system there will always be limitations in the modeling.  First, both hemorrhages and 
calcifications were modeled as relatively large cylindrical lesions positioned centrally in the 
brain. Second, both lesion types were modeled using an agar background and scanned in a 
water-filled insert, which does not accurately represent brain tissue. Third, both lesion types 
were modeled as uniform distributions, with no attempt made to model heterogeneous 
distribution or influences of local environment on the lesion. Lastly, hemorrhage models 
were created without any form of calcium contamination.  It is likely that cross 
contamination will occur clinically, where biology is always more complex than phantoms.  
For example, it has been shown that cavernomas calcify in anywhere from 11-40% of cases 
(102,103), and in those cases we may expect to see both calcification and hemorrhage in 
the same lesion.  Clearly there is potential for overlap and cross contamination between 
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blood and calcium in clinical applications.  Our current study lays a groundwork for a “clean” 
uncontaminated case, leaving more complex mixture phantom models and more 
importantly, clinical applications, to future work.  
Future studies are planned to extend our approach to encompass other dual-energy 
CT vendors, as well as to further test the limits of our method by varying the size and 
location of the lesions, more accurately modeling the brain tissue background and 
environment, and varying the imaging parameters of the dual-energy protocols to potentially 
optimize differentiation. The resulting data will be used to develop appropriate scan 
protocols based on the size and location of intracranial lesions for use in a prospective 
human trial. 
In conclusion, this work has shown that hemorrhagic and calcific lesions with SECT 
attenuation levels between 50 and 100 HU can be reliably differentiated in a phantom 
system using dual-energy CT and material decomposition. The equation for a simple 
threshold plane of differentiation derived from the more complex GMM analysis provides a 
simplified metric for future clinical application. The ability to differentiate between low-
attenuation hemorrhagic and calcific lesions has multiple clinical applications, both 
addressing current clinical needs, and also likely, future unforeseen applications.  This data 
provides justification for future clinical studies in patients.   
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Chapter 4 
4  Lesion Differentiation using a Biologically-Relevant Phantom 
 
This chapter seeks to validate the results of the simplified physics model 
investigated in Chapter 3, using a more biologically relevant phantom system.  Instead of 
agar, a spectrally-equivalent brain background material will be described that better mimics 
the spectral properties of brain tissue.  Intracranial lesions will be modeled at a range of 
sizes and at varying locations within the cranial cavity.  Acquisition parameters will be 
varied in an effort to elucidate the optimal imaging technique, patient population constraints 
and analysis methods for use in a future prospective clinical trial. 
 
4.1 Materials and Methods 
4.1.1 Phantom Preparation 
For this project, an anthropomorphic nuclear 
medicine head phantom was acquired (Capintec, 
RS900T, Figure 4.1).  The anthropomorphic nature of 
the interior of the phantom allowed for the design of a 
novel brain insert to hold lesion models of various 
compositions and sizes at multiple locations within the 
cranial cavity.  Figure 4.2 shows the basic structure of 
the intracranial lesion phantom design.  Spectrally 
equivalent brain slabs would be positioned to cover 
two regions at opposite ends of the imaging spectrum: 
the skull base surrounded by dense bone and the 
cerebrum with little bony anatomy.  The cerebrum slab Figure 4.1:  Interior of anthropomorphic 
nuclear medicine phantom. 
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houses six cylindrical inserts (three hemorrhage inserts and three calcification inserts) at 
three diameters: 0.5 cm, 1 cm and 1.5 cm (Figure 4.2b).  Due to its size as well as the 
difficult imaging environment, the skull base slab houses only two cylindrical inserts: a 1.5 
cm hemorrhage and a 1.5 cm calcification insert (Figure 4.2c).   
 
 
Figure 4.2:  Intracranial lesion phantom plan showing brain slabs in tan, hemorrhage lesion 
models in red and calcification lesion models in blue.  (a) sagittal view showing position of 
cerebrum and skull base brain slabs.  (b) axial view of cerebrum brain slab showing position 
of hemorrhage and calcification lesion models.  (c) axial view of skull base slab showing 
position calcification and hemorrhage model. 
 
In order to maintain the position of the brain slabs and to ensure artifact-free helical 
imaging, a polyurethane rubber was used as a filler material between the slabs. The 
polyurethane product chosen (PMC-121/30-Dry) was a minimally shrinking, amber-colored 
rubber with a specific gravity of 1.04 and a mean CT number of 3 HU using a 120kVp scan 
technique (http://www.smooth-on.com/tb/files/PMC-121_SERIES.pdf).  To ensure the easy 
release of the cured polyurethane rubber, the interior of the phantom was buffed with fine 
grain sand paper.  Any occlusions or holes in the phantom interior were filled with an acrylic 
based epoxy and the final surface coated with several fine layers of aerosolized acrylic to 
obtain a smooth and sealed interior surface. Olive oil was used as a release agent for the 
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polyurethane due to its low effective Z composition in an attempt to avoid high Z 
contamination from the more common silicon based release agents. 
 
4.1.2 Spectrally Equivalent Brain Material 
Spectrally equivalent materials were created by Gammex, Inc. as part of a special 
custom order.  Several samples of potential brain equivalent materials were supplied and 
imaged using both a single-energy CT routine brain protocol and a dual-energy CT protocol 
selected to match the imaging parameters and dose of the single energy protocol (Table 
4.1).  The monoenergetic dual-energy data was compared to existing data from a clinical 
brain study.  Based on these results, the material with the closest spectral HU curve to 
human brain was selected.  The final spectrally equivalent brain slab provided by Gammex 
was validated using the protocol in Table 4.1 and defect free regions were selected for use.   
 
Table 4.1:  Imaging Technique for basic single-energy and matched dual-energy data 
collection. 
Name 
Scan 
Type Pitch Rot  
Beam 
Width Img Thk Interval SFOV DFOV kVp mA Filter 
Routine 
Brain Helical 0.531 0.8s 20 mm 3.75 mm 3 mm Head 25 cm 140 160 STND 
GSI - 26 
Brain Helical 0.531 0.7s 20 mm 3.75 mm 3 mm Head 25 cm NA NA STND 
 
In order to obtain a detailed model of the interior of the nuclear medicine phantom, a 
polyurethane cast was made of both the base and crown of the phantom.  The 
polyurethane filled phantom was then imaged using the single-energy protocol detailed in 
Table 1 and the specific position and dimensions of the cerebrum and skull base slabs were 
determined.  The polyurethane casts were then removed and models of the slabs were cut 
from the casts based on the measurements derived from the imaging.  A projection view of 
the greatest diameter of the polyurethane slab model was made and the spectrally 
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equivalent brain material was cut to that shape.  Orientation marks were added to the 
surfaces of both the polyurethane models and the brain slabs and rough contours were 
created using a belt sander.  Fine details were later created using a combination of air 
powered die grinders and dremmel tools. Once construction on both brain slabs was 
complete, polyurethane filler slabs were created.  The slabs were designed to be removable 
to allow easy access to all lesion models.  The polyurethane filler slabs were created in 
sequence starting with the most inferior and working towards the most superior. To ensure 
a subsequent pour did not cure to a prior filler slab, heavily oiled plastic wrap was placed 
between the layers.   
 
4.1.3 Lesion Models 
Hemorrhage models were created by adding various concentrations of iron oxide to 
the spectrally equivalent brain material, while calcification models were created by adding 
various concentrations of calcium carbonate.  Calcium carbonate was selected over our 
previously used hydroxyapatite due to its similar high calcium content but relatively higher 
ease of use.  Lesion models ranging from 40 HU to 100 HU in 10 HU increments were 
created by Gammex and sent for validation in the form of 2.7 cm diameter, 25 cm long rods.  
These rods were validated using a Gammex Validation Phantom (Figure 4.3) consisting of 
a 15 cm thick, approximately 20 cm diameter solid water phantom with 8 insert positions.  
The two positions on either side of the target insert contained water balloons to provide an 
optimal imaging environment.  All other inserts were relatively low density and did not affect 
imaging of the target insert in the 12 o’clock position.  The validation phantom was imaged 
using a combined protocol covering single-energy acquisitions, dual-energy acquisitions 
and Gammex specific acquisitions (Table 4.2).  The bold line denotes a break in the 
protocol when the insert was repositioned to scan the second half due to its length relative 
to the phantom (25 cm rod vs 15 cm thick phantom).   
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Figure 4.3:  Gammex validation phantom.  Water balloons are positioned in insert 
holes covered by tape.  Target lesion was positioned at 12 o’clock. 
 
Table 4.2:  Imaging technique for validation of lesion model inserts.  Bold line indicates break 
in protocol where insert was repositioned to allow imaging of second half of insert extent.  
Series 2 and 4 were not repeated since their relation to series 3 was already evaluated in the 
first imaging setting. For all series: SFOV: Head, DFOV: 25 cm, Filter: Standard. 
Series Name 
Scan 
Type Pitch 
Rot 
(s) 
Beam 
Width 
(mm) 
Img Thk 
(mm) 
Interval 
(mm) kVp mA 
2 Routine Brain Helical 0.531 0.8 20 3.75 3 140 160 
3 New Routine Brain Helical 0.531 0.8 20 3.75 3 120 220 
4 GSI - 26  Helical 0.531 0.7 20 3.75 3 NA NA 
5 GMX Val 80kV Axial  1 1 40 5 40 80 250 
6 GMX Val 100kV Axial  1 40 5 40 100 250 
7 GMX Val 120kV Axial  1 1 40 5 40 120 250 
8 GMX Val 140kV Axial  1 1 40 5 40 140 250 
9 GMX Val 80kV Axial  1 1 40 5 40 80 250 
10 GMX Val 100kV Axial  1 1 40 5 40 100 250 
11 GMX Val 120kV Axial  1 1 40 5 40 120 250 
12 GMX Val 140kV Axial  1 1 40 5 40 140 250 
13 New Routine Brain Helical 0.531 0.8 20 3.75 3 120 220 
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The single-energy images were downloaded and regions of interest (ROIs) were 
applied using MATLAB.  ROIs were of diameter 0.5 cm, 1 cm and 1.5 cm and covered the 
entire length of the target lesion rod.  The mean and standard deviation of each ROI for 
each image were exported to Excel where the average mean and average standard 
deviation of each ROI size were calculated for each rod.  Outlier limits were set as ±2 HU 
from the average for the mean values and +1 HU from the average for the standard 
deviation.  Using conditional formatting, outlier fields were highlighted in the rod data, 
allowing identification of segments of the lesion rod that were within tolerance based on 
both their mean value and their standard deviation.  Based on the known thicknesses of the 
brain slabs and thus the desired lengths of the lesion models, running averages of set 
numbers of images were calculated.  Those averages representing acceptable rod extents 
were tabulated and the two regions representing a calcification lesion and a hemorrhage 
lesion with equal ROI diameters that had the most similar mean CT number on the single-
energy protocol were selected.  This process was repeated until regions on the rods were 
identified for the creation of matched HU calcification and hemorrhage rods at all diameters 
and lengths.  The desired region on each rod was marked and then sent back to Gammex 
for milling.   
 
4.1.4 Selection of optimal keV level for simulated SECT scanning 
The phantom was prepared with lesion models representing various SECT 
attenuation (HU) levels filling the cerebrum brain slab.  The skull base slab was left empty 
for this experiment.  Ultrasound gel was used to fill the space in the polyurethane at the 
back of the cerebrum slab where the pull ribbon exited the phantom.  The brain and 
polyurethane filler slabs were positioned in the nuclear medicine phantom and the crown of 
the phantom affixed to its base using tape.   
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The phantom was then positioned in the CT head holder and aligned such that the 
plane of division between the crown and the base of the phantom was parallel to the 
imaging plane.  The imaging protocol used is shown in Table 4.3.  Data were collected from 
all lesion models using 11.25 mm diameter ROIs for the 15 mm diameter lesion models, 7.5 
mm diameter ROIs for the 10 mm diameter lesion models and 3.75 mm diameter ROIs for 
the 5 mm diameter lesion models.  ROIs were collected for each GSI-preset while in mega-
mono mode to collect data from multiple monoenergetic keV levels simultaneously.  The 
predicted attenuation (HU) data for keV reconstructions of 40 to 140 keV in 5 keV steps 
were then imported into excel where a second order polynomial was fit to the predicted 
attenuation (HU) curve for Monoenergetic reconstructions from 60 to 80 keV.  Using this 
curve and the knowledge of the true SECT attenuation (HU) from series 2 of the protocol, 
the optimal keV for simulated SECT scanning was calculated.  The average optimal keV 
across all GSI-presets and inserts was then calculated and the difference in attenuation 
from the optimal keV reconstruction and the SECT acquisition was determined.   
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Table 4.3:  Imaging technique for intracranial lesion phantom scanning.  For all series and 
groups (except series 1): SFOV: Head, DFOV: 25 cm, Scan Type: Helical, Beam Width: 20 mm. 
Series Name Pitch Img Thk (mm) 
Interval 
(mm) kVp mA 
Rot 
(s) 
CTDIvol 
(mGy) Filter DE Recon 
1 Scout       120 10         
2 Routine Brain 0.531 1.25 1.25 120 220 0.8 64.8 Standard  
3 
  
  
  
  
GSI-26 0.969 1.25 1.25 80/140 375 0.7 36.7 Standard Mega Mono 
GSI-20 0.969 1.25 1.25 80/140 630 0.5 44.6 Standard Mega Mono 
GSI-19 0.969 1.25 1.25 80/140 640 0.6 54.7 Standard Mega Mono 
GSI-30 0.969 1.25 1.25 80/140 550 0.8 57.9 Standard Mega Mono 
GSI-14 0.969 1.25 1.25 80/140 600 0.8 64.2 Standard Mega Mono 
GSI-9 0.969 1.25 1.25 80/140 600 0.9 72.7 Standard Mega Mono 
4 
  
  
  
  
GSI-26 0.531 1.25 1.25 80/140 375 0.7 67 Standard Mega Mono 
GSI-20 0.531 1.25 1.25 80/140 630 0.5 81.4 Standard Mega Mono 
GSI-19 0.531 1.25 1.25 80/140 640 0.6 99.8 Standard Mega Mono 
GSI-30 0.531 1.25 1.25 80/140 550 0.8 105.6 Standard Mega Mono 
GSI-14 0.531 1.25 1.25 80/140 600 0.8 117.1 Standard Mega Mono 
GSI-9 0.531 1.25 1.25 80/140 600 0.9 132.6 Standard Mega Mono 
 
 
4.1.5 Collection of Lesion Differentiation Data 
Lesion models of a specific SECT attenuation (HU) level were loaded into the 
cerebrum brain slab of the intracranial lesion phantom and imaged using the protocol found 
in Table 4.3. This protocol allowed for the collection of lesion model data based on a variety 
of different GSI-presets and pitch values.  This process was repeated for all SECT 
attenuation (HU) sets of lesion models.  The data from all seven exams (representing the 
seven lesion SECT attenuation (HU) levels evaluated) were reconstructed to allow for 
collection of the optimal keV (determined in Chapter 4.1.4), Water(Calcium) and 
Calcium(Water) material density data, as well as for additional variations in image thickness 
and recon filter (Table 4.4).   
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Table 4.4:  Dual-energy reconstructions for intracranial lesion phantom protocol (detailed in 
Table 4.3).  Prospective recons are listed first and labeled with a P, followed by retrospective 
recons labeled with an R. 
Recon Image Thickness (mm) DFOV (cm) Filter DE Recon 
P2 1.25 25 Standard Water/Ca 
P3 2.5 25 Standard Water/Ca 
P4 3.75 25 Standard Water/Ca 
P5 5 25 Standard Water/Ca 
P6 1.25 25 Standard Ca/Water 
P7 2.5 25 Standard Ca/Water 
P8 3.75 25 Standard Ca/Water 
P9 5 25 Standard Ca/Water 
P10 1.25 25 Standard Optimal keV 
R1 2.5 25 Standard Optimal keV 
R2 3.75 25 Standard Optimal keV 
R3 5 25 Standard Optimal keV 
R4 1.25 25 Soft Water/Ca 
R5 2.5 25 Soft Water/Ca 
R6 3.75 25 Soft Water/Ca 
R7 5 25 Soft Water/Ca 
R8 1.25 25 Soft Ca/Water 
R9 2.5 25 Soft Ca/Water 
R10 3.75 25 Soft Ca/Water 
R11 5 25 Soft Ca/Water 
R12 1.25 25 Soft Optimal keV 
R13 2.5 25 Soft Optimal keV 
R14 3.75 25 Soft Optimal keV 
R15 5 25 Soft Optimal keV 
R16 1.25 25 Detail Water/Ca 
R17 2.5 25 Detail Water/Ca 
R18 3.75 25 Detail Water/Ca 
R19 5 25 Detail Water/Ca 
R20 1.25 25 Detail Ca/Water 
R21 2.5 25 Detail Ca/Water 
R22 3.75 25 Detail Ca/Water 
R23 5 25 Detail Ca/Water 
R24 1.25 25 Detail Optimal keV 
R25 2.5 25 Detail Optimal keV 
R26 3.75 25 Detail Optimal keV 
R27 5 25 Detail Optimal keV 
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Data collection was repeated three times to form three separate studies.  Studies 1 
and 2 were performed on a single scanner, hereafter referred to as Scanner 1, while Study 
3 was performed on a different scanner, hereafter referred to as Scanner 2.  Repeat 
analysis was performed to allow for combined data with reduced noise, as well as to assess 
the inter-scanner and intra-scanner repeatability of this technique.   
 
4.1.6 Data Organization and Structure 
4.1.6.1 SQL Database 
Because a large amount of image data were collected as part of this experiment, an 
SQL database was built in 3DSlicer (Version 4.3.1) to aid with data sorting and 
organization. The database contained one table with data about each series including the 
corresponding exam number and path name, and a second table with file names of 
individual images.  This database was queried in Matlab (Version 2014a, MathWorks) using 
Mksqlite (www.sourceforge.net/projects/mksqlite), and the Patient ID, exam number, and 
the folder path name for each series were acquired and then stored in a Matlab structure. 
 
4.1.6.2 Series Sorting 
For each series, the folder path name was used to access the digital imaging and 
communications in medicine (DICOM) header of a representative image and the pitch, 
DFOV, image thickness, reconstruction filter, and GSI material/keV were acquired using the 
dicominfo function (Image Processing Toolbox 2014a; MathWorks, Natick, MA). These 
fields were then added to the existing Matlab structure for each series. In addition, any 
series not needed for analysis (i.e. scouts and dose reports) were filtered and discarded. 
The remaining series were then sorted first by exam number (which corresponded to the 
HU of the lesion model pair), then pitch, reconstruction filter, image thickness, and 
material/keV respectively.  
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4.1.6.3 Region of Interest Selection 
Images were viewed on an Advantage Workstation (AW) using GSI viewer software 
(Version 2; GE Healthcare), and the image location extents corresponding to the top slab 
and bottom slab were recorded for each exam and each image thickness. Regions-of-
interest (ROIs) corresponding to each of the six cerebral lesion models were placed on a 
single image within the cerebrum (Table 4.5). Similarly, ROIs corresponding to both of the 
skull base lesion models were placed on a single image in the skull base slab (Table 4.5). 
This procedure was repeated for each exam within the study.  The ROIs were saved to a 
comma-separated-value (.csv) file on the AW, detailing the spatial location of each voxel. 
The .csv file for each ROI was then imported into Matlab (2014a; MathWorks, Natick, MA) 
and each voxel’s position within the image was extracted from the ROI data file and 
converted to its corresponding image array position.   
 
Table 4.5: ROI diameters and associated number of voxels based on lesion model size and 
location.  
Lesion Model Location Lesion Model Diameter (mm) 
ROI Diameter 
(mm) Number of Voxels 
Cerebrum 
15 12 465 
10 8 216 
5 4 60 
Skull Base 15 12 465 
 
In order to allow direct comparison of results from the cerebrum and skull base 
lesion models, the number of images analyzed would need to be identical.  Since the 
cerebrum slab was designed 1 cm thicker than the skull base slab, the number of images 
analyzed from the cerebrum slab would need to be reduced to the maximum allowable in 
the skull base.  The number of available images, and the associated image locations, for 
each acquired image thickness was determined using the AW and GSI-viewer software.  
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ROIs of 11.25 mm diameter were placed on the two lesion models in the skull base and all 
images where both models were within 5 HU of their mean model value were identified.  
This image number/location extent was then consolidated to ensure identical extents over 
all exams allowing inter-comparison. Due to the position the cerebrum slab within the 
cranial cavity of the phantom, a number of images were affected by artifact from the gap 
between the base and crown portions of the phantom (Figure 4.4).  Images unaffected by 
this phantom discontinuity were identified on each acquired image thickness.  The image 
number/location extents for the cerebrum were then consolidated to match the number of 
images determined in the skull base and to ensure identical extents over all exams.  The 
final number of images and image extents for each acquired image thickness for both the 
cerebrum and skull base slab can be found in Table 4.6. 
 
 
Figure 4.4: Artifact caused by phantom discontinuity. 
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Table 4.6: Number of images and extent analyzed for both the cerebrum and skull base brain 
slabs. 
Image Thickness (mm) 
1.25 2.5 3.75 5 
Number of Images 21 10 6 4 
Extent (mm) 26.25 25 22.5 20 
 
4.1.6.4 Voxel Data Extraction and Organization 
Because the protocol included multiple scan groups within the same series (Table 
4.3), multiple GSI presets were contained within the same series folder in the database.  To 
resolve this issue, as well as to isolate images from the cerebrum and skull base regions of 
the phantom, a custom Matlab function was created.  For each series folder in the structure, 
the function read in the image thickness and exam number fields and determined the 
appropriate image location extents for the cerebrum and skull base slabs based on Table 
4.6.  The function then accessed the DICOM header for each image and compared the 
image location to the previously determined extents.  If the image location was within the 
extents for either the cerebrum or skull base brain slabs, this image information was 
appended as a new field within the structure. While the DICOM header was open, each 
image was also analyzed to determine the GSI preset used during acquisition.  The 
structure was then reorganized to include GSI preset in its overall organization.   
Images tagged as belonging to the cerebrum slab extent were opened in Matlab 
using the dicomread fuction (Image Processing Toolbox 2014a; MathWorks, Natick, MA).  
The ROIs determined above were then applied to the images and the voxel data 
concatenated into a single column vector and saved within the structure.  This was 
repeated for the skull base slab and a separate single column vector saved within the 
structure.  Table 4.7 shows the size of these column vectors based on the size of the lesion 
model and image thickness of the series in question. 
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Table 4.7:  Total number of voxels included in analysis for both cerebrum and skull base 
brain slabs based on image thickness and lesion diameter.  Note: This total includes multiple 
image locations as defined by Table 4.6. 
Lesion Diameter (mm) 
  15 10 5 
Im
g 
Th
k 
(m
m
) 1.25 9765 4536 1260 
2.5 4650 2160 600 
3.75 2790 1296 360 
5 1860 864 240 
 
The Matlab structure was then collapsed by identifying matched series that had 
identical exam number, GSI preset, pitch, image thickness and reconstruction filter fields 
but different dual-energy reconstructions: optimal keV, Water(Calcium), or Calcium(Water).  
For a given lesion model size and location (i.e. 10 mm diameter and cerebrum brain slab) 
the ROI data in the column vectors for these three series were concatenated into an array 
where each column represented a different dual-energy reconstruction type.  The structure 
then contained a list of series, each representing a unique acquisition type.  For each 
series, three-dimensional dual-energy data was present for all eight lesion models in the 
intracranial lesion phantom: six lesion models in the cerebrum (1.5 cm hemorrhage model , 
1.5 cm calcification model, 1.0 cm hemorrhage model, 1.0 cm calcification model, 0.5 cm 
hemorrhage model and 0.5 cm calcification model) and two lesion models in the skull base 
(1.5 cm hemorrhage model and 1.5 cm calcification model). 
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4.1.7 Determination of Differentiation Accuracy 
4.1.7.1 Gaussian Mixture Model Analysis 
For each series in the Matlab structure, the lesion models were paired based on 
matching diameter and brain slab location.  For each matched model pair, the three-
dimensional dual-energy voxel data for both the hemorrhage model and the calcification 
model were loaded into Matlab and a three dimensional Gaussian mixture model and plane 
analysis were performed as described in Chapter 3.2.5.  The results of the GMM analysis, 
as well as the matched model pair and series acquisition specifics from all three studies 
conducted were printed to a text file and the Matlab workspace saved for future analysis. 
Data derived from all three studies were used to assess trends in differentiation accuracy 
based on all available lesion and acquisition parameters.   
 
4.1.7.2 Support Vector Machine (SVM) Analysis 
For each matched model pair and acquisition type (CTDIvol, image thickness and 
recon filter) combination, the three-dimensional dual-energy voxel data for both the 
hemorrhage model and calcification model were loaded into Matlab (Version 2014a, 
MathWorks).  This process was repeated for each exam, to build a distribution including all 
SECT attenuation (HU) matched model pairs of the given acquisition parameters.  Each 
distribution was then analyzed using a Matlab supplied support vector machine (SVM) 
process employing a 50% trainer, 50% validation approach.   The SVM process determined 
the equation of a plane that best separated the hemorrhage and calcification model data 
using the trainer data set (Figure 4.5).  This plane was then applied to the validation data 
set and lesion type assignments were created for each voxel based on its position relative 
to the plane.  The resulting lesion type assignments for each voxel in the distribution were 
then compared to the known voxel origin and the accuracy score was calculated.  The 
results of the SVM analysis, as well as the matched model pair and series acquisition 
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specifics from all three studies conducted were printed to a text file and the Matlab 
workspace saved for future analysis.  Data derived from all three studies were used to 
assess trends in differentiation accuracy based on all available lesion and acquisition 
parameters.   
 
Figure 4.5: Support vector machine plane (gray) based on identified support vectors (green) 
for the hemorrhage (red) and calcification (blue) distributions. 
 
4.1.7.3 Geometric Bisector (GB) Analysis 
For each matched lesion pair and acquisition type distribution to be described in 
Section 4.2.6.7, a simplified bisector analysis was performed.  Using Matlab, a three-
dimensional linear regression was performed on both the hemorrhage and calcification data 
sets to derive a fit line for both distributions.  These two lines of best fit were compared and 
the bisector was calculated.  A bisector plane was then derived to include the bisector line 
in three-dimensional space and be perpendicular to the plane of the data (see section 
3.2.5) (Figure 4.6).  Each voxel was then assigned a lesion type based on its position 
relative to the geometric bisector plane.  The resulting lesion type assignments for each 
voxel in the distribution were then compared to the known voxel origin and the accuracy 
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score was calculated.  The results of the GB analysis, as well as the matched model pair 
and series acquisition specifics from all three studies conducted were printed to a text file 
and the Matlab workspace saved for future analysis.  Data derived from all three studies 
were used to assess trends in differentiation accuracy based on all available lesion and 
acquisition parameters.   
 
Figure 4.6:  Geometric bisector plane (gray) shown separating the hemorrhage (red) and 
calcification (blue) distributions.  Three dimensional linear regressions of the two 
distributions and the resulting bisector are shown in as color-matched lines. 
 
4.1.7.4 Generalized Geometric Bisector (GGB) Solution 
In order to pursue a generalized geometric bisector plane for optimum 
differentiation, a database containing all voxel data collected in Study 1 was constructed 
(see Chapter 4.1.6.1).  These data were then randomly assigned to equal-sized trainer and 
validation datasets.  A geometric bisector plane was calculated based on all voxel data 
within the trainer dataset.  This plane represents the plane of optimal differentiation across 
all lesions and acquisition parameters.   To determine the effect of lesion and acquisition 
parameters on this plane, this analysis was repeated for subsets of the data based on all 
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available values within each lesion and acquisition parameter.  For example, the full trainer 
dataset was divided by image thickness of the protocol into 1.25 mm, 2.5 mm, 3.75 mm and 
5 mm datasets.  All data acquired using a given image thickness were used to create an 
image thickness-specific plane, including data from all lesions and other acquisition 
parameters.  The general trainer dataset plane, and the parameter-specific planes, were 
each applied to the full validation dataset and the accuracy of differentiation was calculated.  
Each parameter-specific accuracy value was then compared to the general trainer dataset 
accuracy value to determine major sources of variability in the definition of the geometric 
bisector plane. 
 
4.1.7.5 Inter-Method Correlation 
To assess the correlation between the geometric bisector (GB) and support vector 
machine (SVM) analysis methods, Bland-Altman and correlation graphs were created.  To 
assess sources of variability in this correlation, the analysis was repeated for subsets of the 
data based on all available parameters: CTDIvol, rotation time, image thickness, study, and 
lesion size and location.  Investigation of rotation time was included due to its impact on 
other concurrent projects (Chapter 6).  Each parameter was investigated separately, while 
including all values for other variables.  For example, investigation of variability by image 
thickness resulted in four graphs representing the investigated values (1.25, 2.5, 3.75 and 5 
mm) with each graph containing all data from each of the other acquisition parameters 
(CTDIvol, rotation time, study and lesion size and location).  For all analyses, the coefficient 
of variation (CV) was tabulated as a measure of data correlation, while the square of the 
Pearson r-value (R2) was tabulated as a measure of correlation linearity.  The CV and R2 
from these parameter value specific Bland-Altman and correlation graphs were compared 
to the values derived from Bland-Altman and correlation graphs for the full data set.  Based 
on visual assessment of minor and major sources of variability, static evaluation criteria 
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were determined to facilitate comparison of correlation data.  Parameter-value specific R2 
values under 0.75 or CV values greater than 150% of the full data CV value were chosen 
as cutoff criteria for the identification of major sources of variability in the method 
correlation.  Specific parameter values identified as major sources of variability were then 
removed from the full data set and the Bland-Altman analysis was repeated. 
 
4.1.8 Inter-Scanner and Intra-Scanner Correlation 
To assess inter-scanner and intra-scanner correlation, Bland-Altman and correlation 
graphs were created.  Inter-scanner correlation was defined as the comparison of Study 1, 
performed on Scanner 1, to Study 3, performed on Scanner 2.  Intra-scanner correlation 
was defined as the comparison of Study 1, performed on Scanner 1, to Study 2, performed 
on Scanner 1.  To assess sources of variability in this correlation, the analysis was 
repeated for subsets of the data based on all available parameters: CTDIvol, rotation time, 
image thickness, analysis method, and lesion size and location.  Analysis was performed as 
described in Chapter 4.1.7.5. 
 
4.1.9 Validation of Lesion Attenuation 
4.1.9.1 SECT attenuation (HU) correlation with  optimal keV HU 
Verification of the selection of the optimum keV for dual-energy CT scanning of 
intracranial lesions was performed on Study 1.   
The attenuation in HU derived from the optimal SECT corollary keV reconstructions 
(determined in Chapter 4.1.4) for all DECT protocol variations were compared to SECT 
attenuation in HU from reconstructions with matched image thickness and reconstruction 
filter for each lesion model used in the study.  Given that the SECT protocol was acquired 
at a single dose level, comparisons were made between the single SECT protocol and each 
CTDIvol value within the DECT protocol set.  For each lesion model 
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(Calcification/Hemorrhage, SECT attenuation (HU) level, lesion size and location) the mean 
and standard deviation of the error in HU between the SECT and optimal keV methods was 
calculated across all DECT protocol variations.   
Bland-Altman analysis was performed to assess the correlation between the SECT 
attenuation (HU) and optimal keV HU values.  To assess sources of variability, the analysis 
was repeated for subsets of the data based on all available parameters: CTDIvol, rotation 
time, image thickness, lesion identity and lesion size and location (See Chapter 4.1.7.5).  
The CV and R2 from the parameter-value specific Bland-Altman analyses were compared 
to the values derived from the analysis of the full data set.  Parameter-value specific R2 
values under 0.75 or CV values greater than 150% of the full data CV value were identified 
as major sources of variability in the method correlation.  Specific parameter values 
identified as major sources of variability were then removed from the full data set and the 
Bland-Altman analysis was repeated. 
 
4.1.9.2 Lesion Matching using SECT and optimal keV 
To ensure the matching of the calcification and hemorrhage models within the 
matched model pair, the difference in attenuation (HU) was calculated based on both SECT 
and optimal keV attenuation.  This was repeated for each matched model pair (SECT 
attenuation (HU) level, lesion size and location) and the mean and standard deviation of the 
difference in attenuation (HU) between the calcification and hemorrhage was calculated for 
SECT and optimal keV image types across all DECT protocol variations. 
 
4.2 Results 
4.2.1 Spectrally Equivalent Brain Material 
While all potential brain materials supplied by Gammex were equivalent to brain 
tissue using a single-energy acquisition (data not shown), the materials possessed very 
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different spectral characteristics using a dual-energy acquisition.  The results of the spectral 
HU analysis can be seen in Figure 4.7.  The stock Gammex brain material, shown in the 
figure as Gammex A, was similar to brain tissue on a single-energy acquisition using a 70 
keV dual-energy reconstruction but differed greatly from brain tissue with respect to its 
spectral signature.  Gammex B and C were more spectrally equivalent and ultimately, 
Gammex B was selected for our application based on this data. 
 
 
Figure 4.7:  Results of dual-energy analysis for potential spectrally equivalent brain materials.  
Spectral data from a clinical brain study (GE, Waukesha, WI; personal contact) is shown in 
black. 
 
A sagittal reformat of the polyurethane filled nuclear medicine phantom can be seen 
in Figure 4.8.  This view indicated the optimal position and thickness for both the cerebrum 
and skull base slabs within the cranial cavity.  Because the bony anatomy only extends 
upwards into the cranial cavity roughly 3 cm, the skull base slab was reduced from its 
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planned thickness of 4 cm to 3 cm.  The cerebrum brain slab was then positioned in line 
with the phantom split so that equal portions of the slab thickness were in the base and 
crown portions of the phantom.  This position also allowed for some intervening space 
between the end of the cerebrum slab and the start of the skull base slab.  To simplify 
construction, the center of the 4 cm thick cerebrum slab was aligned with the division 
between the base and crown of the phantom.   
 
 
Figure 4.8:  Sagittal reformat of intracranial lesion phantom showing potential positioning of 
cerebrum and skull base slabs.  Red lines show the relative thickness of the cerebrum vs the 
skull base brain slabs while the blue dotted line represents the upper bound of the imaging 
area affected by the bony anatomy of the skull base. 
 
Due to the organic shape of the phantom cranial cavity, the skull base brain slab 
was simplified into its major features and reduced in size slightly to allow for polyurethane 
to be poured around it in the final stage of phantom construction.  Similarly, the shape of 
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the cerebrum brain slab had to be simplified due to the organic shape, as well as, the 
mismatch between the base and crown of the phantom.  Because the edges of the skull 
component of the phantom did not meet perfectly, the outer contour of the slab was 
reduced to a simplified transition between the contours of the lower face of the slab to the 
contour of the upper face of the slab (Figure 4.9).  Additional material was removed as 
needed for easy placement and removal of the brain slab.  Polyurethane was then added to 
the outer contour of the cerebrum slab to fill air gaps left from this simplification and to 
ensure a tight fit in the phantom cranial cavity.  Due to early experiences with the phantom, 
the decision was made to provide some tool to aid the removal of the cerebrum slab from 
the base of the phantom.  A thin nylon ribbon was cured into the surrounding polyurethane 
and fed under the cerebrum slab.  This ribbon would then distribute the user’s force to the 
whole slab and break the vacuum commonly created between the brain and filler slabs. 
 
 
Figure 4.9:  Simplified structure of cerebrum slab based on upper and lower curvatures with 
arrow showing mismatch between phantom base and crown interiors. 
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4.2.2 Lesion Models 
Based on the results of the lesion rod imaging and ROI analysis (Chapter 4.1.3), 
calcification and hemorrhage lesion models free of any artifact or high variability were 
chosen at the required SECT attenuation (HU) levels.  Of the 28 lesion model pairs 
isolated, only four had greater than 1 HU difference between the calcification and 
hemorrhage models based on their mean HU value on the single-energy images (Table 
4.8).  The image location ranges and series numbers for the chosen lesion model positions 
were translated into lengths in mm from the end of the rod and the lesion rods were marked 
appropriately for milling. 
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Table 4.8:  Results of lesion rod imaging and ROI analysis using a SECT acquisition.  Green 
fields represent a matched model pair with < 1 HU difference between the calcification and 
hemorrhage model while orange represents a difference > 1 HU but < 2 HU. Gray regions 
represent data that’s not applicable given the skull base contained only 1.5 cm lesion models. 
   0.5 cm Lesion 1.0 cm Lesion 1.5 cm Lesion 
SECT HU Level Model Mean SECT HU Mean SECT HU Mean SECT HU 
Ce
re
br
um
 
40 
Calcification 40.14 40.06 40.10 
Hemorrhage 40.11 40.06 40.32 
Pair 0.03 0.00 0.22 
50 
Calcification 50.87 50.81 50.44 
Hemorrhage 50.92 50.70 50.62 
Pair 0.05 0.11 0.18 
60 
Calcification 60.20 59.86 60.10 
Hemorrhage 61.17 60.86 61.39 
Pair 0.97 1.01 1.29 
70 
Calcification 70.70 70.46 70.37 
Hemorrhage 71.40 71.42 71.64 
Pair 0.70 0.96 1.26 
80 
Calcification 79.99 80.09 79.92 
Hemorrhage 80.68 80.97 80.79 
Pair 0.69 0.88 0.87 
90 
Calcification 89.83 89.71 89.97 
Hemorrhage 90.22 90.21 90.53 
Pair 0.39 0.50 0.56 
100 
Calcification 100.20 100.41 100.08 
Hemorrhage 100.14 100.51 99.81 
Pair 0.06 0.10 0.27 
Sk
ul
l B
as
e 
40 
Calcification 39.92 
Hemorrhage 40.28 
Pair 0.36 
50 
Calcification 50.78 
Hemorrhage 50.65 
Pair 0.13 
60 
Calcification 60.25 
Hemorrhage 61.37 
Pair 1.12 
70 
Calcification 70.08 
Hemorrhage 71.00 
Pair 0.93 
80 
Calcification 79.92 
Hemorrhage 80.51 
Pair 0.59 
90 
Calcification 90.20 
Hemorrhage 90.79 
Pair 0.59 
100 
Calcification 99.98 
Hemorrhage 99.61 
Pair 0.37 
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Initial validation of milled lesion models identified two matched model pairs with sub-
optimal SECT attenuation (HU) matching (Table 4.9).  Two matched attenuation lesion 
pairs were identified as exceeding 3 HU error in matching between the calcification and 
hemorrhage: 0.5 cm cerebrum lesions at 50 HU and 1.5 cm skull base lesions at 100 HU. 
New regions were identified from the reserved lesion model rods for these two SECT 
attenuation (HU) levels (50 and 100 HU) and marked for milling.  These new lesion models 
were imaged using the single-energy protocol detailed in Table 4.3 and compared to the 
data from the old lesion models.  New matched model pairs were identified which would 
have matched attenuation to within 3 HU SECT (Table 4.10). 
 
Table 4.9:  Initial SECT attenuation (HU) matching of milled lesion model pairs (calcification 
and hemorrhage).  Green denotes matching < 2 HU, orange denotes matching < 3 HU and red 
denotes matching out of tolerance > 3 HU. 
∆ Mean SECT HU 
SECT HU Level 0.5 cm 1.0 cm 1.5 cm 
C
er
eb
ru
m
 
40 0.24 0.21 0.08 
50 3.99 0.22 0.77 
60 1.14 0.51 1.48 
70 2.24 1.42 1.07 
80 1.67 1.01 1.61 
90 2.24 0.78 0.21 
100 2.29 0.80 1.21 
Sk
ul
l B
as
e 
40 1.42 
50 0.46 
60 0.17 
70 0.21 
80 0.15 
90 1.46 
100 3.46 
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Table 4.10:  Final SECT attenuation (HU) matching of lesion model pairs (calcification and 
hemorrhage).  Green denotes matching < 2 HU, orange denotes matching < 3 HU and red 
denotes matching out of tolerance > 3 HU.  Note the improved lesion matching of the 50 HU, 
0.5 cm cerebrum and 100 HU, 1.5 cm skull base lesion pairs. 
∆ SECT Mean 
SECT HU Level 0.5 cm 1.0 cm 1.5 cm 
C
er
eb
ru
m
 
40 0.24 0.21 0.08 
50 0.51 0.22 0.77 
60 1.14 0.51 1.48 
70 2.24 1.42 1.07 
80 1.67 1.01 1.61 
90 2.24 0.78 0.21 
100 2.29 0.80 1.21 
Sk
ul
l B
as
e 
40 1.42 
50 0.46 
60 0.17 
70 0.21 
80 0.15 
90 1.46 
100 2.30 
 
 
4.2.3 Selection of Optimal keV Level for Simulated SECT Scanning 
In order to avoid the necessity of a separate single-energy acquisition that would 
increase patient dose and motion artifacts, we endeavored to determine the keV of a 
monoenergetic reconstruction that could be derived from the dual-energy acquisition but 
provide accurate SECT attenuation (HU) data.  Using the monoenergetic keV and the 
resulting attenuation (HU), a second order polynomial was used to determine the 
monoenergetic kVp necessary to produce an attenuation (HU) equivalent to that from a 
SECT acquisition.  This process was repeated for all inserts and dual-energy presets used 
in the study.  This optimal keV level for simulated single-energy scanning was found to 
have a mean of 68 keV with a standard deviation of 1.75 keV.  The minimum optimal keV 
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across all lesion models and dual-energy protocols was 65 keV while the maximum was 74 
keV.  The average error in the estimated HU using 68 keV and the SECT acquisition over 
all lesion models and dual-energy protocols was found to be 0.3 HU with a standard 
deviation of 1.4 HU.  The minimum and maximum errors were -2.6 HU and 2.6 HU 
respectively. 
 
4.2.4 Validation of Lesion Attenuation 
4.2.4.1 SECT attenuation (HU) Correlation with 68 keV HU 
Based on lesion data collected during Study 1, mean error was calculated between the 
attenuation (HU) estimation by the 68 keV reconstruction and the attenuation from the 
SECT acquisition performed as part of the overall protocol (Figure 4.10).  Analysis was 
divided by lesion identity and includes all protocol variations including reconstruction filter, 
CTDIvol and image thickness.  Mean errors based on protocol variation were within 3 HU for 
all cerebrum lesion models, and within 6 HU for skull base lesion models.  Averaging over 
all lesion parameters and protocol variations, the average mean error was found to be 0.5 
HU and 1 HU for calcification and hemorrhage respectively.  
Bland-Altman analysis of the attenuation from 68 keV and SECT for all available 
protocol and acquisition parameters resulted in a CV of 2.8% and an R2 of 0.990 (Figure 
4.11).  Repeated analysis for subsets of the data based on all available parameters yielded 
no major sources of variability based on the stated criteria (Table 4.11).     
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Figure 4.10: Error in attenuation (HU) measurement between SECT and 68 keV 
reconstructions for both calcification and hemorrhage models.  Error bars represent one 
standard deviation (SD) of the distribution accounting for all image thickness, CTDIvol and 
reconstruction filter protocol variations. 
 
 
 
Figure 4.11: Bland-Altman and Correlation graphs for the correlation of SECT attenuation 
(HU) to 68 keV HU.  Data includes all protocol variations and lesion models. 
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Table 4.11: Sorted results of Bland-Altman analysis of the correlation of attenuation (HU) from 
68 keV and SECT acquisitions organized for subsets of the data based on available protocol 
and lesion parameters.  Parameters and values above the double line indicate worse 
correlation or linearity than the analysis of the full data set while those below the double line 
indicate improved correlation or linearity. 
CV - Correlation Rsquared - Linearity 
Full Data CV Criteria Cutoff Full Data R2 Criteria 
2.8 150% 4.2 0.9903 < 0.75 
Parameter Value CV Parameter Value R2 
Lesion Model 1.5 cm Skull Base 3.5 CTDIvol 132.6 0.988 
CTDIvol 132.6 3.1 CTDIvol 99.8 0.989 
Image Thickness 2.5 2.9 CTDIvol 105.6 0.989 
CTDIvol 105.6 2.9 CTDIvol 117.1 0.989 
CTDIvol 117.1 2.9 Image Thickness 2.5 0.990 
Image Thickness 1.25 2.8 CTDIvol 81 0.990 
CTDIvol 81 2.8 Lesion Model 1.5 cm Skull Base 0.990 
CTDIvol 99.8 2.8 Image Thickness 1.25 0.990 
Lesion Identity Hemorrhage 2.8 Lesion Identity Hemorrhage 0.990 
Image Thickness 3.75 2.7 Image Thickness 3.75 0.991 
Image Thickness 5 2.7 Lesion Identity Calcification 0.991 
Rotation Time 0.9 2.7 Image Thickness 5 0.991 
Lesion Identity Calcification 2.7 Rotation Time 0.5 0.991 
CTDIvol 67 2.6 Rotation Time 0.9 0.991 
Rotation Time 0.5 2.6 Rotation Time 0.6 0.991 
Rotation Time 0.6 2.6 Rotation Time 0.8 0.992 
Rotation Time 0.8 2.6 CTDIvol 44.6 0.992 
CTDIvol 44.6 2.5 CTDIvol 67 0.992 
CTDIvol 54.7 2.4 CTDIvol 54.7 0.993 
CTDIvol 64.2 2.4 CTDIvol 64.2 0.993 
Lesion Model 0.5 cm Cerebrum 2.4 CTDIvol 57.9 0.994 
Rotation Time 0.7 2.4 CTDIvol 72.7 0.994 
CTDIvol 57.9 2.3 Lesion Model 0.5 cm Cerebrum 0.994 
CTDIvol 72.7 2.3 Rotation Time 0.7 0.994 
CTDIvol 36.7 2.2 CTDIvol 36.7 0.995 
Lesion Model 1.0 cm Cerebrum 1.4 Lesion Model 1.0 cm Cerebrum 0.998 
Lesion Model 1.5 cm Cerebrum 1.3 Lesion Model 1.5 cm Cerebrum 0.998 
 
 
69 
 
4.2.4.2 Lesion Matching using SECT and 68 keV 
Average differences between the calcification and hemorrhage models within each 
matched model pair are shown in Figure 4.12 for both 68 keV and SECT acquisitions.  Error 
bars represent one standard deviation (SD) based on the combined data across all protocol 
variations.  Based on evaluation using SECT, all matched model pairs had differences in 
attenuation of less than 3 HU.  Evaluation using 68 keV reconstruction closely followed the 
SECT results, however the two methods agreed to a lesser extent in the skull base.  This 
result is not unexpected given the greater errors between SECT and 68 keV attenuation 
measurements in the skull base, shown in Chapter 4.2.4.1. 
 
 
Figure 4.12:  Lesion matching results based on SECT and 68 keV attenuation evaluation.  
Values represent mean difference in calcification and hemorrhage models across all available 
protocol variations.  Error bars represent one SD of this distribution.   
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4.2.5 Determination of Differentiation Accuracy 
Using the methods described in Chapter 4.1.5 and the scan protocol outlined in 
Table 4.3 and Table 4.4, a total of 407,925 images were collected for analysis across the 
three studies.  Of those images collected, 95,571 images were used to collect a total of 
230,517,252 unique voxels used in the analysis of lesion differentiation. 
 
4.2.5.1 Gaussian Mixture Model Analysis 
By averaging over all three studies and all imaging techniques investigated, the 
effect of lesion size and location on GMM differentiation accuracy can be easily seen 
(Figure 4.13).  Error bars represent one standard deviation within each distribution.  
Differentiation accuracy under 80% is shaded in dark gray while differentiation accuracy 
between 80% and 90% is shaded in light gray.  Averaged over all imaging protocols 
investigated, the maximum average accuracy at 100 HU was 58%, 73% and 97% for the 
0.5 cm cerebrum, 1.0 cm cerebrum and 1.5 cm cerebrum matched model pairs 
respectively.  The maximum average accuracy at 100 HU was 81% for the 1.5 cm skull 
base matched model pair, reflecting the more challenging imaging environment of the skull 
base. 
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Figure 4.13:  Accuracy of 3D GMM differentiation for intracranial lesion pairs based on lesion 
model size and location. Displayed values represent mean of accuracy across the three 
studies and all protocol variations: CTDIvol, image thickness and reconstruction filter. Error 
bars represent one SD of the distribution. 
 
Accuracy results were then graphed by relevant protocol factors including CTDIvol, 
image thickness and reconstruction filter.  In all graphs, darker colored lines were used to 
indicate an increase in protocol value; be it an increase in dose level, image thickness, or 
perceived noise.  Accuracy results graphed by CTDIvol (mGy), revealed increasing GMM 
differentiation accuracy with increasing dose level for 1.5 cm lesion models in the cerebrum 
and skull base (Figure 4.14).  No dose effect was observed in 0.5 cm or 1.0 cm cerebrum 
lesion models.  The effect of dose on differentiation accuracy was more pronounced at 
higher matched model pair SECT attenuation (HU) levels. 
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Figure 4.14: Differentiation Accuracy using Gaussian Mixture Model (GMM) method analyzed 
by CTDIvol.  Displayed values represent mean of accuracy across the three studies and 
additional protocol variations: image thickness and reconstruction filter. Error bars represent 
one SD for each distribution. 
 
Accuracy results graphed by image thickness (mm), revealed increasing GMM 
differentiation accuracy with increasing image thickness (Figure 4.15) for all lesion models 
except the 0.5 cm cerebrum.  Again, the effect of increased image thickness on 
differentiation accuracy was more pronounced at higher matched model pair SECT 
attenuation (HU) levels.   
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Figure 4.15: Differentiation Accuracy using Gaussian Mixture Model (GMM) method analyzed 
by image thickness.  Displayed values represent mean of accuracy across the three studies 
and additional protocol variations: CTDIvol and reconstruction filter. Error bars represent one 
SD for each distribution. 
 
 
Accuracy results graphed by reconstruction filter showed that decreasing smoothing 
increased GMM differentiation accuracy in the 1.0 cm cerebrum lesions (Figure 4.16).  All 
other lesions showed no effect of filter selection on GMM differentiation accuracy.  Error 
bars represent variation across CTDIvol, image thickness and study and show considerable 
overlap between the reconstruction filter types. 
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Figure 4.16: Differentiation Accuracy using Gaussian Mixture Model (GMM) method analyzed 
by reconstruction filter.  Displayed values represent mean of accuracy across the three 
studies and additional protocol variations: CTDIvol and image thickness. Error bars represent 
one SD for each distribution 
 
 
4.2.5.2 Gaussian Mixture Model Instability 
Particularly of note from the GMM results was the unexpected plateau in 
differentiation accuracy at 80 HU and above for the 1 cm cerebrum matched lesion pair.  
Given the similarity in size between these lesion models and the gel vials used in the 
physics model (Chapter 3), these results were unexpected.  Investigation into the results of 
the 1,000 GMMs for all lesion model attenuations for a given acquisition showed that the 
distribution of the differentiation accuracies was, in fact, bimodal (Figure 4.17) 
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Figure 4.17:  Distribution of differentiation accuracy results from 7,000 GMMs (1,000 per 
lesion pair) graphed versus the attenuation of lesion pair.  Data represents 67 mGy CTDIvol, 
3.75 mm image thickness, standard filter acquisition of 1 cm cerebrum matched lesion pairs. 
 
Further analysis pursued by plotting the component accuracies, calcification model 
accuracy and hemorrhage model accuracy, with the general matched model pair result 
(Figure 4.18).  The general matched model pair accuracy was in all cases primarily affected 
by the calcification model component accuracy, while the hemorrhage model component 
accuracy was always greater than 80%.   
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Figure 4.18:  Differentiation accuracy results for calcification model, hemorrhage model and 
combined matched model pair.  Error bars represent standard deviation in accuracy value 
over the 1,000 GMM repetitions.  Data represents 67 mGy CTDIvol, 3.75 mm image thickness, 
standard filter acquisition of 1 cm cerebrum matched lesion pairs.  
 
The 80 HU matched lesion pair data for this acquisition method was visualized and 
seen to be non-Gaussian in nature (Figure 4.19).  Outliers are assumed to be a result of 
inadequate mixing of the compound additives, calcium carbonate or iron oxide, into the 
background material leaving areas of reduced attenuation.  Given that the prime 
assumption of a Gaussian data distribution was invalidated, the GMM iterative fit of the two 
potentially overlapping Gaussian distributions was unstable resulting in two general 
solutions. The first solution yielded hemorrhage and calcification distributions that included 
their respective outliers resulting in high calcification model accuracy and high overall 
matched model pair accuracy.  The second solution yielded a hemorrhage distribution 
covering both the calcification and hemorrhage main distributions and a calcification 
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distribution covering all outliers.  This resulted in a low calcification model accuracy and 
thus high overall matched model pair accuracy. 
 
 
Figure 4.19:  Top: Raw voxel data from a CTDIvol, 3.75 mm image thickness, standard filter 
acquisition of 1 cm cerebrum matched lesion pairs at 80 HU.  Lower Left: GMM solution 
resulting in high calcification model and overall matched model pair accuracies.  Lower 
Right: GMM solution resulting in low calcification model and overall matched model pair 
accuracies.  
 
Based on these results revealing the instability of the GMM analysis, this method 
was dropped from all further analysis, including Studies 2 and 3.  Only the geometric 
bisector and support vector machine methods were retained. 
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4.2.5.3 Support Vector Machine (SVM) Analysis 
By averaging over all three studies and all imaging techniques investigated, the 
effect of lesion size and location on SVM differentiation accuracy can be easily seen (Figure 
4.20).  Error bars represent one standard deviation within each distribution.  Differentiation 
accuracy under 80% is shaded in dark gray while differentiation accuracy between 80% and 
90% is shaded in light gray.  Averaged over all imaging protocols investigated, the 
maximum average accuracy at 100 HU was 78%, 92% and 96% for the 0.5 cm cerebrum, 
1.0 cm cerebrum and 1.5 cm cerebrum matched model pairs respectively.  The maximum 
average accuracy at 100 HU was 90% for the 1.5 cm skull base matched model pair, 
reflecting the more challenging imaging environment of the skull base. 
Compared to GMM analysis (Figure 4.13), SVM analysis increased the average 
maximum differentiation accuracy by 20% for 0.5 cm cerebrum lesions, 29% for 1.0 cm 
cerebrum lesions and 8% for 1.5 cm skull base lesions.  No improvement was seen in 1.5 
cm cerebrum lesions.   
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Figure 4.20:  Differentiation accuracy using support vector machine method.  Displayed 
values represent mean of accuracy across the three studies and all protocol variations: 
CTDIvol, image thickness and reconstruction filter. Error bars represent one SD of the 
distribution. 
 
Accuracy results were then graphed by relevant protocol factors including CTDIvol, 
image thickness and reconstruction filter.  In all graphs, darker colored lines were used to 
indicate an increase in protocol value; be it an increase in dose level, image thickness, or 
perceived noise.  Accuracy results graphed by CTDIvol (mGy), revealed increasing SVM 
differentiation accuracy with increasing dose level (Figure 4.21).  Note that error bars 
represent variation across image thickness, reconstruction filter and study.  The effect of 
dose on differentiation accuracy was more pronounced at higher matched model pair SECT 
attenuation (HU) levels. 
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Figure 4.21:  Differentiation accuracy using support vector machine method analyzed by 
CTDIvol.  Displayed values represent mean of accuracy across the three studies and additional 
protocol variations: image thickness and reconstruction filter. Error bars represent one SD 
for each distribution. 
 
Accuracy results graphed by image thickness (mm), revealed increasing SVM 
differentiation accuracy with increasing image thickness (Figure 4.22).  In this case, error 
bars represent variation across CTDIvol, reconstruction filter and study.  Again, the effect of 
increased image thickness on differentiation accuracy was more pronounced at higher 
matched model pair SECT attenuation (HU) levels.   
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Figure 4.22:  Differentiation accuracy using support vector machine method analyzed by 
image thickness.  Displayed values represent mean of accuracy across the three studies and 
additional protocol variations: CTDIvol and reconstruction filter. Error bars represent one SD 
for each distribution. 
 
Accuracy results graphed by reconstruction filter showed no effect of filter selection 
on SVM differentiation accuracy (Figure 4.23).  Error bars represent variation across 
CTDIvol, image thickness and study and show considerable overlap between the 
reconstruction filter types.  Based on these results, further analysis and visualization of 
support vector machine data was limited to Standard filter to facilitate viewing of the multi-
dimensional data gathered in this study.   
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Figure 4.23:  Differentiation accuracy using support vector machine method analyzed by 
reconstruction filter.  Displayed values represent mean of accuracy across the three studies 
and additional protocol variations: CTDIvol and image thickness. Error bars represent one SD 
for each distribution. 
 
Surface plots for the SVM differentiation accuracy based on attenuation (HU) level 
of the matched model pair and the CTDIvol of the acquisition were created for all lesion 
sizes and locations (Figure 4.24, Figure 4.25).  Data for all image thickness values 
investigated are shown; all data shown are based on a Standard reconstruction filter.  A 
transparent gray plane was included to show 90% differentiation accuracy.  The array of 
plots shows the effect of these lesion (size and location) and acquisition parameters on the 
final SVM differentiation accuracy.  Increasing CTDIvol, attenuation (HU) level of the 
matched model pair, image thickness and lesion size all resulted in increased SVM 
differentiation accuracy. 
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Based on a second order power fit of available data from studies 1-3, the CTDIvol 
(mGy) to ensure 90% SVM differentiation accuracy for a given matched model pair 
attenuation (HU) was calculated.  The results of this calculation for all available SECT 
attenuation (HU) levels and image thicknesses are shown in Table 4.12.  Given that 
reconstruction filter was found to have no effect on differentiation accuracy, the results were 
limited to the standard filter to facilitate visualization of the data.  
Curve fits of 90-100 HU 1 cm lesions in the cerebrum estimating dose necessary for 
90% SVM differentiation accuracy resulted in CTDIvol values below the minimum 
investigated level using 3.75 or 5 mm thick images.  This implies that all dose levels 
investigated would result in 90% differentiation accuracy using SVM method and 3.75-5 mm 
thick images. This was also the case for 1.5 cm cerebrum lesions of 90-100 HU acquired 
with 3.75 or 5 mm thick images.  With the exception of 100 HU lesions acquired with 3.75-5 
mm thick images, none of the 0.5 cm cerebrum lesions were differentiated with greater than 
90% accuracy for any of the CTDIvol levels currently available for use on the DECT scanner. 
In addition, a second order power fit of available data from studies 1-3 was used to 
calculate the attenuation (HU) to ensure 90% SVM differentiation accuracy assuming a 
specific CTDIvol (mGy) value. The results of this calculation for all available CTDIvol values 
and image thicknesses are shown in Table 4.13.  Given that reconstruction filter was found 
to have no effect on differentiation accuracy, the results were limited to the standard filter to 
facilitate visualization of the data. In general, the curve fit for 0.5 cm cerebrum lesions 
resulted in attenuation values above 100 HU for most CTDIvol and image thickness 
combinations.  This implies that investigation of 0.5 cm cerebrum lesions using these 
methods would not provide additional information beyond that already available using 
SECT.  Curve fits for 1.5 cm cerebrum lesions resulted in attenuation values under 100 HU 
using all CTDIvol values investigated using either 3.75 or 5 mm image thickness.  In general, 
the HU value to ensure 90% differentiation accuracy decreased with both increasing image 
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thickness and CTDIvol, as expected.  A graphical representation of these data is shown in 
Figure 4.26 with the shaded region representing lesion attenuations already differentiable 
using conventional SECT. The un-shaded region, therefore, represents previously un-
differentiable lesion attenuations now differentiable with high accuracy using various DECT 
imaging techniques.   
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Figure 4.26:  Graphical representation of lesion attenuation (HU) necessary for 90% SVM 
differentiation accuracy by acquisition parameters (Table 4.13).  The un-shaded region 
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the 
current clinical limit of 100 HU imposed by SECT.  
 
4.2.5.4 Geometric Bisector (GB) Analysis 
By averaging over all three studies and all imaging techniques investigated, the 
effect of lesion size and location on GB differentiation accuracy can be easily seen (Figure 
4.27).  Error bars represent one standard deviation within each distribution.  Differentiation 
accuracy under 80% is shaded in dark gray while differentiation accuracy between 80% and 
90% is shaded in light gray.  Averaged over all imaging protocols investigated, the 
maximum average accuracy at 100 HU was 77%, 92% and 95% for the 0.5 cm cerebrum, 
1.0 cm cerebrum and 1.5 cm cerebrum matched model pairs respectively.  The maximum 
average accuracy at 100 HU was 91% for the 1.5 cm skull base matched model pair, 
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reflecting the more challenging imaging environment of the skull base.  The average 
differentiation accuracies predicted for 100 HU lesions for SVM (Figure 4.20) and GB 
analyses were within 1%, potentially indicating a high degree of correlation between the 
methods.    
 
Figure 4.27:  Differentiation accuracy using geometric bisector method.  Displayed values 
represent mean of accuracy across the three studies and all protocol variations: CTDIvol, 
image thickness and reconstruction filter. Error bars represent one SD of the distribution. 
 
Accuracy results were then graphed by relevant protocol factors including CTDIvol, 
image thickness and reconstruction filter.  In all graphs, darker colored lines were used to 
indicate an increase in protocol value; be it an increase in dose level, image thickness, or 
perceived noise.  Accuracy results graphed by CTDIvol (mGy), revealed increasing GB 
differentiation accuracy with increasing dose level (Figure 4.28).  Note that error bars 
represent variation across image thickness, reconstruction filter and study.  The effect of 
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dose on differentiation accuracy was more pronounced at higher matched model pair SECT 
attenuation (HU) levels. 
 
 
Figure 4.28:  Differentiation accuracy using geometric bisector method analyzed by CTDIvol.  
Displayed values represent mean of accuracy across the three studies and additional 
protocol variations: image thickness and reconstruction filter. Error bars represent one SD 
for each distribution. 
 
Accuracy results graphed by image thickness (mm), revealed increasing GB 
differentiation accuracy with increasing image thickness (Figure 4.29).  In this case, error 
bars represent variation across CTDIvol, reconstruction filter and study.  Again, the effect of 
increased image thickness on differentiation accuracy was more pronounced at higher 
matched model pair SECT attenuation (HU) levels.   
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Figure 4.29:  Differentiation accuracy using geometric bisector method analyzed by image 
thickness.  Displayed values represent mean of accuracy across the three studies and 
additional protocol variations: CTDIvol and reconstruction filter. Error bars represent one SD 
for each distribution. 
 
Accuracy results graphed by reconstruction filter showed no effect of filter selection 
on GB differentiation accuracy (Figure 4.30).  Error bars represent variation across CTDIvol, 
image thickness and study and show considerable overlap between the reconstruction filter 
types.  Based on these results, further analysis and visualization of geometric bisector data 
was limited to Standard filter to facilitate viewing of the multi-dimensional data gathered in 
this study.   
 
 
40
50
60
70
80
90
100
40 50 60 70 80 90 10
0 40 50 60 70 80 90 10
0 40 50 60 70 80 90 10
0 40 50 60 70 80 90 10
0
0.5 1 1.5 1.5
Cerebrum Skull Base
Di
ffe
re
nt
ia
tio
n 
Ac
cu
ra
cy
 
SECT HU Level  
 
Lesion Size (cm)  
 
Location 
GB Differentiation Accuracy by Image Thickness (mm) 
5
3.75
2.5
1.25
93 
 
 
Figure 4.30:  Differentiation accuracy using geometric bisector method analyzed by 
reconstruction filter.  Displayed values represent mean of accuracy across the three studies 
and additional protocol variations: CTDIvol and image thickness. Error bars represent one SD 
for each distribution. 
 
Surface plots for the GB differentiation accuracy based on attenuation (HU) level of 
the matched model pair and the CTDIvol of the acquisition were created for all lesion sizes 
and locations (Figure 4.31, Figure 4.32).  Data for all image thickness values investigated 
are shown; all data shown are based on a Standard reconstruction filter.  A transparent 
gray plane was included to show 90% differentiation accuracy.  The array of plots shows 
the effect of these lesion (size and location) and acquisition parameters on the final GB 
differentiation accuracy.  Increasing CTDIvol, attenuation (HU) level of the matched model 
pair, image thickness and lesion size all result in increased GB differentiation accuracy.  
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Based on a second order power fit of available data from studies 1-3, the CTDIvol 
(mGy) to ensure 90% GB differentiation accuracy for a given matched model pair 
attenuation (HU) was calculated.  The results of this calculation for all available SECT 
attenuation (HU) levels and image thicknesses are shown in Table 4.14.  Given that 
reconstruction filter was found to have no effect on differentiation accuracy, the results were 
limited to the standard filter to facilitate visualization of the data.  
Curve fits for 100 HU 1 cm lesions in the cerebrum estimating dose necessary for 
90% GB differentiation accuracy resulted in CTDIvol values below the minimum investigated 
level when using 5 mm image thickness.  This implies that all dose levels investigated 
would result in 90% differentiation accuracy using the GB method and 5 mm-thick images.  
This was also the case for 1.5 cm cerebrum lesions of 90 to 100 HU acquired with 3.75 or 5 
mm-thick images.  None of the 0.5 cm cerebrum lesions were differentiated with greater 
than 90% accuracy for any of the CTDIvol levels currently available for use on the DECT 
scanner. 
In addition, a second order power fit of available data from studies 1-3 was used to 
calculate the attenuation (HU) to ensure 90% GB differentiation accuracy assuming a 
specific CTDIvol (mGy) value. The results of this calculation for all available CTDIvol values 
and image thicknesses are shown in Table 4.15.  Given that reconstruction filter was found 
to have no effect on differentiation accuracy, the results were limited to the standard filter to 
facilitate visualization of the data.  
With the possible exception of 105.6 and 132.6 mGy acquisitions reconstructed at 5 
mm image thickness, curve fits for 0.5 cm cerebrum lesions resulted in attenuation values 
above 100 HU for all CTDIvol and image thickness combinations.  This implies that 
investigation of 0.5 cm cerebrum lesions using these methods would not provide additional 
information beyond that already available using SECT.  Curve fits for 1.5 cm cerebrum 
lesions resulted in attenuation values under 100 HU using all CTDIvol values investigated 
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using either 3.75 or 5 mm image thickness.  In general, the HU value to ensure 90% 
differentiation accuracy decreased with both increasing image thickness and CTDIvol, as 
expected.  A graphical representation of these data is shown in Figure 4.33 with the shaded 
region representing lesion attenuations already differentiable using conventional SECT. The 
un-shaded region, therefore, represents previously un-differentiable lesion attenuations now 
differentiable with high accuracy using various DECT imaging techniques.    
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Figure 4.33: Graphical representation of lesion attenuation (HU) necessary for 90% GB 
differentiation accuracy by acquisition parameters (Table 4.15).  The un-shaded region 
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the 
current clinical limit of 100 HU imposed by SECT. 
 
4.2.5.5 Generalized Geometric Bisector (GGB) Solution 
The results of the parameter-specific geometric bisector planes can be seen in Table 
4.16.  The major sources of variability identified were the 0.5 cm cerebrum lesions and 1.5 
cm skull base lesions.  All other accuracy differences were less than 2%. Plane coefficients 
were remarkably stable across parameter-specific solutions.  The equations for the three 
generalized geometric bisector plane solutions can be found in Table 4.17. 
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Table 4.16:  Results of parameter-specific geometric bisector plane calculations.  Both raw 
accuracy and accuracy difference (relative to all data solution) are shown.  Plane coefficients 
follow the equation form Ax+By+Cz+D = 0, where x is water density, y is calcium density and 
z is measured attenuation (HU) at 68 keV.  Those parameters identified as major sources of 
variability based on their accuracy difference are shown in red.  Note: Location (Skull Base) 
and Lesion Model (1.5 cm Skull Base) represent identical analysis because only 1.5 cm 
lesions were evaluated in the skull base. 
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 Plane Equation Coefficients  
Parameter Value A B C D Accuracy Accuracy Difference 
Lesion Model 0.5 cm Cerebrum -0.93 0.37 0.03 939.94 69.82 -5.74 
Location Skull Base -0.94 0.33 -0.07 950.47 73.31 -2.26 
Lesion Model 1.5 cm Skull Base -0.94 0.33 -0.07 950.47 73.31 -2.26 
CTDIvol 44.6 -0.94 0.34 -0.06 949.74 74.04 -1.53 
Rotation 0.5 -0.94 0.33 -0.08 952.76 74.24 -1.32 
CTDIvol 81.4 -0.94 0.32 -0.10 955.18 74.43 -1.14 
Location Cerebrum -0.94 0.33 -0.07 955.73 75.07 -0.50 
Lesion Model 1.0 cm Cerebrum -0.94 0.34 -0.05 952.84 75.11 -0.46 
Lesion Model 1.5 cm Cerebrum -0.94 0.33 -0.08 957.56 75.24 -0.33 
CTDIvol 36.7 -0.94 0.34 -0.05 951.76 75.38 -0.19 
CTDIvol 57.9 -0.94 0.33 -0.06 954.30 75.42 -0.15 
CTDIvol 54.7 -0.94 0.34 -0.06 952.51 75.48 -0.09 
Filter Detail -0.94 0.34 -0.06 953.13 75.49 -0.07 
Image 
Thickness 1.25 -0.94 0.33 -0.06 953.41 75.52 -0.05 
CTDIvol 117.1 -0.94 0.32 -0.09 956.48 75.52 -0.05 
CTDIvol 64.2 -0.94 0.33 -0.08 954.84 75.52 -0.05 
Rotation 0.7 -0.94 0.33 -0.07 954.83 75.53 -0.04 
Rotation 0.6 -0.94 0.33 -0.07 953.87 75.54 -0.03 
CTDIvol 105.6 -0.94 0.32 -0.10 958.35 75.56 -0.01 
Image 
Thickness 2.5 -0.94 0.33 -0.08 955.71 75.56 -0.01 
CTDIvol 99.8 -0.94 0.33 -0.08 955.09 75.57 0.00 
All Data All Data -0.94 0.33 -0.08 955.18 75.57 0.00 
Filter Soft -0.94 0.32 -0.09 956.78 75.57 0.00 
Filter Standard -0.94 0.33 -0.08 955.43 75.57 0.00 
CTDIvol 67 -0.94 0.33 -0.09 957.28 75.59 0.02 
Image 
Thickness 5 -0.94 0.32 -0.11 957.92 75.60 0.03 
Image 
Thickness 3.75 -0.94 0.32 -0.10 957.52 75.60 0.03 
Rotation 0.8 -0.94 0.33 -0.08 956.11 75.64 0.08 
Rotation 0.9 -0.94 0.32 -0.10 957.71 75.66 0.09 
CTDIvol 72.7 -0.94 0.33 -0.09 956.81 75.66 0.09 
CTDIvol 132.6 -0.94 0.32 -0.11 958.48 75.67 0.10 
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Table 4.17: Generalized geometric bisector plane results assuming prior knowledge of lesion 
location and size. Plane coefficients follow the equation form Ax+By+Cz+D = 0, where x is 
water density, y is calcium density and z is measured attenuation (HU) at 68 keV.   
 Plane Equation Coefficients 
Lesion Population A B C D 
Cerebrum Lesions ≤ 0.5 cm diameter -0.93 0.37 0.03 939.94 
Cerebrum Lesions > 0.5 cm diameter -0.94 0.33 -0.07 956.15 
Skull Base Lesions -0.94 0.33 -0.07 950.47 
 
 
4.2.5.6 Inter-Method Correlation 
Inter-method correlation of geometric bisector and support vector machine resulted 
in a CV correlation of 2.6% and R2 linearity of 0.980.  Repeated analysis for subsets of the 
data based on all available parameters yielded one major source of variability based on CV 
and R2 cutoff criteria: 0.5 cm Cerebrum matched model pairs (Table 4.18).  Bland-Altman 
and correlation graphs for the full data as well as the 0.5 cm Cerebrum matched model pair 
data can be seen in Figure 4.34.  Removing these data from analysis reduced the overall 
CV correlation to 1.7% and increased the R2 linearity to 0.988. 
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Table 4.18:  Sorted results of Bland-Altman analysis for inter-method correlation between 
SVM and GB methods for subsets of data based on available protocol and lesion parameters.  
Parameters and values above the double line indicate worse correlation or linearity than the 
full data set while those below the double line indicate improved correlation or linearity.  Text 
in red indicates a major source of variability based on CV or R2 cutoff criteria. 
CV – Correlation Rsquared - Linearity 
Full Data CV Criteria Cutoff Full Data R2 Criteria 
2.61 150% 3.92 0.9803 < 0.75 
Parameter Value CV Parameter Value R2 
Lesion Model 0.5 cm Cerebrum 4.9 Lesion Model 0.5 cm Cerebrum 0.942 
ImageThickness 3.75 2.8 CTDIvol 36.7 0.974 
CTDIvol 36.7 2.8 ImageThickness 5 0.976 
Study 3 2.8 CTDIvol 54.7 0.976 
CTDIvol 54.7 2.8 CTDIvol 132.6 0.977 
ImageThickness 5 2.8 ImageThickness 3.75 0.977 
CTDIvol 105.6 2.8 CTDIvol 72.7 0.977 
CTDIvol 132.6 2.8 RotationTime 0.9 0.977 
RotationTime 0.9 2.8 CTDIvol 105.6 0.978 
CTDIvol 72.7 2.67 RotationTime 0.6 0.978 
RotationTime 0.6 2.7 CTDIvol 99.8 0.979 
CTDIvol 57.9 2.6 Study 3 0.979 
RotationTime 0.7 2.6 CTDIvol 81.4 0.980 
RotationTime 0.8 2.6 RotationTime 0.7 0.981 
CTDIvol 44.6 2.5 RotationTime 0.5 0.981 
CTDIvol 99.8 2.5 Study 1 0.981 
Study 1 2.5 CTDIvol 44.6 0.981 
RotationTime 0.5 2.5 CTDIvol 57.9 0.981 
Study 2 2.45 RotationTime 0.8 0.981 
CTDIvol 117.1 2.5 Study 2 0.981 
CTDIvol 81.4 2.5 ImageThickness 2.5 0.982 
ImageThickness 2.5 2.4 CTDIvol 117.1 0.982 
CTDIvol 67 2.3 CTDIvol 64.2 0.983 
CTDIvol 64.2 2.3 CTDIvol 67 0.983 
Lesion Model 1.5 cm Skull Base 2.1 Lesion Model 1.5 cm Skull Base 0.984 
ImageThickness 1.25 2.1 ImageThickness 1.25 0.985 
Lesion Model 1.0 cm Cerebrum 1.6 Lesion Model 1.0 cm Cerebrum 0.985 
Lesion Model 1.5 cm Cerebrum 1.2 Lesion Model 1.5 cm Cerebrum 0.994 
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Figure 4.34: Bland-Altman and Correlation graphs for inter-method correlation between SVM 
and GB methods.  Top: Full data results including all protocol variations and lesion models.  
Middle: Results for 0.5 cm cerebrum matched model pair, identified as a major source of 
variability in Table 4.18.  Bottom: Results for full data excluding 0.5 cm cerebrum matched 
model pair values. 
106 
 
4.2.6 Inter-Scanner and Intra-Scanner Correlation 
4.2.6.1 Inter-Scanner Correlation 
Support Vector Machine Inter-Scanner Correlation 
Inter-scanner correlation of Study 1 and Study 3 based on support vector machine 
differentiation accuracy data resulted in a CV correlation of 8.1% and R2 linearity of 0.824.  
Repeated analysis for subsets of the data based on all available protocol and lesion 
parameters yielded three major sources of variability based on CV and R2 cutoff criteria: 
44.6 mGy CTDIvol, 0.5 cm Cerebrum matched model pairs and 0.5sec rotation time (Table 
4.19).  Bland-Altman and correlation graphs for the full data as well as the parameters and 
values identified as major sources of variability can be seen in Figure 4.35.  Removing the 
data for these major sources of variability from analysis reduced the overall CV correlation 
to 4.8% and increased the R2 linearity to 0.908.  Note that extreme outliers in the correlation 
were influenced by all three major sources of variability: 0.5 cm lesion models scanned 
using 44.6 mGy CTDIvol and a 0.5sec rotation time.   
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Table 4.19: Sorted results of Bland-Altman analysis of SVM inter-scanner correlation for 
subsets of data based on available protocol and lesion parameters.  Parameters and values 
above the double line indicate worse correlation or linearity than the full data set while those 
below the double line indicate improved correlation or linearity.  Text in red indicates a major 
source of variability based on CV or R2 cutoff criteria. 
CV - Correlation Rsquared - Linearity 
Full Data CV Criteria Cutoff Full Data R2 Criteria 
8.1 150% 12.2 0.824 < 0.75 
Parameter Value CV Parameter Value R2 
CTDIvol 44.6 15.2 CTDIvol 44.6 0.467 
Lesion Model 0.5 cm Cerebrum 14.9 Lesion Model 0.5 cm Cerebrum 0.561 
RotationTime 0.5 12.5 RotationTime 0.5 0.596 
CTDIvol 81.4 9.7 CTDIvol 81.4 0.756 
ImageThickness 3.75 9.6 ImageThickness 3.75 0.764 
CTDIvol 54.7 8.5 CTDIvol 36.7 0.795 
CTDIvol 36.7 8.5 ImageThickness 5 0.802 
ImageThickness 5 8.4 Lesion Model 1.0 cm Cerebrum 0.817 
RotationTime 0.7 7.8 RotationTime 0.7 0.827 
RotationTime 0.6 7.7 CTDIvol 54.7 0.833 
CTDIvol 57.9 7.6 CTDIvol 67 0.840 
CTDIvol 67 7.3 RotationTime 0.6 0.843 
ImageThickness 2.5 7.3 CTDIvol 57.9 0.844 
RotationTime 0.9 7.1 CTDIvol 99.8 0.850 
CTDIvol 72.7 7.1 ImageThickness 2.5 0.852 
CTDIvol 99.8 7.0 CTDIvol 64.2 0.864 
CTDIvol 132.6 7.0 CTDIvol 72.7 0.864 
CTDIvol 64.2 6.6 RotationTime 0.9 0.865 
ImageThickness 1.25 6.3 ImageThickness 1.25 0.867 
RotationTime 0.8 6.3 CTDIvol 132.6 0.870 
CTDIvol 105.6 5.5 RotationTime 0.8 0.892 
Lesion Model 1.0 cm Cerebrum 5.5 Lesion Model 1.5 cm Skull Base 0.902 
Lesion Model 1.5 cm Skull Base 5.4 CTDIvol 105.6 0.916 
CTDIvol 117.1 5.1 Lesion Model 1.5 cm Cerebrum 0.929 
Lesion Model 1.5 cm Cerebrum 4.1 CTDIvol 117.1 0.933 
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Geometric Bisector Inter-Scanner Correlation 
Inter-scanner correlation of Study 1 and Study 3 based on geometric bisector 
differentiation accuracy data resulted in a CV correlation of 8.3% and R2 linearity of 0.814.  
Repeated analysis for subsets of the data based on all available protocol and lesion 
parameters yielded three major sources of variability based on CV and R2 cutoff criteria: 
44.6 mGy CTDIvol, 0.5 cm Cerebrum matched model pairs and 0.5sec rotation time (Table 
4.20).  Based solely on R2 criteria, an additional two parameters were identified as major 
sources of variability: 81.4 mGy CTDIvol and 3.75 mm image thickness.  Bland-Altman and 
correlation graphs for the full data as well as the parameters and values identified as major 
sources of variability by both CV and R2 cutoffs can be seen in Figure 4.36.  Removing the 
data for these major sources of variability from analysis reduced the overall CV correlation 
to 4.6% and increased the R2 linearity to 0.915.  Note that extreme outliers in the correlation 
were influenced by all three major sources of variability: 0.5 cm lesion models scanned 
using 44.6 mGy CTDIvol and a 0.5sec rotation time.   
  
110 
 
Table 4.20: Sorted results of Bland-Altman analysis of GB inter-scanner correlation for 
subsets of data based on available protocol and lesion parameters.  Parameters and values 
above the double line indicate worse correlation or linearity than the full data set while those 
below the double line indicate improved correlation or linearity.  Text in red indicates a major 
source of variability based on CV or R2 cutoff criteria. 
CV - Correlation Rsquared - Linearity 
Full Data CV Criteria Cutoff Full Data R2 Criteria 
8.3 150% 12.4 0.814 < 0.75 
Parameter Value CV Parameter Value R2 
Lesion Model 0.5 cm Cerebrum 15.2 CTDIvol 44.6 0.453 
CTDIvol 44.6 15.0 Lesion Model 0.5 cm Cerebrum 0.515 
RotationTime 0.5 12.6 RotationTime 0.5 0.581 
CTDIvol 81.4 10.3 CTDIvol 81.4 0.717 
ImageThickness 3.75 9.9 ImageThickness 3.75 0.738 
CTDIvol 36.7 8.8 CTDIvol 36.7 0.772 
ImageThickness 5 8.4 ImageThickness 5 0.796 
CTDIvol 54.7 8.0 Lesion Model 1.0 cm Cerebrum 0.812 
RotationTime 0.7 7.9 RotationTime 0.7 0.822 
CTDIvol 57.9 7.6 ImageThickness 2.5 0.841 
RotationTime 0.6 7.6 CTDIvol 54.7 0.842 
ImageThickness 2.5 7.4 CTDIvol 57.9 0.843 
CTDIvol 72.7 7.2 CTDIvol 72.7 0.843 
CTDIvol 67 7.2 CTDIvol 99.8 0.844 
CTDIvol 99.8 7.1 RotationTime 0.6 0.846 
RotationTime 0.9 7.0 CTDIvol 67 0.848 
CTDIvol 132.6 6.7 CTDIvol 64.2 0.860 
RotationTime 0.8 6.7 RotationTime 0.9 0.865 
CTDIvol 64.2 6.6 ImageThickness 1.25 0.868 
CTDIvol 105.6 6.3 RotationTime 0.8 0.874 
ImageThickness 1.25 6.2 CTDIvol 132.6 0.881 
CTDIvol 117.1 6.1 CTDIvol 105.6 0.890 
Lesion Model 1.0 cm Cerebrum 5.7 CTDIvol 117.1 0.895 
Lesion Model 1.5 cm Skull Base 4.7 Lesion Model 1.5 cm Cerebrum 0.926 
Lesion Model 1.5 cm Cerebrum 4.3 Lesion Model 1.5 cm Skull Base 0.927 
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4.2.6.2 Intra-Scanner Correlation 
Support Vector Machine Intra-Scanner Correlation 
Intra-scanner correlation of Study 1 and Study 2 based on support vector machine 
differentiation accuracy data resulted in a CV correlation of 6.2% and R2 linearity of 0.886.  
Repeated analysis for subsets of the data based on all available protocol and lesion 
parameters yielded two major sources of variability based on CV and R2 cutoff criteria: 44.6 
mGy CTDIvol and 0.5 cm Cerebrum matched model pairs (Table 4.21).  Bland-Altman and 
correlation graphs for the full data as well as the parameters and values identified as major 
sources of variability can be seen in Figure 4.37.  Removing the data for these major 
sources of variability from analysis reduced the overall CV correlation to 3.7% and 
increased the R2 linearity to 0.945.  Note that extreme outliers in the correlation were 
influenced by both major sources of variability: 0.5 cm lesion models scanned using a 44.6 
mGy CTDIvol protocol.   
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Table 4.21: Sorted results of Bland-Altman analysis of SVM intra-scanner correlation for 
subsets of data based on available protocol and lesion parameters.  Parameters and values 
above the double line indicate worse correlation or linearity than the full data set while those 
below the double line indicate improved correlation or linearity.  Text in red indicates a major 
source of variability based on CV or R2 cutoff criteria. 
CV - Correlation Rsquared - Linearity 
Full Data CV Criteria Cutoff Full Data R2 Criteria 
6.2 150% 9.3 0.886 < 0.75 
Parameter Value CV Parameter Value R2 
Lesion Model 0.5 cm Cerebrum 11.6 Lesion Model 0.5 cm Cerebrum 0.657 
CTDIvol 44.6 10.7 CTDIvol 44.6 0.701 
RotationTime 0.5 9.0 RotationTime 0.5 0.750 
CTDIvol 54.7 8.9 CTDIvol 54.7 0.757 
CTDIvol 36.7 8.3 CTDIvol 36.7 0.791 
RotationTime 0.6 7.7 RotationTime 0.6 0.818 
CTDIvol 81.4 7.2 CTDIvol 81.4 0.822 
ImageThickness 5 7.1 ImageThickness 5 0.845 
RotationTime 0.7 6.9 RotationTime 0.7 0.863 
CTDIvol 99.8 6.4 CTDIvol 99.8 0.865 
ImageThickness 3.75 6.3 ImageThickness 3.75 0.878 
ImageThickness 2.5 5.9 Lesion Model 1.0 cm Cerebrum 0.879 
CTDIvol 67 5.5 ImageThickness 2.5 0.890 
ImageThickness 1.25 5.0 CTDIvol 67 0.912 
CTDIvol 105.6 4.7 ImageThickness 1.25 0.915 
Lesion Model 1.0 cm Cerebrum 4.7 CTDIvol 64.2 0.932 
CTDIvol 57.9 4.6 CTDIvol 105.6 0.935 
CTDIvol 64.2 4.5 CTDIvol 57.9 0.942 
RotationTime 0.8 4.4 CTDIvol 72.7 0.943 
CTDIvol 72.7 4.2 RotationTime 0.8 0.943 
RotationTime 0.9 4.0 RotationTime 0.9 0.946 
Lesion Model 1.5 cm Skull Base 3.8 Lesion Model 1.5 cm Skull Base 0.952 
CTDIvol 132.6 3.6 CTDIvol 117.1 0.959 
CTDIvol 117.1 3.6 Lesion Model 1.5 cm Cerebrum 0.963 
Lesion Model 1.5 cm Cerebrum 3.0 CTDIvol 132.6 0.964 
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Geometric Bisector Intra-Scanner Correlation 
Intra-scanner correlation of Study 1 and Study 2 based on geometric bisector 
differentiation accuracy data resulted in a CV correlation of 6.1% and R2 linearity of 0.885.  
Repeated analysis for subsets of the data based on all available protocol and lesion 
parameters yielded three major sources of variability based on CV and R2 cutoff criteria: 
44.6 mGy CTDIvol, 0.5 cm Cerebrum matched model pairs and 0.5sec rotation time (Table 
4.22).  Bland-Altman and correlation graphs for the full data as well as the parameters and 
values identified as major sources of variability can be seen in Figure 4.38.  Removing the 
data for these major sources of variability from analysis reduced the overall CV correlation 
to 3.3% and increased the R2 linearity to 0.946.  Note that extreme outliers in the correlation 
were influenced by all three major sources of variability: 0.5 cm lesion models scanned 
using 44.6 mGy CTDIvol and a 0.5sec rotation time.   
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Table 4.22: Sorted results of Bland-Altman analysis of GB intra-scanner correlation for 
subsets of data based on available protocol and lesion parameters.  Parameters and values 
above the double line indicate worse correlation or linearity than the full data set while those 
below the double line indicate improved correlation or linearity.  Text in red indicates a major 
source of variability based on CV or R2 cutoff criteria. 
CV - Correlation Rsquared - Linearity 
Full Data CV Criteria Cutoff Full Data R2 Criteria 
6.1 150% 9.2 0.885 < 0.75 
Parameter Value CV Parameter Value R2 
Lesion Model 0.5 cm Cerebrum 11.7 Lesion Model 0.5 cm Cerebrum 0.610 
CTDIvol 44.6 11.2 CTDIvol 44.6 0.659 
RotationTime 0.5 9.2 RotationTime 0.5 0.739 
CTDIvol 36.7 8.5 CTDIvol 36.7 0.778 
CTDIvol 54.7 7.5 CTDIvol 54.7 0.824 
CTDIvol 81.4 7.1 CTDIvol 81.4 0.825 
RotationTime 0.6 7.0 RotationTime 0.6 0.846 
ImageThickness 5 7.0 ImageThickness 5 0.847 
RotationTime 0.7 6.8 CTDIvol 99.8 0.861 
CTDIvol 99.8 6.3 RotationTime 0.7 0.865 
ImageThickness 3.75 6.3 ImageThickness 3.75 0.872 
ImageThickness 2.5 5.9 ImageThickness 2.5 0.888 
CTDIvol 67 5.2 Lesion Model 1.0 cm Cerebrum 0.895 
ImageThickness 1.25 4.8 ImageThickness 1.25 0.915 
CTDIvol 72.7 4.6 CTDIvol 67 0.922 
CTDIvol 57.9 4.6 CTDIvol 72.7 0.923 
CTDIvol 64.2 4.6 RotationTime 0.9 0.929 
RotationTime 0.9 4.5 CTDIvol 64.2 0.930 
Lesion Model 1.0 cm Cerebrum 4.3 CTDIvol 57.9 0.940 
RotationTime 0.8 4.2 RotationTime 0.8 0.945 
CTDIvol 132.6 4.0 CTDIvol 117.1 0.946 
CTDIvol 117.1 4.0 Lesion Model 1.5 cm Cerebrum 0.954 
Lesion Model 1.5 cm Skull Base 3.7 CTDIvol 132.6 0.954 
CTDIvol 105.6 3.6 CTDIvol 105.6 0.959 
Lesion Model 1.5 cm Cerebrum 3.0 Lesion Model 1.5 cm Skull Base 0.964 
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4.3 Discussion 
4.3.1 Gaussian Mixture Model (GMM) Analysis 
Prior work (Chapter 3) investigating the differentiation of calcification and 
hemorrhage using 1.0 cm diameter agar gel lesion models and GMM analysis resulted in 
90% differentiation accuracy starting at 50 HU.  Repeat analysis of the same lesion size 
using an equivalent protocol in the current project, resulted in a maximum differentiation 
accuracy of 81% at 100 HU.  In fact, the only lesion type differentiable using GMM analysis 
was the 1.5 cm cerebrum lesion.  Investigation of the reduced accuracy results from the 
current project led to the identification of higher order heterogeneity in the epoxy resin 
lesion models relative to the agar gel models used in the prior work.  Although the 
compound used in the calcification lesion type for this project was changed from 
hydroxyapatite to calcium carbonate, the increase in heterogeneity was similar for both 
hemorrhage and calcification model types, indicating the mixing method, rather than the 
compound change, was likely responsible.  The epoxy resin materials used in this project 
were created by an outside vendor (Gammex, Middleton, WI) using an automated mixing 
method.  All lesion models were validated to ensure general homogeneity, however, 
estimation of low frequency heterogeneity due to material fabrication would have required 
more advanced analysis considered beyond the scope of this work.  
 
4.3.2 Support Vector Machine and Geometric Bisector Analyses 
While this heterogeneity had a negative impact on the GMM analysis by invalidating 
the base assumption of a Gaussian distribution, the support vector and geometric bisector 
analyses were unaffected.  First, neither SVM nor GB analyses assume a specific 
distribution type.  Second, since the “tails” in the distribution (Figure 4.19) were simply due 
to areas with less compound additive, they were in line with the full distribution of multiple 
attenuation (HU) level lesion models.  As a consequence, methods based on analysis of the 
full multiple- SECT attenuation (HU) level distributions were less affected by the more 
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heterogeneous models.  Support vector analysis was found to increase the accuracy of 
differentiation relative to GMM analysis for all lesions except the 1.5 cm cerebrum lesions, 
where the limited overlap of the two distributions likely outweighed the effect of the tails for 
the GMM method.  The increase in accuracy of SVM relative to GMM analysis was less for 
the 0.5 cm cerebrum and 1.5 cm skull base lesions, most likely due to the increased noise 
found in these data sets.  The 0.5 cm cerebrum lesions have a much smaller sample size 
and are more likely to be affected by partial volume and sub-optimal ROI placement than all 
other lesion types.  The 1.5 cm skull base lesions, while large, are more heavily affected by 
the surrounding bony anatomy than those lesions in the cerebrum, increasing both overlap 
and spread of the distributions.      
Several differentiation accuracy trends were identified based on acquisition 
parameters using both the SVM and GB analysis methods.  In general, increased accuracy 
was associated with increased CTDIvol (Figure 4.21, Figure 4.28).  As the number of 
photons incident on the phantom (or patient) increases, the number of photons incident on 
the detector increases.  While the percentage of photons attenuated is constant, the 
number of photons un-attenuated and thus reaching the detector is increased.  More 
photons at the detector means improved counting statistics and thus a richer data set to pull 
from to characterize the attenuations of the materials within the phantom (or patient).  In the 
case of dual-energy CT, the increased dose benefits the lower 80kVp projections 
preferentially, where a larger percentage of the beam is attenuated by the patient.  If too 
few of the 80kVp photons make it to the detector, the material decomposition process will 
be poorly characterized, resulting in errors in both the material density and monoenergetic 
images.  Increased image thickness led to increased differentiation accuracy for both SVM 
and GB methods (Figure 4.22, Figure 4.29).  This is likely due to the reduction in low 
frequency noise (mottled appearance on a level greater than the voxel scale) by data 
averaging resulting in reduced lesion inhomogeneity.  Reconstruction filter was found to 
have no effect on differentiation accuracy using either SVM or GB method (Figure 4.23, 
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Figure 4.30).  It seems that reduction in high frequency noise (white noise on the level of 
the voxel scale) does not have as pronounced an effect as the reduction in low frequency 
noise by data averaging.   
Based on these trends, a generalized protocol can be recommended: high dose with 
thick images using any of the investigated filters.  Dose (CTDIvol) should be as high as 
possible while balancing risk with clinical need.  Image thickness should be as thick as 
possible without exceeding the dimensions of the lesion and including partial volume effect 
of the surrounding tissues.  One recommendation would be the acquisition of data at 1.25 
mm images followed by reconstruction at increasingly higher image thicknesses until the 
maximum image thickness to avoid partial volume effect is determined.  Since it has no 
effect on differentiation accuracy, the reconstruction filter may be selected based on clinical 
use at the institution and visual preference of the radiologists.   
Results of the generalized geometric bisector solution indicate that a combination of 
three plane definitions should provide equally accurate results to the un-generalized 
geometric bisector method: cerebrum lesions less than 0.5 cm in diameter, cerebrum 
lesions greater than 0.5 cm in diameter, and skull base lesions (Table 4.16).  While this 
would necessitate some prior knowledge of the lesion’s size and location, all protocol 
variations were included in the creation of the plane, allowing physicians to determine 
CTDIvol and image thickness on a case by case basis. 
 
4.3.3 Inter- and Intra-Scanner Correlation 
In addition to the similar trends discussed above, the SVM and GB methods were 
found to have a high degree of correlation (CV of 1.7%) and linearity (R2 of 0.988) once the 
effect of the 0.5 cm cerebrum lesions were removed from analysis.  Neither method was 
preferred for these lesions, instead the noise due to their small size, partial volume effects 
and ROI placement variability simply obscured the correlation between the two analysis 
methods (Figure 4.34). Given the high degree of correlation between the two methods, it is 
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reasonable to recommend the GB over the SVM due to the former’s simplicity and ease of 
use.  While the support vector machine method requires iterative analysis and heavy 
computational power, the geometric bisector method requires only linear regression and 
simple geometric calculations.  The simplicity of this method would also lead to easier 
implementation and would allow for interim updates to the plane of optimal differentiation as 
patient data is collected. 
 
Table 4.23: Summary of inter-scanner (Study 1 versus Study 3) and intra-scanner (Study 1 
versus Study 2) correlations based on both SVM and GB methods.  Parameters identified as 
major sources of variability are listed along with the initial CV and R2 for the full data, as well 
as, the final CV and R2 with the sources of variability removed from analysis. 
 Method CV (Initial) 
R2 
(Initial) Sources of Variability 
CV 
(Final) 
R2 
(Final) 
In
te
r-
Sc
an
ne
r SVM 8.1% 0.824 44.6 mGy CTDIvol 
0.5 cm 
Cerebrum 
Lesions 
0.5sec 
Rotation 
Time 
4.8% 0.908 
GB 8.3% 0.814 44.6 mGy CTDIvol 
0.5 cm 
Cerebrum 
Lesions 
0.5sec 
Rotation 
Time 
4.6% 0.915 
In
tr
a-
Sc
an
ne
r SVM 6.2% 0.886 44.6 mGy CTDIvol 
0.5 cm 
Cerebrum 
Lesions 
 3.7% 0.945 
GB 6.1% 0.885 44.6 mGy CTDIvol 
0.5 cm 
Cerebrum 
Lesions 
0.5sec 
Rotation 
Time 
3.3% 0.946 
 
In general, intra-scanner correlations were better than inter-scanner correlations, 
indicating that repeatability of the differentiation accuracy result would be greater if the 
same scanner were used (Table 4.23).  These differences were quite small however, and 
as such, the clinical impact of scanner selection would be minimal, assuming the behavior 
of the scanners investigated is representative of overall scanner behavior.  In general, 
correlations for the GB method were better than those of the SVM method, supporting 
limiting future use to the simpler GB method.  All evaluations of inter- and intra-scanner 
correlation identified the same major sources of variability: 44.6 mGy CTDIvol, 0.5 cm 
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cerebrum lesions and 0.5 cm rotation time.  Intra-scanner correlation using SVM method 
did not identify 0.5sec rotation time as a major source of variability; however, it was the 
parameter with the next highest CV and next lowest R2 value (Table 4.21).  The issues 
associated with 0.5 cm cerebrum lesions have already been discussed and these issues’ 
effect on inter- and intra- scanner correlations is expected.  Low dose (CTDIvol) has also 
been discussed, however the CTDIvol level identified as a major source of variability was not 
the lowest dose level investigated.  By investigating the GSI-presets associated with the 
two lowest CTDIvol values (36.7 mGy and 44.6 mGy), it was found that the preset 
associated with the 36.7 mGy CTDIvol used a 0.7sec rotation time, while the preset 
associated with the 44.6 mGy CTDIvol used a 0.5sec rotation time.  Thus it is reasonable to 
conclude that the 44.6 mGy CTDIvol level was identified due to a combination of its low dose 
and a rotation time identified separately as a major source of variability.  Concurrent work 
has suggested that reduced rotation times have a detrimental effect on the fast-kVp 
switching x-ray tube, specifically resulting in reduced uniformity (see Chapter 6.3.2.2).  
Given the speed of the fast-kVp switching waveform, and the time required to transition 
from one kVp to the other, it is reasonable to suggest that a faster rotation time may result 
in reduced spectral separation between the high and low kVp projections. This reduced 
separation may lead to reduced accuracy of the material decomposition process, errors in 
material density and monoenergetic images and thus reduced differentiation accuracy 
between calcification and hemorrhage. 
 
4.3.4 Validation of Optimal keV Level for Simulated SECT Scanning 
Calculation of the difference between 68 keV attenuation (HU) and the gold standard 
SECT attenuation (HU) yielded errors within 3 HU for lesion models in the cerebrum (Figure 
4.10).  This is in line with error estimates of -2.6 HU to 2.6 HU from the initial selection of 68 
keV as the optimal keV level for simulated SECT scanning (Chapter 4.2.3).  The mean error 
across all acquisition parameters for cerebrum lesions was found to be 0.5 HU, again 
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supporting the estimated mean error of 0.3 HU during keV selection.  Mean error in the 
skull base was found to be 1.0 HU with a maximum error of approximately 6 HU, 
surpassing the estimated error during the selection process.  Since the keV selection 
process was performed using only cerebrum lesions, it is not surprising that the keV was 
not optimized for equivalent attention between 68 keV and SECT in the skull base.  Due to 
the increased bony anatomy in the skull base relative to the cerebrum, it is likely that the 
80kVp beam was more highly attenuated, affecting the results of the material 
decomposition.  However, given the high degree of correlation (CV 2.8%) and linearity (R2 
0.99) between the 68 keV and SECT attenuation (HU) across all lesion and acquisition 
parameters (Table 4.11), 68 keV dual-energy reconstruction seems to be a reasonable 
substitute for SECT acquisition for intracranial lesions in this attenuation range.  An added 
SECT acquisition does not appear warranted for in-vivo scanning at this time. 
 
4.3.5 Power Fits for 90% Differentiation Accuracy 
Second order power fits of available data yielded results in the form of CTDIvol 
necessary for 90% differentiation accuracy based on a given lesion attenuation (HU) and 
lesion attenuation (HU) necessary for 90% differentiation accuracy based on a given 
protocol CTDIvol (mGy).  In both cases, the relationship of the resulting values to the given 
parameter was not linear.  In other words, linearly increasing lesion attenuation (HU) did not 
always result in a linear decrease in CTDIvol necessary for 90% differentiation accuracy.  
This is likely an effect of the CTDIvol values being associated with specific GSI-presets.  
These presets are a fixed combination of a dose (CTDIvol), beam width, mA, bowtie filter 
and rotation time.  In order to obtain data on a wide range of dose values, the scan protocol 
used was generated with a wide range of GSI-presets with varying mA values and rotation 
times.  The effects of these other components of the GSI-preset cannot be controlled at this 
time, and may have a substantial effect on the differentiation accuracy results.  Given this 
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constraint, the use of these tables showing the relationship of lesion attention (HU) and 
dose (CTDIvol) for protocol development is limited.   
   
4.3.6 Limitations 
As with any phantom study, there are limitations stemming from the inexact 
modeling of the biological system.  Calcification and hemorrhage lesion models were 
created using a cylindrical shape, and assessed at three sizes (0.5, 1.0 and 1.5 cm) and 
two locations within the cranium (cerebrum and skull base).  Given the large differences in 
differentiation accuracy between the 0.5 cm and 1.0 cm cerebrum lesions, further 
investigation into intermediate sizes is warranted.  Lesion models were also created to be 
homogeneous and without contamination, thus the usefulness of this technique for 
heterogeneous or mixed lesions cannot be confirmed.  Protocol recommendations are 
based on fixed GSI-presets, limiting the ability to evaluate protocol parameters such as mA, 
rotation time and CTDIvol directly.  In addition, a range of CTDIvol values was created 
through manipulating the pitch, which might have different effects on differentiation than 
increasing the mA.  The DFOV was limited to 25 cm to allow for visualization of the full 
cranium.  Reduced DFOV may aid the differentiation accuracy of the 0.5 cm cerebrum 
lesions through an increase in sample size, reduction in partial volume effect and increased 
ease of ROI placement.  Finally, inter- and intra-scanner correlations were based on single 
study comparisons which may affect the results.   
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Chapter 5 
5 Lesion Classification using Unknown Lesion Models 
 
This chapter applies the methods and protocols developed in Chapter 4 to the 
classification of unknown intracranial lesions of either hemorrhagic or calcific composition.  
Unknown lesion models were created at varying attenuation, size and location within the 
cranial cavity.  The lesions were blinded for data acquisition (scanning) and analysis, and 
the ability of DECT to correctly classify these lesions with 90% confidence was determined. 
 
5.1 Materials and Methods 
5.1.1 Fabrication and Evaluation of Unknown Lesion Models 
To validate the results from Chapter 4, and move beyond differentiation and towards 
identification, a new set of “validation” hemorrhage and calcification lesion models were 
fabricated by the third party vendor (Gammex Inc., Middleton, WI) used for the previous 
biologically relevant phantom (Chapter 4). Five calcification and five hemorrhage lesion 
models were commissioned at varying SECT attenuation (HU) between 50 and 100 HU.  
Given that the previous differentiation work was performed on calcification and hemorrhage 
models within 3 HU of each decade between 40 and 100 HU, unknown lesions were 
requested at varying SECT attenuation (HU) from 50 to 100 HU while avoiding ± 2 HU of 
each decade.  For example, in order to avoid a repeat measure of a 70 HU calcification 
model, unknown lesions were ordered to be between 62 and 68 HU and between 72 and 
78 HU.  Each lesion type and attenuation level resulted in the fabrication of a 15 cm long, 
2.8 cm diameter rod.  In order to minimize the handling of the unknown lesion models by 
the evaluation group, these rods were immediately machined to create each lesion size and 
location specific model: 0.5 cm cerebrum, 1.0 cm cerebrum, 1.5 cm cerebrum and 1.5 cm 
skull base.  The lesion models were then grouped by the vendor into lesion composition 
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and attenuation specific bags, each labeled with a letter to allow blinded material 
verification, data collection and analysis.  These lesion models (n=40) will be referred to 
throughout this document as “unknown lesions”. 
These pre-milled, unknown lesions were then simply evaluated for defects and 
uniformity by a third party.  The lesion models were imaged on the table top using a basic 
protocol (Table 5.1).  Single-energy, 60 keV and Iodine(Water) images were evaluated 
visually for defects and overall homogeneity.  This lesion model fabrication and verification 
process differed from that used in the earlier differentiation work (Chapter 4).  The original 
lesion models used for evaluation of lesion differentiation were milled after extensive 
verification of the bulk material (Chapter 4.1.3).  This was necessary due to validate the 
untested methods used by the lesion material manufacturer as well as to ensure the 
attenuation matching of the calcification and hemorrhage matched model pairs.  Given that 
the lesion models needed for the lesion classification work did not require attenuation 
matched model pairs and that the methods used by the manufacturer had been previously 
validated, the validation methods were streamlined to allow for the pre-milling of the lesion 
models by the manufacturer.  
 
Table 5.1: Unknown lesion material verification and evaluation protocol.  Both series were 
acquired in helical mode, using a 20 mm beam width, 25 cm DFOV and Head SFOV.  Images 
were evaluated visually to confirm the lesion models were homogeneous and free of defects. 
Series Name Pitch 
Image 
Thickness 
(mm) 
Interval 
(mm) kVp mA 
Rot 
(s) 
CTDIvol 
(mGy) Filter 
1 SE 0.531 3.75 3.75 120 220 0.8 64 Standard 
2 GSI-26 0.531 3.75 3.75 NA 375 0.7 67 Standard 
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5.1.2 Unknown Lesion Data Acquisition 
Unknown lesion models were scanned using the same phantom used for lesion 
differentiation (Chapter 4).  Each of the 10 lesion groups defined by a composition 
(hemorrhage or calcification) and an attenuation (roughly 50-100 HU in decades) were 
imaged individually.  For each of the 10 exams, the four lesion sizes and locations (0.5 cm 
cerebrum, 1.0 cm cerebrum, 1.5 cm cerebrum and 1.5 cm skull base) corresponding to that 
lesion type and attenuation were inserted into the phantom. Low attenuation (40 HU) lesion 
models from the prior differentiation work (Chapter 4) were used to fill the remaining four 
available spaces (Figure 4.2).   
 
5.1.2.1 Determination of Scan Protocol 
Based on the results of the prior differentiation work (Chapter 4), a more limited 
scan protocol was designed for validation of unknown lesion classification (Table 5.2).  
Specifically, higher dose protocols reconstructed with thicker images were targeted for 
investigation and the use of GSI-presets with 0.5sec rotation time was avoided.  To this 
aim, three CTDIvol levels were selected: 132.6 mGy to evaluate the highest dose available 
on the system, 67 mGy to represent a dose level similar to the institution’s routine brain 
protocol (Table 4.3, series 2), and 105.6 mGy as a midpoint between the two. All three dose 
levels were evaluated using an image thickness of 3.75 and a standard filter to mimic 
routine clinical practice.  A single-energy 64 mGy acquisition was added to provide 
verification of 68 keV attenuation values.  All dual-energy acquisitions were reconstructed at 
68 keV, Water(Calcium) and Calcium(Water) to allow for the collection of the three-
dimensional (3D) DECT signature data. 
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Table 5.2: Unknown lesion validation protocol.  For all acquisitions: helical, 20 mm beam 
width, 25 cm DFOV, Head SFOV. 
Series Name Pitch 
Image 
Thickness 
(mm) 
Interval 
(mm) kVp mA 
Rot 
(s) 
CTDIvol 
(mGy) Filter 
1 SE 0.531 3.75 3.75 120 220 0.8 64 Standard 
2 
GSI-26 0.531 3.75 3.75 NA 375 0.7 67 Standard 
GSI-30 0.531 3.75 3.75 NA 550 0.8 105.6 Standard 
GSI-9 0.531 3.75 3.75 NA 600 0.9 132.6 Standard 
 
5.1.2.2 Data Collection and Organization 
Data were collected and organized following the same method used for the prior 
differentiation work (Chapter 4.1.6.1-4).  Series sorting was limited to relevant parameters 
including, but not limited to, image number, GSI-preset, and dual-energy reconstruction 
type.  Matlab (Version 2014a, MathWorks) was used to query the database to combine the 
dual-energy reconstructions to create 3D-DECT data for each lesion model based on 
acquisition type.  Given two lesion types (calcification and hemorrhage), five attenuation 
levels (roughly 50 to 100 HU in decades), 4 lesion sizes/location combinations (0.5 cm 
cerebrum, 1.0 cm cerebrum, 1.5 cm cerebrum and 1.5 cm skull base), and 3 DECT 
acquisitions (67, 105.6 and 132.6 mGy), a total of 120 unique unknown lesion data sets 
were collected. 
 
5.1.3 Unknown Lesion Classification Methods 
5.1.3.1 Geometric Bisector (GB) Method 
Due to the equivalence of the support vector machine and geometric bisector 
methods found in the prior differentiation work (Chapter 4), Geometric bisector was 
selected due to its ease of use and overall simplicity.  A lookup table was created in Matlab 
based on the geometric bisector plane results from the prior differentiation work (Chapter 
4.1.7.3) for all acquisitions and lesion size and locations investigated in this validation 
study.  12 planes were compiled: 3 CTDIvol levels (67 mGy, 105.6 mGy and 132.6 mGy) for 
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each lesion size and location (0.5 cm cerebrum, 1.0 cm cerebrum, 1.5 cm cerebrum and 
1.5 cm skull base).  Then 3D-DECT unknown lesion data was opened in Matlab and the 
database queried for the matched-acquisition, matched-lesion parameter geometric 
bisector plane (Figure 5.1).  The mean of the 3D-DECT data for the unknown lesion model 
(black diamond) was applied to the plane and lesion classification derived from the position 
of the mean location relative to the plane (gray).  .  Mean values that shared the side of the 
plane as the original hemorrhage differentiation data (red) were classified as hemorrhage 
while mean values that shared the side of the plane as the original calcification 
differentiation data (blue) were classified as calcification.  The confidence in this 
classification was defined as the percentage of voxels within the unknown lesion distribution 
that were on the same side of the plane as the mean value (here, 90%).     
 
 
Figure 5.1:  Application of lesion and acquisition specific geometric bisector plane (gray) to 
an example unknown lesion model.  The lesion model mean is shown as a black diamond to 
the left of the plane.  The voxel data also on the left of the plane (and thus contributing to the 
classification confidence) is shown in red, while the voxel data on the right side of the plane 
(and thus counting against the classification confidence) is shown in blue. 
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The final classification of each lesion was compared to the lesion composition and 
the number of lesions with correct classification was calculated.  Next, the number of 
lesions correctly classified with greater than 80% and greater than 90% confidence was 
calculated.  To assess trends in classification confidence with CTDIvol, second order power 
fits were employed to determine the lowest lesion attenuation (HU) necessary for 90% and 
80% confidence given a particular CTDIvol.  While this process was repeated in the past to 
obtain the CTDIvol necessary given a certain lesion attenuation (HU), the limited number of 
data points for CTDIvol made this curve fit highly unstable and thus was not pursued. 
 
5.1.3.2 Generalized Geometric Bisector (GGB) Method 
Based on the results of prior work comparing lesion and acquisition parameter-
specific geometric bisector planes (Chapter 4.2.5.5), three parameters were identified as 
major sources of variability in the geometric bisector plane solution (Table 4.16): cerebrum 
lesions of 0.5 cm in diameter, cerebrum lesions of greater than 0.5 cm in diameter and skull 
base lesions.  In order to assess whether a more generalized geometric bisector plane 
might provide similar results to lesion and acquisition parameter-specific planes, these 
three generalized planes were evaluated for their ability to classify the validation unknown 
lesions.  Unknown lesion data were analyzed using lesion parameter-specific plane 
(cerebrum lesions of 0.5 cm diameter, cerebrum lesions of greater than 0.5 cm diameter, 
and skull base lesions) and the classification, and the confidence in that classification, was 
calculated as described above (Chapter 5.1.3.1). 
 
5.1.3.3 Probability Distribution (PD) Method 
Using the raw 3D-DECT data collected as part of the prior differentiation work, a 
distribution of calcification probability was derived.  For each acquisition (n=3 based on 
series 2 of Table 5.2) and lesion size and location (n=4) combination investigated as part of 
the validation study, a distribution of the raw 3D-DECT data was created based on data 
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from Study1 of the prior differentiation project described in Chapter 4.  Using this prior 
differentiation data collected in Study 1, each lesion (size and location) specific and 
acquisition (CTDIvol, image thickness, reconstruction filter) specific matched model pair 
(n=12) was analyzed using a multivariate logistic regression model (104).  This model 
correlated the 3D-DECT measurements (68 keV attenuation, water material density and 
calcium material density) with the probability of being calcification.  Odds ratios were then 
derived based on the increased probability of being calcification given a unit increase in a 
measurement (68 keV, Water(Calcium) or Calcium(Water)).  In addition, the coefficients of 
the multivariate logistic regression model were used to create a formula for the probability 
the lesion is a calcification and probability the lesion is a hemorrhage based on input of the 
mean lesion value in the 3D-DECT signature space (Equation 12,Equation 13,Equation 14).   
 
Equation 12 ???????????????????????????????????? ??
??? ??????????????????? ????????????????????????????????? ?? 
 
Equation 13  ?????????????????????????? ?? ? ?
???
?? ? ???? ?  
Equation 14 ??????????????????????? ? ? ? ??????????????????????????   
 
Lookup tables were created in Matlab for these acquisition and lesion specific 
probability formulas.   Then 3D-DECT unknown lesion data was opened in Matlab and the 
database then queried for the acquisition and lesion specific probability formula.  The mean 
unknown lesion value based on the 3D-DECT data was then input into the formula and the 
probability the lesion is calcification was derived (Equation 12, Equation 13).  The 
probability the lesion is hemorrhage was then calculated using Equation 14.  Unknown 
lesions were classified as either calcification or hemorrhage based on a greater than 50% 
probability.  The probability was then used a measure of confidence in that classification.      
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The final classification of each lesion was compared to the actual lesion composition 
and the number of lesions with correct classification was calculated.  Next, the number of 
lesions correctly classified with greater than 80% and greater than 90% confidence was 
calculated.  To assess trends in classification confidence with CTDIvol, second order power 
fits were employed to determine the lowest lesion attenuation (HU) necessary for 90% and 
80% confidence given a particular CTDIvol.   
  
5.1.4 Inter-Method correlation 
To assess the correlation between the geometric bisector (GB) and probability 
distribution (PD) analysis methods, Bland-Altman and correlation graphs were created.  To 
assess sources of variability in this correlation, the analysis was repeated for subsets of the 
data based on all available parameters: lesion model composition, CTDIvol, rotation time 
and lesion size and location.  Investigation of rotation time was included due to its impact in 
other concurrent analyses (Chapter 6).  Each parameter was investigated separately, while 
including all values for other variables.  For all analyses, the coefficient of variation (CV) 
was tabulated as a measure of data correlation, while the square of the Pearson r-value 
(R2) was tabulated as a measure of correlation linearity.  The CV and R2 from these 
parameter value specific Bland-Altman and correlation graphs were compared to the values 
derived from Bland-Altman and correlation graphs for the full data set.  Parameter-value 
specific R2 values under 0.75 or CV values greater than 150% of the full data CV value 
were identified as major sources of variability in the method correlation (see Chapter 4.1.7.5 
for description of criteria development).  Specific parameter values identified as major 
sources of variability were then removed from the full data set and the Bland-Altman 
analysis was repeated. 
This method was repeated to assess the correlation between the geometric bisector 
and generalized geometric bisector analysis methods.  Given that the correlation was 
already assessed between the geometric bisector and probability distribution methods, and 
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that the generalized geometric bisector was an extension of the geometric bisector method, 
the correlation between the generalized geometric bisector and probability distribution 
methods was not assessed. 
 
5.2 Results 
5.2.1 Fabrication and Evaluation of Unknown Lesion Models 
All unknown lesion models were free of defects and homogeneous.  None of the 
lesion models required replacement or modification.  
 
5.2.2 Probability Distribution Definition 
Odds ratios correlating the 3D-DECT measurements with probability of being 
calcification based on multivariate logistic regression model of differentiation data collected 
as part of Study 1 in Chapter 4 can be seen in Table 5.3.  The odds ratio represents the 
increase in probability of calcification based on a unit increase on one of the 3D-DECT 
image types.  For example, an odds ratio of 1.59 means that the probability of being a 
calcification is increased 59% by a unit increase in the voxel measurement on that image 
type.  Increased water and calcium density image measurements were significantly 
associated with increased probability of calcification for all acquisitions and lesion 
parameters save one: calcium density image for a 132.6 mGy acquisition of a 1.0 cm 
cerebrum lesion.  Decreased 68 keV monoenergetic image measurements were 
significantly associated with increased probability of being calcification.  This is most likely 
due to hemorrhage lesion models having slightly higher attenuations than calcification 
models but still within our 2 HU matching constraint for the differentiation study (Chapter 
4.2.4.2). 
 Coefficients of the multivariate logistic regression model can be found in Table 5.4.  For 
a specific lesion and acquisition, the coefficients form a formula describing the point 
estimate of a lesions probability of being calcification (Equation 11, Equation 12).  While the 
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coefficients themselves have 95% upper confidence levels (UCL) and 95% lower 
confidence levels (LCL), no estimate can be made on the confidence interval of the lesion 
probability.     
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Table 5.3: Summary of multivariate logistic regression model results correlating water, 
calcium, and 68 keV measurements with probability of the unknown lesion being calcification. 
Odds ratio is for each unit increase in the measurement. Odds ratio greater than 1 means an 
increased probability of being calcification. LCL and UCL refer to the lower and upper 
confidence limits, respectively. 
Lesion 
Location 
CTDIvol 
(mGy) 
Lesion Size 
(cm) 
DECT Image 
Type 
Odds 
Ratio 
95% 
LCL 
95% 
UCL 
P-
value 
Cerebrum 
67 
0.5 
Water 1.59 1.51 1.68 <.0001 
Calcium 2.10 1.85 2.38 <.0001 
68 keV 0.72 0.69 0.76 <.0001 
1 
Water 1.65 1.60 1.71 <.0001 
Calcium 1.54 1.42 1.67 <.0001 
68 keV 0.83 0.80 0.86 <.0001 
1.5 
Water 1.98 1.92 2.04 <.0001 
Calcium 1.84 1.71 1.97 <.0001 
68 keV 0.78 0.76 0.80 <.0001 
105 
0.5 
Water 1.39 1.32 1.46 <.0001 
Calcium 1.27 1.11 1.46 0.0004 
68 keV 0.88 0.84 0.93 <.0001 
1 
Water 1.68 1.62 1.75 <.0001 
Calcium 1.14 1.03 1.26 0.01 
68 keV 0.92 0.89 0.96 <.0001 
1.5 
Water 2.54 2.44 2.64 <.0001 
Calcium 1.85 1.69 2.03 <.0001 
68 keV 0.76 0.74 0.79 <.0001 
132 
0.5 
Water 1.46 1.38 1.54 <.0001 
Calcium 1.37 1.19 1.58 <.0001 
68 keV 0.86 0.81 0.91 <.0001 
1 
Water 1.66 1.59 1.73 <.0001 
Calcium 1.10 0.99 1.22 0.06 
68 keV 0.94 0.90 0.98 0.002 
1.5 
Water 2.57 2.46 2.68 <.0001 
Calcium 1.49 1.35 1.65 <.0001 
68 keV 0.84 0.81 0.87 <.0001 
Skull Base 
67 1.5 
Water 1.63 1.60 1.67 <.0001 
Calcium 1.87 1.78 1.97 <.0001 
68 keV 0.77 0.76 0.79 <.0001 
105 1.5 
Water 1.96 1.91 2.02 <.0001 
Calcium 1.98 1.85 2.11 <.0001 
68 keV 0.75 0.73 0.77 <.0001 
132 1.5 
Water 2.06 2.00 2.12 <.0001 
Calcium 1.98 1.85 2.12 <.0001 
68 keV 0.75 0.73 0.77 <.0001 
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Table 5.4:  Summary of logistic regression model coefficients based on analysis of Study 1 
differentiation data (Chapter 4).  These coefficients work with Equations 12-14 to calculate the 
probability of being calcification based on an unknown lesion’s mean 3D-DECT measurement. 
Lesion Location CTDIvol (mGy) Lesion Size (cm) Coefficient Estimate 95% LCL 95% UCL 
Cerebrum 
67 
0.5 
b0 (Intercept) -467.408 -517.763 -417.052 
b1 (Water) 0.4656 0.4153 0.5159 
b2 (Calcium) 0.7407 0.6145 0.8669 
b3 (68 keV) -0.3233 -0.3737 -0.273 
1 
b0 (Intercept) -507.724 -541.804 -473.644 
b1 (Water) 0.5025 0.4685 0.5365 
b2 (Calcium) 0.4331 0.3506 0.5155 
b3 (68 keV) -0.188 -0.22 -0.1561 
1.5 
b0 (Intercept) -690.804 -720.042 -661.566 
b1 (Water) 0.6829 0.6538 0.7121 
b2 (Calcium) 0.6082 0.5386 0.6778 
b3 (68 keV) -0.2475 -0.2744 -0.2206 
105 
0.5 
b0 (Intercept) -330.154 -382.396 -277.912 
b1 (Water) 0.3271 0.2749 0.3793 
b2 (Calcium) 0.2423 0.107 0.3776 
b3 (68 keV) -0.1244 -0.1781 -0.0707 
1 
b0 (Intercept) -528.486 -569.166 -487.806 
b1 (Water) 0.5215 0.4809 0.5621 
b2 (Calcium) 0.1315 0.0317 0.2314 
b3 (68 keV) -0.0782 -0.1168 -0.0397 
1.5 
b0 (Intercept) -943.308 -983.62 -902.997 
b1 (Water) 0.9316 0.8914 0.9718 
b2 (Calcium) 0.6177 0.5252 0.7102 
b3 (68 keV) -0.2682 -0.304 -0.2323 
132 
0.5 
b0 (Intercept) -381.112 -434.797 -327.426 
b1 (Water) 0.3777 0.324 0.4314 
b2 (Calcium) 0.3165 0.1761 0.4569 
b3 (68 keV) -0.1521 -0.2079 -0.0963 
1 
b0 (Intercept) -512.821 -553.609 -472.033 
b1 (Water) 0.506 0.4653 0.5467 
b2 (Calcium) 0.0953 -0.0057 0.1963 
b3 (68 keV) -0.0612 -0.1003 -0.0222 
1.5 
b0 (Intercept) -956.451 -1000.16 -912.743 
b1 (Water) 0.943 0.8994 0.9866 
b2 (Calcium) 0.3992 0.299 0.4994 
b3 (68 keV) -0.175 -0.2139 -0.1362 
Skull Base 
67 1.5 
b0 (Intercept) -493.734 -514.718 -472.75 
b1 (Water) 0.4915 0.4706 0.5125 
b2 (Calcium) 0.6266 0.5759 0.6772 
b3 (68 keV) -0.2599 -0.2797 -0.2402 
105 1.5 
b0 (Intercept) -678.958 -706.174 -651.742 
b1 (Water) 0.6745 0.6474 0.7017 
b2 (Calcium) 0.681 0.617 0.745 
b3 (68 keV) -0.2863 -0.3111 -0.2614 
132 1.5 
b0 (Intercept) -725.187 -754.321 -696.053 
b1 (Water) 0.7204 0.6913 0.7495 
b2 (Calcium) 0.6854 0.6172 0.7535 
b3 (68 keV) -0.2858 -0.3122 -0.2593 
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5.2.3 Classification of Unknown Lesions 
5.2.3.1 Binary Classification 
Geometric Bisector Method 
Given binary classification (hemorrhage or calcification), 98% of unknown 
lesions/acquisition combinations investigated (n=120) were classified correctly using the 
GB method.  Two lesions/acquisition combinations were misclassified: 49.9 HU, 0.5 cm 
hemorrhage in the cerebrum imaged with 67 mGy and the same lesion model imaged with 
132.6 mGy.  60% (73/120) of those were classified with greater than 90% confidence, while 
74% (90/120) were classified with greater than 80% confidence.  GB confidence for all 
unknown lesions based on composition, location, size and attenuation can be seen in 
Figure 5.2. 
 
 
Figure 5.2:  Classification confidence results for all unknown lesion models using the 
geometric bisector method.  Calcification lesion models are shown in blue while hemorrhage 
models are shown in red. 
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Generalized Geometric Bisector Method 
96% of unknown lesions/acquisition combinations investigated (n=120) were 
classified correctly using the GGB method.  Three lesions/acquisition combinations were 
misclassified: 49.9 HU, 0.5 cm hemorrhage in the cerebrum imaged with 67 mGy, 105.6 
mGy and 132.6 mGy.  61% (75/120) of those were classified with greater than 90% 
confidence, while 75% (92/120) were classified with greater than 80% confidence.  GGB 
confidence for all unknown lesions based on composition, location, size and attenuation 
can be seen in Figure 5.3. 
 
 
Figure 5.3: Classification confidence results for all unknown lesion models using the 
generalized geometric bisector method.  Calcification lesion models are shown in blue while 
hemorrhage models are shown in red. 
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Probability Distribution Method 
98% of unknown lesions/acquisition combinations investigated (n=120) were 
classified correctly using the probability distribution (PD) method. The two misclassified 
lesion/acquisition combinations were the same as those misclassified by the GB method 
above.  Again, similarly to the GB  and GGB methods, 59% (71/120) of lesion/acquisition 
combinations were classified with greater than 90% confidence, and 74% (90/120) were 
classified with greater than 80% confidence.  Of the lesion/acquisition combinations 
classified with greater than 90% confidence, 62 were so classified using all three methods 
(84%, 83% and 87% agreement for GB, GGB and PD methods respectively).  Of the 
lesion/acquisition combinations classified with greater than 80% confidence, 84 were so 
classified using all three methods (93%, 91% and 93% for GB, GGB, and PD methods 
respectively).  PD confidence for all unknown lesions based on composition, location, size 
and attenuation can be seen in Figure 5.4. 
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Figure 5.4: Classification confidence results for all unknown lesion models using the 
probability distribution method.  Calcification lesion models are shown in blue while 
hemorrhage models are shown in red. 
 
5.2.3.2 Classification Trends with CTDIvol 
Geometric Bisector Method 
GB confidence trends with acquisition CTDIvol for all hemorrhage lesion models 
(based on lesion composition not method classification) can be seen in Figure 5.5.  GB 
confidence trends with acquisition CTDIvol for all calcification lesion models can be seen in 
Figure 5.6.   
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Figure 5.5: Geometric bisector confidence in classification of hemorrhage unknown lesions.  
Darker shades of red indicate higher CTDIvol levels. 
 
 
Figure 5.6: Geometric bisector confidence in classification of calcification unknown lesions.  
Darker shades of blue indicate higher CTDIvol levels. 
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Second order power fits of GB confidence data for all available lesion/acquisition 
combinations resulted in the SECT attenuation (HU) necessary for 90% classification 
confidence (Table 5.5).  0.5 cm calcification lesions in the cerebrum could not be classified 
with greater than 90% confidence using any of the available CTDIvol levels. 1.0 and 1.5 cm 
calcifications in the cerebrum could be classified with 90% confidence down to the minimum 
investigated SECT attenuation (HU) using either 105.6 or 132.6 mGy CTDIvol.   
 
Table 5.5: SECT attenuation (HU) necessary for 90% classification confidence using the GB 
method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 90% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 90% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 90% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. 
 Lesion Composition Calcification Hemorrhage 
 Lesion Location Cerebrum Skull Base Cerebrum 
Skull 
Base 
 Lesion Size (cm) 0.5 1.0 1.5 1.5 0.5 1.0 1.5 1.5 
CT
DI
vo
l 
(m
Gy
) 67.0 >100 HU 63 HU 62 HU 87 HU 70 HU 68 HU 67 HU 87 HU 
105.6 >100 HU 58 HU 58 HU 81 HU 58 HU 64 HU 59 HU 70 HU 
132.6 >100 HU 58 HU 58 HU 71 HU 59 HU 69 HU 63 HU 76 HU 
 
Second order power fits of GB confidence data for all available lesion/acquisition 
combinations resulted in the SECT attenuation (HU) necessary for 80% classification 
confidence (Table 5.6).  1.0 and 1.5 cm calcification lesions in the cerebrum could be 
classified with 80% confidence down the minimum investigated SECT attenuation (HU) 
using any of the available CTDIvol levels. 1.5 cm hemorrhage lesions in either the cerebrum 
or skull base could be classified with 80% confidence down to the minimum investigated 
SECT attenuation (HU) using either 105.6 or 132.6 mGy CTDIvol.   
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Table 5.6: SECT attenuation (HU) necessary for 80% classification confidence using the GB 
method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 80% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 80% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 80% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. 
 Lesion Composition Calcification Hemorrhage 
 Lesion Location Cerebrum Skull Base Cerebrum 
Skull 
Base 
 Lesion Size (cm) 0.5 1.0 1.5 1.5 0.5 1.0 1.5 1.5 
CT
DI
vo
l 
(m
Gy
) 67.0 >100 HU 58 HU 58 HU 70 HU 68 HU 59 HU 57 HU 65 HU 
105.6 >100 HU 58 HU 58 HU 67 HU 60 HU 57 HU 56 HU 58 HU 
132.6 >100 HU 58 HU 58 HU 62 HU 72 HU 61 HU 56 HU 58 HU 
 
Generalized Geometric Bisector Method 
GGB confidence trends with acquisition CTDIvol for all hemorrhage lesion models 
(based on lesion composition not method classification) can be seen in Figure 5.7.  GB 
confidence trends with acquisition CTDIvol for all calcification lesion models can be seen in 
Figure 5.8. 
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Figure 5.7: Generalized geometric bisector confidence in classification of hemorrhage 
unknown lesions.  Darker shades of red indicate higher CTDIvol levels. 
  
 
Figure 5.8: Generalized geometric bisector confidence in classification of calcification 
unknown lesions.  Darker shades of red indicate higher CTDIvol levels. 
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Second order power fits of GGB confidence data for all available lesion/acquisition 
combinations resulted in the SECT attenuation (HU) necessary for 90% classification 
confidence (Table 5.7).  0.5 cm calcification lesions in the cerebrum could not be classified 
with greater than 90% confidence using any of the available CTDIvol levels. 1.0 and 1.5 cm 
calcifications in the cerebrum could be classified with 90% confidence down to the minimum 
investigated SECT attenuation (HU) using any of the investigated CTDIvol levels.   
 
Table 5.7: SECT attenuation (HU) necessary for 90% classification confidence using the GGB 
method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 90% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 90% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 90% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. 
 Lesion Composition Calcification Hemorrhage 
 Lesion Location Cerebrum Skull Base Cerebrum 
Skull 
Base 
 Lesion Size (cm) 0.5 1 1.5 1.5 0.5 1 1.5 1.5 
CT
DI
vo
l 
(m
Gy
) 67.0 >100 HU 58 HU 58 HU 85 HU 70 HU 71 HU 70 HU 89 HU 
105.6 >100 HU 58 HU 58 HU 74 HU 60 HU 65 HU 64 HU 75 HU 
132.6 >100 HU 58 HU 58 HU 66 HU 59 HU 67 HU 65 HU 75 HU 
 
Second order power fits of GGB confidence data for all available lesion/acquisition 
combinations resulted in the SECT attenuation (HU) necessary for 80% classification 
confidence (Table 5.8).  All calcification lesions greater than 0.5 cm in diameter could be 
classified with 80% confidence down the minimum investigated SECT attenuation (HU) 
using any of the available CTDIvol levels. Hemorrhage lesions of any size in the cerebrum 
could be classified with 80% confidence down to approximately 60 HU using any of the 
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CTDIvol levels investigated.  Hemorrhage lesions in the skull base could be classified with 
80% confidence down to approximately 70 HU using any of the CTDIvol values investigated. 
  
Table 5.8: SECT attenuation (HU) necessary for 80% classification confidence using the GGB 
method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 90% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 90% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 90% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. 
Lesion Composition Calcification Hemorrhage 
 Lesion Location Cerebrum 
Skull 
Base Cerebrum 
Skull 
Base 
Lesion Size (cm) 0.5 1 1.5 1.5 0.5 1 1.5 1.5 
CT
DI
vo
l 
(m
Gy
) 67 >100 HU 58 HU 58 HU 62 HU 60 HU 62 HU 62 HU 70 HU 
105.6 >100 HU 58 HU 58 HU 62 HU 55 HU 59 HU 59 HU 64 HU 
132.6 >100 HU 58 HU 58 HU 62 HU 55 HU 60 HU 59 HU 65 HU 
 
Probability Distribution Method 
PD confidence trends with acquisition CTDIvol for all hemorrhage lesion models 
(based on lesion composition not method classification) can be seen in Figure 5.9.  PD 
confidence trends with acquisition CTDIvol for all calcification lesion models can be seen in 
Figure 5.10.   
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Figure 5.9: Probability distribution confidence in classification of hemorrhage unknown 
lesions.  Darker shades of red indicate higher CTDIvol levels. 
 
 
Figure 5.10: Probability distribution confidence in classification of calcification unknown 
lesions.  Darker shades of blue indicate higher CTDIvol levels. 
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Second order power fits of PD confidence data for all available lesion/acquisition 
combinations resulted in the SECT attenuation (HU) necessary for 90% classification 
confidence (Table 5.9).  With the exception of hemorrhage lesions imaged using 132.6 
mGy, 0.5 cm cerebrum lesions could not be classified with greater than 90% confidence 
using any of the available CTDIvol levels. 1.5 cm calcifications in the cerebrum could be 
classified with 90% confidence down to the minimum investigated SECT attenuation (HU) 
using all CTDIvol levels investigated.  1.5 cm cerebrum lesions of either calcification or 
hemorrhage composition could be classified with greater than 90% confidence down to the 
minimum investigated SECT attenuation (HU) using 132.6 mGy CTDIvol. 
 
Table 5.9: SECT attenuation (HU) necessary for 90% classification confidence using the PD 
method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 90% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 90% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 90% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. 
 Lesion Composition Calcification Hemorrhage 
 Lesion Location Cerebrum Skull Base Cerebrum 
Skull 
Base 
 Lesion Size (cm) 0.5 1.0 1.5 1.5 0.5 1.0 1.5 1.5 
CT
DI
vo
l 
(m
GY
) 67.0 >100 HU 79 HU 58 HU 94 HU >100 HU 64 HU 61 HU 79 HU 
105.6 >100 HU 58 HU 58 HU 78 HU >100 HU 61 HU 55 HU 62 HU 
132.6 >100 HU 58 HU 58 HU 62 HU 77 HU 64 HU 56 HU 66 HU 
 
Second order power fits of PD confidence data for all available lesion/acquisition 
combinations resulted in the SECT attenuation (HU) necessary for 80% classification 
confidence (Table 5.10).  1.5 cm lesions in the cerebrum could be classified with greater 
than 80% confidence down to the minimum investigated SECT attenuation (HU) for both 
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lesion compositions and all CTDIvol levels investigated.  1.0 cm calcification lesions in the 
cerebrum were classifiable with greater than 80% confidence down to the minimum SECT 
attenuation (HU) investigated.  1.0 cm hemorrhage lesions in the cerebrum resulted in 
SECT attenuation (HU) necessary for 80% confidence within 2 HU of the minimum 
investigated value.  Both lesion compositions in the skull base were classified with greater 
than 80% confidence down to the minimum investigated SECT attenuation (HU) for both 
105.6 and 132.6 mGy CTDIvol acquisitions. 
 
Table 5.10: SECT attenuation (HU) necessary for 80% classification confidence using the PD 
method.  Gray regions represent lesion/acquisition combinations that would only be 
classified with 80% confidence above the 100 HU limit imposed by SECT.  Green regions 
represent lesion/acquisition combinations that would be classified with 80% confidence 
below the minimum SECT investigated.  White regions represent lesion/acquisition 
combinations that would be classified with 80% confidence within the investigated lesion 
attenuation range.  Text in red indicates a curve fit R2 with less than 0.8. 
 Lesion Composition Calcification Hemorrhage 
 Lesion Location Cerebrum Skull Base Cerebrum 
Skull 
Base 
 Lesion Size (cm) 0.5 1.0 1.5 1.5 0.5 1.0 1.5 1.5 
CT
DI
vo
l 
(m
GY
) 67.0 >100 HU 58 HU 58 HU 74 HU 85 HU 58 HU 56 HU 65 HU 
105.6 >100 HU 58 HU 58 HU 62 HU 76 HU 57 HU 56 HU 58 HU 
132.6 >100 HU 58 HU 58 HU 62 HU 72 HU 59 HU 56 HU 58 HU 
 
5.2.4 Inter-Method Correlations 
Inter-method correlation of geometric bisector and probability distribution methods 
resulted in a CV correlation of 6.2% and R2 linearity of 0.824.  Repeated analysis for 
subsets of the data based on all available parameters yielded one major source of 
variability based on R2 cutoff criteria: hemorrhage lesion models (Table 5.11).  Bland-
Altman and correlation graphs for the full data as well as the hemorrhage lesion model data 
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can be seen in Figure 5.11.  Removing these data from analysis reduced the overall CV 
correlation to 3.9% and increased the R2 linearity to 0.938.  While the estimation of inter-
method correlation for only a single lesion model type is not particularly informative, it was 
assessed in an effort to provide uniform analysis of correlation with and without major 
sources of variability across both the differentiation (Chapter 4) and unknown lesion 
studies. 
 
Table 5.11: Sorted results of GB vs PD inter-method Bland-Altman analysis for subsets of 
data based on available protocol and lesion parameters.  Parameters and values above the 
double line indicate worse correlation or linearity than the full data set while those below the 
double line indicate improved correlation or linearity.  Text in red indicates a major source of 
variability based on CV or R2 cutoff criteria. 
CV - Correlation Rsquared - Linearity 
Full Data CV Criteria Cutoff Full Data R2 Criteria 
6.25 150% 9.37 0.8242 < 0.75 
Parameter Value CV Parameter Value R2 
Lesion Model 0.5 cm Cerebrum 8.2 Model Composition Hemorrhage 0.705 
Model Composition Hemorrhage 7.9 CTDIvol 105.6 0.791 
CTDIvol 105.6 6.8 RotationTime 0.8 0.791 
RotationTime 0.8 6.8 CTDIvol 132.6 0.820 
CTDIvol 132.6 6.2 RotationTime 0.9 0.820 
RotationTime 0.9 6.2 Lesion Model 1.5 cm Skull Base 0.831 
CTDIvol 67 5.8 Lesion Model 0.5 cm Cerebrum 0.834 
RotationTime 0.7 5.8 CTDIvol 67 0.850 
Model Composition Calcification 3.9 RotationTime 0.7 0.850 
Lesion Model 1.5 cm Skull Base 3.8 Lesion Model 1.5 cm Cerebrum 0.918 
Lesion Model 1.0 cm Cerebrum 2.6 Lesion Model 1.0 cm Cerebrum 0.925 
Lesion Model 1.5 cm Cerebrum 2.3 Model Composition Calcification 0.938 
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Figure 5.11: Bland-Altman and Correlation graphs for inter-method correlation between GB 
and PD methods.  Top: Full data results including all lesion/acquisition combinations.  
Middle: Results for hemorrhage lesion models, identified as a major source of variability in 
Table 5.11.  Bottom: Results for full data excluding hemorrhage lesion model values. 
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Inter-method correlation of geometric bisector and generalized geometric bisector 
methods resulted in a CV correlation of 4.7% and R2 linearity of 0.899.  Repeated analysis 
for subsets of the data based on all available parameters yielded one major source of 
variability based on CV cutoff criteria: 0.5 cm cerebrum lesion models (Table 5.12).  Bland-
Altman and correlation graphs for the full data as well as the hemorrhage lesion model data 
can be seen in Figure 5.12.  Removing these data from analysis reduced the overall CV 
correlation to 3.9% and decreased the R2 linearity to 0.8608.  Given the 0.5 cm cerebrum 
data was not identified as a major source of variability by the linearity criteria and in fact had 
greater linearity than the general data set, it is not surprising the linearity decreased in this 
way.  It is likely this decrease has minimal clinical significance. 
 
Table 5.12: Sorted results of GB vs GGB inter-method Bland-Altman analysis for subsets of 
data based on available protocol and lesion parameters.  Parameters and values above the 
double line indicate worse correlation or linearity than the full data set while those below the 
double line indicate improved correlation or linearity.  Text in red indicates a major source of 
variability based on CV or R2 cutoff criteria. 
CV - Correlation Rsquared - Linearity 
Full Data CV Criteria Cutoff Full Data R2 Criteria   
4.72 150% 7.08 0.8990 < 0.75 
Parameter Value CV Parameter Value R2 
Lesion Model 0.5 cm Cerebrum 7.3 Lesion Model 1.5 cm Skull Base 0.802 
CTDIvol 105.6 5.9 CTDIvol 105.6 0.818 
RotationTime 0.8 5.9 RotationTime 0.8 0.818 
Lesion Model 1.5 cm Cerebrum 4.5 Lesion Model 0.5 cm Cerebrum 0.875 
Model Composition Hemorrhage 4.4 Lesion Model 1.5 cm Cerebrum 0.881 
CTDIvol 67 4.4 Model Composition Calcification 0.906 
RotationTime 0.7 4.4 CTDIvol 67 0.923 
Lesion Model 1.5 cm Skull Base 4.4 RotationTime 0.7 0.923 
Model Composition Calcification 4.2 Lesion Model 1.0 cm Cerebrum 0.935 
CTDIvol 132.6 3.7 CTDIvol 132.6 0.947 
RotationTime 0.9 3.7 RotationTime 0.9 0.947 
Lesion Model 1.0 cm Cerebrum 2.6 Model Composition Hemorrhage 0.948 
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Figure 5.12: Bland-Altman and Correlation graphs for inter-method correlation between GB 
and GGB methods.  Top: Full data results including all lesion/acquisition combinations.  
Middle: Results for 0.5 cm cerebrum lesion models, identified as a major source of variability 
in Table 5.12.  Bottom: Results for full data excluding 0.5 cm cerebrum lesion model values. 
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5.3 Discussion 
5.3.1 Effect of Lesion Parameters on Classification Confidence 
Intracranial unknown lesion models 1.0 cm and larger, were correctly classified to a 
SECT attenuation (HU) level beyond that currently possible using SECT using DECT and 
either GB or PD methods.  This improvement was present regardless of lesion location or 
CTDIvol used.  In general, 1.0 and 1.5 cm cerebrum lesion models were correctly classified 
with 80% confidence down to approximately 60 HU using either GB or PD method and 
using any of the CTDIvol levels investigated.  1.5 cm skull base lesion models were correctly 
classified with 80% confidence down to approximately 70 HU using either GB or PD method 
and using any of the CTDIvol levels investigated.   
Classification results for 0.5 cm cerebrum lesion were less encouraging, especially 
in the case of the calcification models.  For both GB and PD methods, the classification 
confidence for 0.5 cm calcification models was substantially less than that of the 
hemorrhage models (Figure 5.13).  In order to determine the cause of this difference in 
classification confidence, the distance of the lesion mean value to the matched-acquisition 
GB plane was plotted (Figure 5.14).  Calcification models show reduced relative Euclidian 
distance to the plane within the 3D-DECT environment relative to hemorrhage models for 
the 0.5 cm cerebrum lesions, consistent with lower confidence in classification as defined 
by our methods.  In addition, the 1.0 cm cerebrum, 1.5 cm cerebrum and 1.5 cm skull base 
results showed a decrease in distance to the plane for the low attenuation hemorrhage 
lesions, similar to the reduced confidence in the classification of these lesions shown in 
Figure 5.13.  Since the pattern in distance to the plane and classification confidence is so 
similar, it is reasonable to assume the reduced confidence for the calcifications occurred 
due to their proximity to the differentiating GB plane.   
It is worth noting however that the correct classification of small intracranial 
hemorrhage is of greater clinical importance than the correct classification of small 
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intracranial classification.  The incorrect classification of intracranial hemorrhage as 
calcification would prompt physicians to administer potentially harmful anticoagulant 
therapies to patients with high risk of repeat brain hemorrhage.  The incorrect classification 
of intracranial calcification as hemorrhage, on the other hand, may keep physicians from 
administering anticoagulant therapies however would not lead to a life threatening outcome. 
 
 
Figure 5.13:  Summary of GB (solid lines) and PD (dashed lines) classification confidence 
based on lesion size and location.  Error bars represent one SD of the CTDIvol levels 
investigated.  Hemorrhage data is shown in red while calcification data is shown in blue. 
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Figure 5.14: Distance between unknown lesion mean value and parameter-specific GB plane.  
Error bars represent one SD of the CTDIvol levels investigated.  Hemorrhage model data is 
shown in red while calcification model data is shown in blue. 
 
To assess if the unknown lesion models are in some way distinct from the 
differentiation lesion models used in the prior work to determine the GB plane, the mean 
lesion values for both populations were plotted together on a single figure.  Figure 5.15 and 
Figure 5.16 show the relative position of the unknown lesion mean values (shown as 
circles) to the differentiation lesion mean values (shown as Xs) for a 0.5 cm and 1.0 cm 
cerebrum lesion.  GB plane and fit lines for both calcification and hemorrhage derived from 
data collected as part of the prior differentiation work (Chapter 4) are shown as reference. 
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Figure 5.15:  Visualization of unknown lesion and prior differentiation lesion mean values for 
a 1.0 cm cerebrum lesion imaged using 105.6 mGy, 3.75 mm image thickness, and Standard 
reconstruction filter.  Acquisition matched GB plane and hemorrhage and calcification line 
fits shown. 
 
 
Figure 5.16: Visualization of unknown lesion and prior differentiation lesion mean values for a 
0.5 cm cerebrum lesion imaged using 105.6 mGy, 3.75 mm image thickness, and Standard 
reconstruction filter.  Acquisition matched GB plane and hemorrhage and calcification line 
fits shown. 
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Visual comparison of the unknown lesion and differentiation lesion mean values for 
the 1.0 cm cerebrum lesion (Figure 5.15) seems to support that both data sets occupy the 
same general region of space.   
For both lesion types (calcification and hemorrhage) and both model populations 
(differentiation lesions and unknown lesions), the lesion means seemed to trend at lower 68 
keV attenuation towards higher water density values than the linear fit would have 
predicted.  This trend led to lower attenuation lesion models having skewed classification 
confidence due to the deviation from the linear fits used to calculate the geometric bisector 
plane.  For example, low attenuation hemorrhage which trended towards higher water 
density brought the lesion mean artificially closer to the geometric bisector line and leaded 
to an artificially low classification confidence.  On the other side, low attenuation 
calcification which trended towards higher water density pushed the lesion mean artificially 
farther from the geometric bisector line and leaded to an artificially high classification 
confidence.  This discrepancy between the predicted line fit and the lesion means at the 
lower 68 keV attenuations is likely due to increased distributions overlap and variability in 
this lower attenuation range.  This led to the geometric bisector solution being ill 
characterized at the lower attenuations and eventually led to the difference in the 
classification confidence between the hemorrhage and calcification unknown lesion models.   
Visual comparison of the unknown lesion and differentiation lesion mean values for 
the 0.5 cm cerebrum lesion (Figure 5.16) showed a much smaller angle between the 
hemorrhage and calcification distributions, resulting in lesion means much closer to the GB 
plane.  Visual comparison also showed higher variability in the distributions for both the 
unknown lesion models and differentiation lesion models.  The hemorrhage mean values 
from the unknown lesion study (red circles) do appear to be farther from the geometric 
bisector plane than the calcification mean values (blue circles).  As discussed above, high 
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variability and overlap directly lead to the definition of the GB plane being ill characterized.  
Without strong separation between the calcification and hemorrhage distributions to form 
the plane, the definition of the plane will be suboptimal.  It is likely that the small angle 
between the distributions is directly responsible for the larger discrepancy between the 
classification confidences derived for the hemorrhage and calcification unknown lesion 
models.   
While both GB and PD methods showed a discrepancy between hemorrhage and 
calcification classification confidence for 0.5 cm cerebrum lesions, the effect was greater for 
the GB method than for the PD method.  In addition to the position of the mean lesion value 
relative to the plane, the GB method uses raw voxel data to determine the confidence in the 
classification.  This allows the GB method to account for the variance within the lesion 
distribution.  The PD method however, is limited to a point measurement of probability at 
the mean lesion value and does not take into account the variance in the lesion distribution.  
The effect of lesion variance on final classification confidence is likely the reason the two 
methods were less correlated for hemorrhage lesions (Table 5.11).   
 
 
5.3.2 Effect of CTDIvol on Classification Confidence 
The effect of CTDIvol on calcification classification was minimal for 0.5 cm cerebrum 
lesions using either GB or PD methods.  Increased CTDIvol led to increased classification 
accuracy for all other lesion sizes and locations using either method.  The effect of CTDIvol 
on hemorrhage classification was minimal for 1.0 and 1.5 cm cerebrum lesion models using 
either the GB or PD method.  0.5 cm cerebrum and 1.5 cm skull base lesion models 
showed increased confidence using either the 105.6 or 132.6 mGy CTDIvol levels relative to 
the 67 mGy CTDIvol level.  Increased CTDIvol from 105.6 mGy to 132.6 mGy did not 
universally lead to an increase in hemorrhage classification confidence (Figure 5.5, Figure 
5.9).  While statistical significance cannot be assessed without repeat measures, the 
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difference in classification confidence between the 105.6 mGy and 132.6 mGy acquisition is 
likely below clinical significance.   
 
5.3.3 Generalizability of the Geometric Bisector Plane Solution 
Based on the results of prior differentiation work, the geometric bisector plane was 
found to be generalizable across acquisition protocol (see Chapter 4.2.5.5).  Lesion size 
and location was found to have a major effect on the plane and thus three generalized 
geometric bisector solutions were identified: cerebrum lesions of 0.5 cm diameter, 
cerebrum lesions of greater than 0.5 cm diameter and skull base lesions.  Assuming prior 
knowledge of the lesion size and location, a generalized solution could be applied, allowing 
physicians to select the acquisition protocol on a case by case basis.  This added flexibility 
did not highly influence the confidence in lesion classification, as shown by the high degree 
of correlation between the two methods (Figure 5.12).  Without prior knowledge of the 
lesion size and location, a plane derived from all available data, or super generalized 
geometric bisector (SGGB) plane could be employed, however the classification confidence 
tends to suffer (Figure 5.17 and Figure 5.18).  In some cases, the application of the SGGB 
plane to the unknown lesion data seems to improve the confidence in classification.  This is 
however a simple bias in the results due to misregistration between the SGGB plane and 
the unknown lesion data, and the overall confidence across the paired calcification and 
hemorrhage lesion results is not improved.  Because of this, the SGGB method should be 
avoided.   
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Figure 5.17: Summary of geometric bisector results for hemorrhage lesions by availability of 
prior knowledge.  GB (dotted line) is lesion and acquisition parameter-specific and thus 
requires prior knowledge of the lesion size and location and acquisition to be used.  GGB 
(dashed line) requires knowledge of only the lesion size and location.  SGGB (solid line) 
assumes no prior knowledge of either the lesion or acquisition.  
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Figure 5.18: Summary of geometric bisector results for calcification lesions by availability of 
prior knowledge.  GB (dotted line) is lesion and acquisition parameter-specific and thus 
requires prior knowledge of the lesion size and location and acquisition to be used.  GGB 
(dashed line) requires knowledge of only the lesion size and location.  SGGB (solid line) 
assumes no prior knowledge of either the lesion or acquisition. 
 
5.3.4 Protocol Recommendations for Optimal Classification Confidence 
Based on the above discussed effect of lesion and acquisition parameters on 
classification confidence, several recommendations can be formed.  105.6 and 132.6 mGy 
CTDIvol acquisitions generally yielded similar results, with the exception of low-attenuation 
calcification lesion models in the skull base where increased dose led to substantially 
higher classification confidence.  For both the calcification and hemorrhage lesion model 
analysis, 67 mGy CTDIvol acquisitions led to substantially reduced classification confidence 
in all lesion sizes and locations.  Thus it is recommended that without prior knowledge of 
lesion size, location or attenuation, CTDIvol values less than or equal to 67 mGy be avoided.  
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Lesions known to be in the skull base would benefit from the added classification 
confidence associated with the 132.6 mGy CTDIvol level.  
Given that the GB and PD methods resulted in highly correlated data (Figure 5.11), 
the GB method is recommended due to its increased simplicity and ease of use.  The PD 
method, while effective, requires additional statistical analysis and does not take into 
account the distribution of voxels within the unknown lesion.  While the lesion and 
acquisition parameter-specific GB method is supported when both lesion and acquisition 
specifics are known, the GGB method can be employed for more flexibility in protocol 
selection.  
 
5.3.5 Limitations 
In addition to the limitations associated with phantom materials discussed in 
Chapter 4.3.6, the results of this work are limited by the methods employed for unknown 
lesion classification.  Both the GB and PD methods assumed additive binary classification 
and therefore did not allow for identification of materials other than hemorrhage and 
calcification.  Applying this method to intracranial lesions other than hemorrhage or 
calcification would result in incorrect classification of the intracranial lesion as either 
hemorrhage or calcification.  In addition, the probability distribution method was employed 
assuming voxel data was independent due to computational limits.  Assuming some 
structure or dependence within the voxel data might strengthen the model.  Future work 
includes pursuing this structured model as well as employing cross validation and 
independent validation through a trainer-validation approach.  Finally, a Bayesian logistic 
model could be pursued to allow for the derivation of upper and lower confidence intervals 
on the confidence in lesion classification. 
While this project represents our best approximation of intracranial lesion 
classification in patients, there are still several limitations on clinical implementation using 
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these data.  Calcification and hemorrhage lesion models were created using a cylindrical 
shape, and assessed at three sizes (0.5, 1.0 and 1.5 cm) and two locations within the 
cranium (cerebrum and skull base).  Given the large differences in both differentiation 
accuracy and classification confidence between the 0.5 cm and 1.0 cm cerebrum lesions, 
further investigation into intermediate sizes is warranted.  Calcification and hemorrhage 
lesion models were created to be homogeneous and free of contamination and as such, the 
effect of heterogeneity and contamination on classification confidence cannot be assessed.  
Finally, the applicability of the geometric bisector plane equations to patient data cannot be 
established without further investigation beyond that possible in a phantom study. 
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Chapter 6 
6 Dual-Energy CT Quality Control Program Development 
 
This chapter investigates the accuracy and stability of dual-energy data derived from 
DECT scanning based on a phantom and protocol variations.  Given that the data collection 
for Chapters 3-5 spanned several years, verification that the data and results collected 
throughout the dissertation research are comparable is necessary.  A dual-energy quality 
control phantom system was developed to evaluate a number of test metrics including 
uniformity, noise, iodine accuracy and monoenergetic attenuation (HU) stability.  In order to 
evaluate the effect of acquisition parameters on the results of these test metrics, quality 
control protocols were developed to cover a wide range of protocol variation.  In addition, 
inter- and intra-scanner variances were assessed to inform the design of a future 
prospective clinical trial. 
 
6.1 Introduction 
Recently, the ACR has released its recommendations for routine quality control of 
computed tomography scanners, including daily monitoring of the mean and standard 
deviation of the CT number of water and artifact analysis (105).  While this document 
represents an excellent standard for use with single-energy CT imaging, little attention has 
been paid to quality control of clinical dual-energy CT systems.  These scanners often 
incorporate more advanced hardware such as the fast-kVp switching system used by GE 
(29) or the dual-source system used by Siemens  (27,28).  In addition, dual-energy CT 
scanners produce distinct image types such as virtual monoenergetic, virtual non-contrast 
and material density images that are unique to dual-energy imaging (37,106).  Neither the 
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capabilities of this hardware nor the consistency of these unique image types can be 
monitored using a single-energy quality control program.   
Since the release of the first clinical dual-energy CT scanner in 2005 (27), many 
studies have been performed in an attempt to characterize the system response.  Of 
particular interest was the use of the virtual monoenergetic reconstructions, which allow for 
variable contrast by modulating the keV of the reconstruction and thus the relative influence 
of photoelectric and Compton processes (22,35,99).  Several studies have shown that 
monoenergetic reconstructions of 65 to 72 keV provide improved iodine contrast-to-noise 
ratio (CNR) compared to standard single-energy acquisitions of 100kVp or greater 
(41,62,107).  Evaluation of noise for the monoenergetic reconstructions has shown a similar 
range of 65 to 77 keV to have equivalent or improved noise measurements relative to 
traditional single-energy CT (41,42,48,63,107).  Zhang et al. investigated the noise 
properties of the monoenergetic reconstructions based on the fast-kVp switching technique.  
They concluded that while the shape of the noise power spectrum (NPS) curve was similar 
regardless of reconstruction keV, noise was optimal at 65 keV but lower energy 
reconstructions resulted in higher noise (42).  In addition to noise and CNR, dual-energy 
images have also been evaluated for spatial resolution (42) and low contrast detectability 
(43).  Due to the theoretical reduction in beam hardening possible with dual-energy 
techniques (22,35,99,106), monoenergetic images have been investigated for their 
reduction in beam hardening from bone (48,108), as well as reduction in metal artifact 
(109–113). 
Since dual-energy CT is used in an increasingly quantitative fashion, it is vital to 
validate the attenuations derived from monoenergetic reconstructions as well as the 
material concentrations derived from material density images.  Of particular interest has 
been the accuracy of iodine, either using calculated concentration (56,114,115) or 
enhancement (106,116,117) based on iodine overlay images provided by Siemens systems 
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or concentration values from a material density image provided by GE systems (42,118).  In 
general, measurements of iodine concentration and enhancement were found to be highly 
correlated with true iodine concentration (56,115,118).  Iodine accuracy was shown to vary 
with position within a phantom by Zhang et al. (42), however the opposite was found by 
Matsuda et al. (118).  It is worth noting, however, that Matsuda et al. evaluated iodine 
accuracy solely based on a 65 keV monoenergetic reconstruction and not with material 
density images.  Iodine accuracy was also shown to decrease with increasing phantom size 
(115), however, this effect has been disputed by other studies (56,106,118).  Evaluation of 
the attenuation accuracy for monoenergetic reconstructions has shown dependence on 
phantom size, as well as greater inaccuracies for dense materials for low keV 
reconstructions  (61). This effect may be due to lesser correction of beam hardening effects 
for these energies.  The presence of tin filtration has also been shown to effect the 
attenuation from monoenergetic reconstructions created using the Siemens systems 
(116,117). 
While these studies have shed light on the characterization of these dual-energy CT 
systems, evaluation has yet to be performed on multiple scanners over time in order to lay 
the framework for a dual-energy quality control (DEQC) process.  In this paper, we develop 
a phantom system and protocol for collection of these data.  Protocol development will 
cover a wide range of acquisition parameters and dual-energy reconstructions.  Metrics 
evaluated will include iodine accuracy and stability of the attenuations derived from 
monoenergetic reconstructions, as well as, single-energy QC analogs such as noise and 
uniformity.  Longitudinal data will be acquired in order to develop a clinically implementable 
quality control program for long-term validation of dual-energy CT data. 
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6.2 Materials and Methods 
6.2.1 Phantom Design 
In order to validate both body specific and neuro specific GSI-presets as part of our 
DEQC program, a two-part phantom was designed (Figure 6.1).  The outer shape of the 
phantom was elliptical in design to better approximate the shape of the human torso.  The 
phantom dimensions were 30 cm in height by 40 cm in width to mimic the challenges of 
imaging a somewhat larger patient with a waist circumference of 109 cm.  This elliptical 
body phantom contained an insert 22 cm in diameter which could be removed for separate 
scanning of the neuro specific GSI-presets.  When separate from the body phantom, this 
insert will be referred to as the “head phantom”.  Both phantoms were designed to be 15 cm 
in length (z-direction) to allow for continuous helical acquisition. 
Unfortunately a 15 cm thick piece of solid water could not be obtained for fabrication 
of the phantom, therefore three separate 5 cm thick slabs were used.  To ensure the slabs 
would not drift apart with use, fixation bolts were added to keep the slabs tightly pressed 
together.  Two bolts were included in the head phantom, while four were included in the 
body phantom.  The bolts in the head phantom were constructed to allow for the inclusion 
of a polyvinyl chloride (PVC) bar, 14 cm by 3.8 cm and 2.5 cm deep to provide a surface for 
use of a bubble level on both phantoms (see Figure 6.1).  The bolts were fabricated using 
high density polyethylene (HDPE) and threaded on one side to allow for manual tightening.  
The body and head phantom were both machined from the same pieces of solid water, so a 
1 cm wide, HDPE slip-ring was needed between the head and body phantom portions to 
replace material lost during milling.  This ring was permanently affixed to the inside of the 
body phantom and remained attached to the body phantom shell when the head phantom 
was removed for separate scanning.   
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Figure 6.1: Basic structure and measurements of DEQC phantom.  Solid water components 
are shown in dark brown, HDPE components in tan and PVC in light gray. 
 
6.2.1.1 Tissue and Material Inserts 
Due to DECT’s focus on tissue characterization and material separation, a variety of 
tissue and material inserts were included in the DEQC phantom (Table 6.1). Insert 
compositions were chosen based on current clinical applications of DECT, as well as the 
prevalence of materials or tissue types in research studies and emerging applications.  The 
concentrations of various materials selected were then referenced to either clinically used 
values, as in the case of the iodine enhancement rods, or relevant concentration in the 
human body, as in the case of the calcium rods.  For the calcium and iodine material 
inserts, three concentrations were selected so that the linearity of the DECT response to 
the material could be assessed over a range of concentrations in both the head and body 
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phantom.  The arrangement of the inserts within the phantom is shown in Figure 6.2 and 
was determined based on the reduction of beam hardening and test metric considerations 
(see Chapter 6.2.2). The insert rods measure 2.8 cm in diameter and extend the entire 15 
cm length of the phantom.  
  
Table 6.1:  List of DEQC phantom insert types. 
Insert Background Additive HU at 120 kVp Biology Modeled 
Blood Solid Water Fe2O3 40 Blood 
Blood Solid Water Fe2O3 70 Clot (Normal) 
Blood Solid Water Fe2O3 100 Clot (Extreme) 
Calcium Solid Water CaCo3 198 Calcification 
Calcium Solid Water CaCo3 334 Bone 
Calcium Solid Water CaCo3 838 Bone (dense) 
Iodine Solid Water C6H5I 51 NA 
Iodine Solid Water C6H5I 128 NA 
Iodine Solid Water C6H5I 356 NA 
Iodine 
Enhancement 
Solid Water Fe2O3 + 
C6H5I 
40+50 Typical enhancement 
threshold for neuro studies 
Iodine 
Enhancement 
Solid Water Fe2O3 + 
C6H5I 
40+100 Typical enhancement 
threshold for thoracic studies 
Soft Tissue NA NA 35 Soft Tissue 
Adipose NA NA -100 Adipose 
Brain NA NA 15 Brain 
 
 
Figure 6.2:  DEQC insert layout with average 120kVp HU level of inserts labeled. 
171 
 
To ensure repeatable positioning of the rod inserts within the DEQC phantom, a 
thin, transparent polycarbonate plate was added to the back surface of the phantom (Figure 
6.3a).  This would allow the rods to be positioned flush with this fixed surface, allowing 
repeatable positioning.  In addition, the plate was designed with several 2 cm diameter 
holes, matching the positions of the rod inserts so that a thin tool through the hole in the 
plate and the inserts could be easily removed.  The plate was affixed to the posterior slab of 
the body phantom by three solid water bolts extending 2 cm into the body phantom. To 
ensure the proper alignment of the head insert within the body phantom, an orientation peg 
was added to the posterior surface of the head phantom, and a matching hole was drilled 
through the acrylic plate (Figure 6.3b).  The surface of the peg was rounded, allowing the 
peg to naturally seek its corresponding hole in the acrylic alignment plate without significant 
effort on the part of the user. 
 
 
Figure 6.3: a) Polycarbonate plate attached to back of phantom with solid water bolts visible 
at the bottom and side periphery of the phantom (white arrows).  b) Detail of lower solid water 
bolt as well as the orientation plug (red arrow) used to ensure proper alignment of the head 
phantom within the body phantom. 
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6.2.1.2 Insert Validation 
Material and tissue equivalent inserts detailed in Table 6.1 were acquired from 
Gammex, Inc.  All inserts underwent both quantitative and qualitative testing to ensure 
uniformity, accuracy and if needed, inter-comparability.  Inserts were scanned using a 
vendor-provided 20 cm diameter, 15 cm long solid water phantom with eight insert 
positions.  Two water balloons were inserted in the positions on either side of the DEQC 
insert under evaluation to minimize artifacts or beam hardening.  The phantom was then 
imaged using the scan protocol in Table 6.2 which included several vendor-specified 
protocols (series 3-6).  Images were viewed with GSI viewer software (Version 2; GE 
Healthcare).  Using 20 mm x 20 mm ROIs, quantitative data (Table 6.3) was collected at 
several points along the insert, and all images were viewed for any signs of defects.  Any 
inserts not uniform to within 2 HU along their length or showing any visible defects were 
returned to the vendor for replacement.  The three soft tissue inserts included in the 
phantom were further validated to verify they were interchangeable based on both their 
single-energy attenuation data and dual-energy spectral curves. 
 
Table 6.2:  DEQC insert validation protocol. For all series: SFOV: Head, DFOV: 25 cm, Filter: 
Standard. 
Series Mode Name Scan Type Pitch 
Rot 
(s) 
Beam 
Width 
(mm) 
Image 
Thickness 
(mm) 
Interval 
(mm) kVp mA 
1 SE Routine Brain Helical 0.531 0.8 20 3.75 3 140 160 
2 DE GSI - 26 Brain Helical 0.531 0.7 20 3.75 3 80/140 375 
3 SE Gammex Val 80kV Axial 1 1 40 5 40 80 250 
4 SE Gammex Val 100kV Axial 1 1 40 5 40 100 250 
5 SE Gammex Val 120kV Axial 1 1 40 5 40 120 250 
6 SE Gammex Val 140kV Axial 1 1 40 5 40 140 250 
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Table 6.3: Reconstructions created from DEQC validation data and quantitative data acquired. 
Series Mode Description/Reconstruction Quantitative Data Acquired 
1 SE Routine Brain Mean SD 
102 DE 50 keV Mean SD 
102 DE 70 keV Mean SD 
102 DE 100 keV Mean SD 
102 DE 140 keV Mean SD 
102 DE Water (Iodine) Mean SD 
102 DE Iodine (Water) Mean SD 
102 DE Water (Calcium) Mean SD 
102 DE Calcium (Water) Mean SD 
3 SE Gammex Val 80kV Mean SD 
4 SE Gammex Val 100kV Mean SD 
5 SE Gammex Val 120kV Mean SD 
6 SE Gammex Val 140kV Mean SD 
 
6.2.2 Test Metrics 
SECT QC has converged on a number of routine tests reflecting important imaging 
parameters: standard deviation of water (noise), mean CT# of water (absolute CT number 
accuracy), artifact analysis (detector uniformity), Uniformity (field homogeneity) and 
Linearity (relative CT number accuracy).  Due to the unique capabilities and imaging 
concerns revolving around DECT, as well as the structure of our DEQC phantom, 
modifications were made to these standard SEQC tests. 
Noise is usually assessed over a large ROI in a uniform phantom, however due to 
the constraints of our phantom model, noise was assessed as the standard deviation within 
the brain insert in the head phantom portion of the DEQC phantom system.  This insert is 
present during both body phantom and separate head phantom scanning and is the insert 
with the SECT attenuation (HU) closest to water (15 HU vs 0 HU).  This noise test metric 
was applied to both monoenergetic and material density image types. 
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Due to the ability of DECT to create virtual monoenergetic data visualizations at a 
variety of different keV levels, the concept of absolute CT number accuracy takes on an 
additional dimension. An effective DEQC program must not only test that the CT number is 
consistent using a single protocol, but that it is also spectrally consistent over a range of 
monoenergetic visualizations.  This new test metric, Monoenergetic HU Stability, was 
defined as the average CT number over all voxels within the three soft tissue rods in the 
DEQC phantom.  This definition provides positional independence due to the spacing of the 
soft tissue rods within the phantom as well as basing the metric in a clinical CT number 
range (approximately 35 HU).  To allow for the verification of Monoenergetic HU Stability at 
various points along the dual-energy spectral curve, four keV energy levels were chosen: 
50 keV, 70 keV, 110 keV and 140 keV.  These specific keV energy levels were selected 
due to their common clinical use for iodine conspicuity – 50 keV (62), 120kVp corollary and 
low noise – 70 keV (41,107), and metal artifact reduction – 140 keV (110,111,113), 
respectively. 
In SECT, linearity is assessed by documenting the mean CT number of several 
substances, most commonly, water, air and acrylic.  While the mean CT number of water is 
meant to be an absolute measure of CT number accuracy, linearity, is more a relative 
measure of CT number accuracy, because the Hounsfield unit is a material’s linear 
attenuation relative to that of water.  In DECT, the process of material decomposition is 
used to create paired material density images which display the densities of two different 
materials that together would mimic the attenuation properties of the target material or 
tissue (29,37).  These material density images are expressed in mg/mL and, unlike 
Hounsfield numbers, are absolute measures of a physical quantity associated with the 
material or tissue.  These values can be quantitative if the material is made solely of the two 
materials present in the material basis pair.  For example, a water/iodine material 
decomposition of a solution of iodine and water should yield accurate material densities on 
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both images.  To test the accuracy and linearity of this response, three inserts consisting 
solely of solid water and iodine were included in the DEQC phantom, each with a different 
known density of iodine.  The accuracy of the material density on the iodine material density 
image from a water/iodine material decomposition was then compared to the known iodine 
density for each rod. This value was investigated as both absolute error and percent error 
relative to the known iodine material density for each of the three rods. 
While uniformity is commonly defined in a water phantom, the heterogeneity of our 
DEQC phantom required modification from this classical definition.  Soft tissue rods were 
positioned at the center of the DEQC phantom, periphery of the DEQC head phantom and 
periphery of the DEQC body phantom (Figure 6.2).  To minimize the potential of beam 
hardening from linearly positioned inserts, the head phantom peripheral inserts were offset 
from body phantom peripheral inserts.  Uniformity was then defined as the mean ROI value 
of the most peripheral soft tissue rod minus the mean ROI value of the central soft tissue 
rod.  Uniformity was assessed on both monoenergetic and material density image types.  
Both water and iodine material density images were assessed due to the differing influence 
of the 80 and 140kV acquisitions on these image types.  Water density images have a 
higher percent contribution from the higher 140kV beam, while iodine density images have 
a higher percent contribution from the lower 80kV beam.  Given that the two energies would 
likely be effected by phantom (or patient) size and beam hardening to different extents, the 
collection of uniformity data using both water and iodine density images was pursued.  
A full list of test metrics included in the DEQC program as well as applicable image 
types can be found in Table 6.4. 
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Table 6.4:  List of test metrics included in DEQC program and their application to various 
image reconstruction types, as well as the composition and position of the rods used to 
evaluate the metric. 
 
Test Metric Noise Monoenergetic HU Stability 
Iodine 
Accuracy Uniformity 
 Rod 
Composition Brain Soft Tissue Iodine Soft Tissue 
 
Rod Position 
    
Im
ag
e 
Ty
pe
 50 keV X X  X 
70 keV X X  X 
110 keV X X  X 
140 keV X X  X 
Iodine (Water) X  X X 
Water (Iodine) X   X 
 
 
6.2.3 Protocol Development 
6.2.3.1 DEQC Protocol Version 1: Initial Data Collection 
In order to determine which acquisition parameters may play a role in the overall 
performance of the DECT system and would warrant further investigation, highly variable 
scan protocols were designed for both the head and body phantoms.  Both protocols 
contained variations in CTDIvol, rotation time, image thickness and pitch.  For the head 
phantom, three GSI-presets were chosen covering a CTDIvol range of 36.7 to 132.6 mGy, 
rotation times from 0.5 to 1s, pitch values of 0.531 and 0.969 and two image thicknesses, 
1.25 and 3.75, selected for their clinical applicability (Table 6.5).  For the body phantom, 
four GSI-presets were chosen covering a CTDIvol range of 10.3 to 62 mGy, rotation times 
from 0.5 to 1s, pitch values of 0.516 and 0.984 and two image thicknesses, 2.5 and 3.75, 
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selected for their clinical applicability (Table 6.6).  Both protocols included a single energy 
acquisition selected to mimic a current routine SECT protocol. 
 
Table 6.5: Head Phantom DEQC Protocol Version 1. All acquisitions used helical acquisition 
mode, beam width of 20 mm, Head SFOV, DFOV of 25 cm, and Standard reconstruction 
algorithm. A total of 5 images were acquired per group. 
Series Name GSI-Preset Pitch Rot (s) mA CTDIvol (mGy) Img Thk (mm)  
2 Single Energy (120kVp) 0.531 1 300 54.65 3.75  
3 GSI-26 GSI-26 0.531 0.7 375 67 1.25  
    GSI-26 0.531 0.7 375 67 3.75  
    GSI-26 0.969 0.7 375 36.7 1.25  
    GSI-26 0.969 0.7 375 36.7 3.75  
4 GSI-20 GSI-20 0.531 0.5 630 81.4 1.25  
    GSI-20 0.531 0.5 630 81.4 3.75  
    GSI-20 0.969 0.5 630 44.6 1.25  
    GSI-20 0.969 0.5 630 44.6 3.75  
5 GSI-9 GSI-9 0.531 0.9 600 132.6 1.25  
    GSI-9 0.531 0.9 600 132.6 3.75  
    GSI-9 0.969 0.9 600 72.7 1.25  
    GSI-9 0.969 0.9 600 72.7 3.75  
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Table 6.6:  Body Phantom DEQC Protocol Version 1. All acquisitions used helical acquisition 
mode, beam width of 40 mm, Large Body SFOV, 42 cm DFOV, and Standard reconstruction 
algorithm.  A total of 5 images were acquired per group. 
Series Name GSI-Preset Pitch Rot (s) mA CTDIvol (mGy) Img Thk (mm) 
2 Single Energy (120kVp) 0.984 0.5 400 12.46 2.5 
3 GSI-36 GSI-36 0.516 0.8 260 19.6 2.5 
    GSI-36 0.516 0.8 260 19.6 5 
    GSI-36 0.984 0.8 260 10.3 2.5 
    GSI-36 0.984 0.8 260 10.3 5 
4 GSI-1 GSI-1 0.516 0.5 630 33.9 2.5 
    GSI-1 0.516 0.5 630 33.9 5 
    GSI-1 0.984 0.5 630 17.8 2.5 
    GSI-1 0.984 0.5 630 17.8 5 
5 GSI-10 GSI-10 0.516 0.8 600 48.6 2.5 
    GSI-10 0.516 0.8 600 48.6 5 
    GSI-10 0.984 0.8 600 25.5 2.5 
    GSI-10 0.984 0.8 600 25.5 5 
6 GSI-5 GSI-5 0.516 1 600 62 2.5 
    GSI-5 0.516 1 600 62 5 
    GSI-5 0.984 1 600 32.5 2.5 
    GSI-5 0.984 1 600 32.5 5 
 
Both the DEQC head and body protocols included several dual-energy 
reconstructions.  These reconstructions were selected based on the test metrics listed in 
Chapter 6.2.2 and are shown in Table 6.7.  They include monoenergetic reconstructions at 
50 keV, 70 keV, 110 keV and 140 keV, used in tests of monoenergetic HU stability, 
uniformity and noise.  Also included were material density images from a water/iodine 
material decomposition, used in tests of iodine accuracy, uniformity and noise.  For all 
reconstructions, the minimum number of images allowable were created to facilitate data 
transmission and storage.  The minimum number of images allowed using a material 
density reconstruction was one, while monoenergetic reconstructions required the full 
image set to be reconstructed. 
 
179 
 
Table 6.7:  Dual-energy reconstructions applied to all dual-energy acquisitions in both the 
version 1 DEQC Body and Head protocols. The number of images reconstructed was based 
on the minimum setting for each reconstruction type: five for monoenergetic and one for 
material density. 
Recon Recon Name Dual-energy Recon Details No. of Images 
R1 Mega Mono 70 keV + GSI Data File 5 
R2 Water (Iodine) Water(Iodine) 1 
R3 Iodine (Water) Iodine(Water) 1 
R4 70 keV 70 keV  5 
R5 110 keV 110 keV  5 
R6 140 keV 140 keV  5 
Manual 50 keV 50 keV  5 
 
These protocols were used to scan the DEQC head and DEQC body phantoms ten 
times over the course of two weeks on a single GE 750HD CT scanner to assess intra-
scanner repeatability, and twice on nine other scanners to assess inter-scanner 
repeatability.  The results of this trial were used to inform the development of the DEQC 
protocol version 2 for extended data collection. 
 
6.2.3.2 DEQC Protocol Version 2: Extended Data Collection 
After the initial data collection based on DEQC Protocol Version 1, a second 
protocol version was developed to target those factors found influential while removing 
those found unnecessary for further investigation (see Chapter 6.3.1).  Additional GSI 
presets were included in both the head and the body protocols to better separate the dose 
and rotation time effects. In each protocol, GSI presets were chosen that had similar 
CTDIvol values but with different rotation times. Three such groups were found among the 
body GSI presets, while only one dose matched pair was found among the head GSI 
presets. Pitch was varied solely to provide additional variation in CTDIvol across the limited 
GSI-preset options.  Image thickness was reduced to a single value across both head and 
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body phantom protocols to allow for more direct comparison of DEQC results.  A 5 mm 
thickness was selected due to its clinical applicability and reduced noise.  Prep group 
delays were added between all acquisitions to minimize tube cooling delays.  The updated 
DEQC head and body phantom protocols are shown in Table 6.8 and Table 6.9 for the 
head and body phantoms, respectively. 
 
Table 6.8:  DEQC Head Phantom Protocol Version 2. All acquisitions used helical scan mode, 
20 mm beam width, Head SFOV, 25 cm DFOV, and Standard reconstruction algorithm. 
Series GSI-Preset Pitch Rot (s) mA CTDIvol (mGy) Img Thk (mm) Prep (s) 
1 GSI-30 0.531 0.8 550 105.6 5 0 
 GSI-20 0.531 0.5 630 81.4 5 15 
 GSI-26 0.531 0.7 375 67 5 15 
 GSI-19 0.969 0.6 640 54.7 5 15 
 GSI-39 0.531 0.8 208 47.8 5 15 
 GSI-20 0.969 0.5 630 44.6 5 15 
 GSI-26 0.969 0.7 375 36.7 5 15 
 GSI-39 0.969 0.8 208 26.2 5 15 
 
Table 6.9: DEQC Body Phantom Protocol Version 2. All acquisitions used helical scan mode, 
40 mm beam width, Large Body SFOV, 42 cm DFOV, and Standard reconstruction algorithm. 
Series GSI-Preset Pitch Rot (s) mA CTDIvol (mGy) Img Thk (mm) Prep (s) 
1 GSI-5 0.516 1 600 62 5 0 
 GSI-10 0.516 0.8 600 48.6 5 15 
 GSI-1 0.516 0.5 630 33.9 5 15 
 GSI-5 0.984 1 600 32.5 5 15 
 GSI-10 0.984 0.8 600 25.5 5 15 
 GSI-1 0.984 0.5 630 17.8 5 15 
 GSI-54 0.516 0.6 275 17.4 5 15 
 GSI-48 0.516 0.7 260 17.2 5 15 
 GSI-51 0.984 0.5 360 10.3 5 15 
 GSI-36 0.984 0.8 260 10.3 5 15 
 
 
181 
 
Table 6.10: Dual-energy reconstructions applied to all dual-energy acquisitions in both the 
version 2 DEQC body and head protocols. The number of images reconstructed was based 
on the minimum setting for each reconstruction type: five for monoenergetic and one for 
material density. 
Recon Recon Name Dual-Energy Recon Details No. of Images 
R1 Mega Mono 70 keV + GSI Data File 5 
R2 Water(Iodine) MD: Water(Iodine) 1 
R3 Iodine(Water) MD: Iodine(Water) 1 
R4 70 keV 70 keV  5 
R5 110 keV 110 keV  5 
R6 140 keV 140 keV  5 
Manual 50 keV 50 keV  5 
 
Weekly DEQC scans were performed on ten GE 750HD CT scanners over a 12 
week period in order to characterize the test metric dependence on acquisition parameters, 
assess inter-scanner and intra-scanner variance and to inform the creation of a streamlined 
DEQC protocol appropriate for clinical implementation.   
 
6.2.4 Data Collection 
6.2.4.1 DEQC Protocol Version 1 
Due to inherent limitations on the GE 750HD CT scanners, 50 keV reconstructions 
could not be made automatically and necessitated manual intervention.  The GSI data file 
for each acquisition was opened using the GSI viewer (version 2, Wakausha, WI) available 
on the scanner at time of scan.  A 50 keV reformat was then created and saved as a 
separate series.  This series, along with all other images acquired or reconstructed as part 
of the DEQC Protocol Version1 were transferred to a local workstation where the data were 
downloaded for further analysis.  A representative image from the DEQC body phantom 
data with an S0 image location was then opened using the GSI viewer (version 2, 
Waukesha, WI) and 20 mm diameter ROIs were placed on all inserts.  Each ROI was saved 
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as a comma delimited file to retain the spatial coordinates of each voxel contained within 
the ROI.  This procedure was then repeated for a representative image from the DEQC 
head phantom. 
All images were loaded into Matlab (Version 2014a, MathWorks) and filtered to 
retain only those images with an S0 image location.  Comma delimited ROI files from both 
the representative DEQC body and head phantoms were loaded into Matlab and the spatial 
coordinates of each voxel were transformed into voxel locations using the known DFOV 
and image matrix dimensions.  The voxel locations for each ROI were then applied to the 
appropriate phantom images and the mean and standard deviation calculated.  Test metrics 
were calculated for appropriate image types for both the DEQC body and head phantom.  
The ROI summary statistics, as well as the results of the test metrics were then written out 
to a text file for all images and exams.    
Test metric results were plotted against a range of acquisition parameters to isolate 
parameters with the greatest impact on dual-energy QC.  Those with limited or well 
established effects on test metrics were excluded, while acquisition parameters with 
marked and uncharacterized effects on test metrics were retained for further study.  
 
6.2.4.2 DEQC Protocol Version 2: Creation of an In-House AutoQC Program 
Due to the large amount of data collected as part of this protocol as well as the long 
duration of data collection, a more automated and robust analysis method was needed. 
Weekly DEQC exams were sent to a DICOM server which archived all relevant images in a 
MySQL database (Oracle, Redwood City, CA).  A custom analysis program was written in 
Python which processed the images allowing for collection of DEQC results and test 
metrics.  The analysis program, or AutoQC, queried unprocessed images from the MySQL 
database with image location equal to S0.  The AutoQC then segmented the phantom from 
the surrounding air by means of k-means segmentation (119) followed by post-processing 
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using a morphological closing operator to remove small air gaps and outliers (120).  This 
mask was then processed to identify the two centrally-located fixation bolts and the mask 
was transformed using a Radon transform to produce a sinogram (121).  In sinogram 
space, the center of the phantom is identified by minimizing the sum of the squares of the 
distance between the center of the phantom and its periphery, while any rotation in the 
phantom was identified by the average of the angles between the phantom center and the 
left and right fixation bolts.  After the phantom image was centered and corrected for 
rotation, 12 mm diameter ROIs were applied to all rods based on a lookup table which 
contains distances from the center of the phantom as well as angles from the center of the 
right fixation bolt. Mean and standard deviation values were calculated for each ROI and 
saved to a separate MySQL database for archival. 
A web interface was developed in Python (Python Software Foundation), to allow for 
download of the DEQC ROI statistics as well as visualization of DEQC results.  The 
interface allowed both scanner-specific and date range searches of the database.  For each 
exam, a single representative image was shown as well as representative test metrics 
calculated from the ROI statistics.  Test metrics falling outside established constraints can 
be displayed in red for increased ease of identification. 
 
6.2.4.3 DEQC Protocol Version 2: Statistical Analysis 
In order to assess whether changes in acquisition parameters resulted in statistically 
significant changes in the test metric results, linear mixed models were used (122).  This 
method was able to take into account any correlation between the multiple measurements 
from a given scanner.  In the case where the overall likelihood ratio test was significant 
implying differences between groups, pairwise comparisons with Tukey-Kramer adjustment 
were performed between the values for a given acquisition parameter (122).  In the case of 
noise, values were logarithmically transformed before statistical modeling due to right 
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skewness.  Statistical significance was set at a two-sided p-value of 0.05.  Variance 
component analysis was performed on uniformity, iodine accuracy and monoenergetic HU 
stability to estimate both inter-scanner and intra-scanner variation (122).  All statistical 
analysis was performed using SAS version 9 (SAS Institute, Cary, NC). 
 
6.3 Results 
6.3.1 Determination of Relevant Acquisition Parameters 
Results of DEQC protocol version 1 (Chapter 6.2.4.1) are shown in Table 6.11 and 
Table 6.12 for the DEQC body phantom and DEQC head phantom respectively.   CTDIvol 
was found to influence iodine accuracy, monoenergetic HU stability and noise for the DEQC 
body phantom, and only iodine accuracy and noise for the DEQC head phantom.  While the 
relationship between CTDIvol and noise is known, the effect on the other two metrics 
warranted further investigation.  Rotation time was found to influence iodine accuracy, 
uniformity and noise using both the DEQC body and DEQC head phantoms.  Effects due to 
CTDIvol and effects due to rotation time were compounded due to the fixed nature of the 
GSI-presets.  Future investigation would require the two parameters to be separated 
through the selection of GSI presets where one parameter (e.g. CTDIvol) could be varied 
independently of the other (e.g. rotation time).  Other than the obvious association with 
dose, pitch was found to have no effect on any of the test metrics for either the DEQC body 
or DEQC head phantoms and was therefore excluded from further analysis.  Image 
thickness was only found to affect noise using either the DEQC body or DEQC head 
phantom.  Given that this effect is known and straightforward, image thickness was also 
excluded from further analysis. 
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Table 6.11: Results of DEQC protocol 1 for the DEQC Body phantom showing which factors 
were found to influence the test metrics investigated.  Marked cells indicate that the 
acquisition parameter was found to have an effect on the test metric.  Empty cells indicate no 
effect was identified. 
 Acquisition Parameter 
  CTDIvol 
Rotation 
Time Pitch 
Image 
Thickness 
Te
st
 M
et
ric
 Iodine Accuracy X X   
Monoenergetic HU Stability X    
Uniformity  X   
Noise X X  X 
 
Table 6.12:  Results of DEQC protocol 1 for the DEQC head phantom showing which factors 
were found to influence the test metrics investigated.  Marked cells indicate that the 
acquisition parameter was found to have an effect on the test metric.  Empty cells indicate no 
effect was identified. 
 Acquisition Parameter 
  CTDIvol 
Rotation 
Time Pitch 
Image 
Thickness 
Te
st
 M
et
ric
 Iodine Accuracy X X   
Monoenergetic HU Stability     
Uniformity  X   
Noise X X  X 
 
6.3.2 DECT Response by Test Metric 
For each test metric under evaluation, results were plotted against all acquisition 
parameters investigated to determine the parameter(s) responsible for trends in the test 
metric results.  In some cases, the effect was complex, requiring the visualization of primary 
and secondary effects on the test metric.  In the figures that follow, primary effects are 
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shown on the lower portion of the x-axis while secondary effects are shown directly above 
the primary.  Results are shown by scanner to allow for a visual interpretation of the inter-
scanner variance.  Results for the inter- and intra-scanner variance (based on statistical 
analysis described in Chapter 6.2.4.3) were also investigated graphically and primary and 
secondary effects determined.   
 
6.3.2.1 Iodine Accuracy 
DEQC Body Phantom: 
 Iodine accuracy using the DEQC body phantom was found to be affected primarily by 
effective milliampere-second (mAs) and secondarily by CTDIvol for all three iodine rods 
investigated (Figure 6.4).  Images obtained using low mAs protocols tended to over-
estimate the iodine concentration in the case of the 2 mg/mL rod, however the iodine 
concentration for the 5 mg/mL rod was under-estimated.  Effects of both mAs and CTDIvol 
were fairly limited for the 15 mg/mL rod.  The variation in the effect of these parameters 
could potentially be due to their position within the phantom and their surrounding 
environment (e.g. the effect of surrounding material rods).  Both inter- and intra- scanner 
variance were primarily affected by CTDIvol and secondarily affected by mAs likely 
indicating the effect of image noise on the repeatability of these results. 
 Results of the linear mixed model analysis for the effect of the primary acquisition 
parameter, mAs, on iodine accuracy in the DEQC body phantom can be seen in Table 6.13.  
The over-estimation of the 2 mg/mL iodine rod and the under-estimation of the 5 mg/mL 
iodine rod at low mAs values can been seen in the reversed ranking order.   
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Figure 6.4: DEQC body phantom results for iodine accuracy.  Left: Iodine accuracy trends 
sorted primarily by mAs and secondarily by CTDIvol for 2 mg/mL, 5 mg/mL, and 15 mg/mL 
iodine rods displayed by scanner.  Right: Iodine accuracy inter- and intra-scanner variance 
trends sorted primarily by CTDIvol and secondarily by mAs for 2 mg/mL, 5 mg/mL, and 15 
mg/mL iodine rods. 
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Table 6.13:DEQC body phantom results for the effect of mAs on iodine accuracy based on 
linear mixed model analysis. 
Iodine Rod mAs effect on Iodine Accuracy 
2 mg/mL 165 >> 182 > 208 >> 315 >> 180  = 480 >> 600 
5 mg/mL 600 > 480 >> 315 >> 182 > 208 >> 180 >> 165 
15 mg/mL 480 = 315 >> 600 > 182 = 208 >> 165 > 180 
 
Legend 
>> Significantly Different P < 0.05 
> Not Significantly Different 0.05 < P < 0.9 
= Statistically Equivalent P > 0.9 
 
DEQC Head Phantom: 
Iodine accuracy using the DEQC head phantom was found to be affected primarily 
by mAs and secondarily by CTDIvol, similar to that determined using the DEQC body 
phantom (Figure 6.5).  In contrast to the DEQC body phantom, lower mAs protocols 
provided higher iodine accuracy, while higher mAs protocols provided lower iodine 
accuracy, underestimating the concentration.  It is worth noting however that the variance 
between scanners is somewhat higher using these lower mAs protocols.  This trend is 
supported by the inter- and intra-scanner variance results showing increasing mAs has a 
beneficial result on inter-scanner variance. However due to the matched scaling between 
the DEQC body and DEQC head phantom results, this cannot easily be visualized.  Intra-
scanner variance did not seem to be directly affected by any of the acquisition parameters 
investigated.  Compared to the results from the DEQC body phantom, the iodine accuracy 
using the DEQC head phantom was much improved.  The maximum error in the iodine 
concentration measurement was approximately 20% using the DEQC body phantom, but 
only 8% using the DEQC head phantom.  Inter- and intra- scanner variances were also 
reduced from a maximum value of 1.61% and 0.66%, respectively, to 0.009% and 0.012%.  
This represents a dramatic improvement in result repeatability for the DEQC head phantom, 
relative to that of the DEQC body phantom.   
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Results of the linear mixed model analysis for the effect of the primary acquisition 
parameter, mAs, on iodine accuracy in the DEQC body phantom can be seen in Table 6.14.   
 
 
Figure 6.5: DEQC head phantom results for iodine accuracy.  Left: Iodine accuracy trends 
sorted primarily by mAs and secondarily by CTDIvol for 2 mg/mL and 5 mg/mL iodine rods 
displayed by scanner.  Right: Iodine accuracy inter- and intra-scanner variance trends sorted 
primarily by mAs and secondarily by CTDIvol for 2 mg/mL and 5 mg/mL iodine rods. 
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Table 6.14: DEQC head phantom results for the effect of mAs on iodine accuracy based on 
linear mixed model analysis. 
Iodine Rod mAs effect on Iodine Accuracy 
2 mg/mL 315 >> 208 >> 262.5 > 440 > 384 
5 mg/mL 208 >> 315 = 262.5 >> 440 >> 384 
 
Legend 
>> Significantly Different P < 0.05 
> Not Significantly Different 0.05 < P < 0.9 
= Statistically Equivalent P > 0.9 
 
 
 
6.3.2.2 Uniformity 
DEQC Body Phantom: 
 Uniformity using the DEQC body phantom was affected primarily by rotation time and 
secondarily by CTDIvol for all dual-energy reconstructions investigated (Figure 6.6, Figure 
6.7).  For 50 keV and Iodine(Water) reconstructions, low mAs protocols resulted in high 
uniformity values (peripheral results greater than central), which was improved by 
increasing the mAs.  For 110 keV, 140 keV and Water(Iodine) reconstructions, low mAs 
protocols resulted in slightly low (-2 HU on average) uniformity values (central results 
greater than peripheral).  Increasing the mAs resulted in initial improvement followed by 
increasingly high (5-6 HU on average) uniformity values (peripheral results greater than 
central).  Uniformity response for 70 keV was flat across all rotation times investigated; 
however, the uniformity result was routinely high with an average of approximately 4 HU.  
Maximum absolute uniformity was found in 50 keV (17.8 HU) followed by Water(Iodine) (-
6.6 mg/mL), 70 keV (6.2 HU), Iodine(Water) (4.6 mg/mL), 140 keV (-4.2 HU), and finally 
110 keV (-2.7 HU).  Both inter- and intra-scanner variance was primarily affected by CTDIvol 
and secondarily by mAs.  With the exception of the inter-scanner variance for 50 keV 
reconstruction, increasing CTDIvol and mAs were associated with reduced variance.  In 
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general, intra-scanner variance was greater than inter-scanner variance, with increased 
intra-scanner variance corresponding with increased absolute uniformity.    
 Results of the linear mixed model analysis for the effect of the primary acquisition 
parameter, rotation time, on uniformity in the DEQC body phantom can be seen in Table 
6.15.  The opposite effects of increased rotation time on the 50 keV and Iodine(Water) 
versus the 110 keV, 140 keV and Water(Iodine) can be seen in the reversed ranking order.   
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Figure 6.6:  DEQC body phantom results for uniformity.  Left: Uniformity trends sorted 
primarily by rotation time and secondarily by CTDIvol for 50, 70, 110 and 140 keV 
monoenergetic reconstructions and displayed by scanner.  Right: Uniformity inter- and intra-
scanner variance trends sorted primarily by CTDIvol and secondarily by mAs for 50, 70, 110, 
and 140 keV monoenergetic reconstructions. 
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Figure 6.7: DEQC body phantom results for uniformity.  Left: Uniformity trends sorted 
primarily by rotation time and secondarily by CTDIvol for Water(Iodine) and Iodine(Water) 
material density reconstructions and displayed by scanner.  Right: Uniformity inter- and intra-
scanner variance trends sorted primarily by CTDIvol and secondarily by mAs for Water(Iodine) 
and Iodine(Water) material density reconstructions. 
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Table 6.15: DEQC body phantom results for the effect of rotation time on uniformity based on 
linear mixed model analysis. 
Dual-Energy Reconstruction Rotation Time effect on Uniformity 
50 keV 0.6 >> 0.5 >> 0.7 >> 0.8 >> 1 
70 keV 0.6 >> 0.7 >> 1 = 0.5 = 0.8 
110 keV 1 >> 0.8 >> 0.7 >> 0.6 > 0.5 
140 keV 1 >> 0.8 >> 0.7 >> 0.5 = 0.6 
Water (Iodine) 1 >> 0.8 >> 0.7 >> 0.5 = 0.6 
Iodine (Water) 0.6 >> 0.5 >> 0.7 >> 0.8 >> 1 
 
Legend 
>> Significantly Different P < 0.05 
> Not Significantly Different 0.05 < P < 0.9 
= Statistically Equivalent P > 0.9 
 
 The effect of rotation time, mAs and the keV of the monoenergetic reconstruction can 
be seen in Figure 6.8.  Uniformity is independent of reconstructed keV only using only one 
of the protocols investigated: GSI-10 (0.8sec rotation time, 480mAs).  Low rotation time 
protocols resulted in wide variation in uniformity based on keV of the monoenergetic 
reconstruction.   
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Figure 6.8:  DEQC body phantom results for uniformity sorted primarily by rotation time and 
secondarily by mAs for 50, 70, 110 and 140 keV monoenergetic reconstructions. 
 
DEQC Head Phantom: 
 Uniformity using the DEQC head phantom was found to be affected primarily by mAs 
and secondarily by CTDIvol for all dual-energy reconstructions investigated (Figure 6.9, 
Figure 6.10). Unlike the DEQC body phantom, uniformity was not noticeably affected by 
rotation time.  In addition, uniformity using the DEQC head phantom was universally 
improved by increases in the primary acquisition parameter (mAs).  Similarly to the DEQC 
body phantom results, uniformity for 70 keV monoenergetic reconstruction was fairly 
invariant to changes in acquisition parameter; however, the DEQC head phantom uniformity 
result was much closer to 0 HU than that of the DEQC body phantom.   Uniformity was 
vastly improved for 50 keV monoenergetic reconstruction from a maximum absolute value 
of 17.8 HU in the DEQC body phantom to 4.9 HU in the DEQC head phantom.  Maximum 
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absolute uniformity, representing the greatest deviation from the ideal value of zero, was 
found in Water(Iodine) (5.2 mg/mL) followed by 50 keV (-4.9 HU), 140 keV (4.2 HU), 110 
keV (3.5 HU), Iodine(Water) (-1.9 mg/mL), and finally 70 keV (-1.8 HU).  Intra-scanner 
variance was primarily affected by CTDIvol and secondarily by mAs and corresponded with 
increased absolute uniformity.  Inter-scanner variance was generally on the same order as 
intra-scanner variance, however, none of the acquisition parameters investigated were 
found to correlate with reduced inter-scanner variance. 
 Of note in Figure 6.9 are the abnormal uniformity results for CT 6 using 50 keV 
monoenergetic reconstruction.  For all protocols investigated, acquisitions on CT 6 resulted 
in substantially higher uniformity values than the rest of the scanner population.  This might 
indicate a service issue present on this scanner, however, since the metric value is 
improved relative to the other scanners, the appropriate course of action is uncertain at this 
point. 
 Results of the linear mixed model analysis for the effect of the primary acquisition 
parameter, mAs, on uniformity in the DEQC head phantom can be seen in Table 6.16.  
Although increased mAs did seem to lead to improved uniformity, statistical analysis 
indicated that the 315 and 384 mAs protocols resulted in the best uniformity for the DEQC 
head phantom.  These results are supported by the simplified visualization of uniformity 
results by mAs and reconstructed keV (Figure 6.11).  The lowest mAs value investigated, 
208mAs, results in wider uniformity variation with changes in the keV of the monoenergetic 
reconstruction. 
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Figure 6.9: DEQC head phantom results for uniformity.  Left: Uniformity trends sorted 
primarily by mAs and secondarily by CTDIvol for 50, 70, 110 and 140 keV monoenergetic 
reconstructions and displayed by scanner.  Right: Uniformity inter- and intra-scanner 
variance trends sorted primarily by CTDIvol and secondarily by mA for 50, 70, 110, and 140 
keV monoenergetic reconstructions. 
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Figure 6.10: DEQC head phantom results for uniformity.  Left: Uniformity trends sorted 
primarily by mAs and secondarily by CTDIvol for Water(Iodine) and Iodine(Water) material 
density reconstructions and displayed by scanner.  Right: Uniformity inter- and intra-scanner 
variance trends sorted primarily by CTDIvol and secondarily by mA for Water(Iodine) and 
Iodine(Water) material density reconstructions. 
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Table 6.16:  DEQC head phantom results for the effect of mAs on Uniformity based on linear 
mixed model analysis. 
Dual-Energy 
Reconstruction mAs effect on Uniformity 
50 keV 384 >> 440 = 262.5 >> 315 >> 208 
70 keV 208 >> 262.5 >> 440 = 384 >> 315 
110 keV 208 >> 262.5 >> 440 > 384 > 315 
140 keV 208 >> 262.5 > 440 >> 384 > 315 
Water (Iodine) 208 >> 262.5 > 440 >> 384 = 315 
Iodine (Water) 384 >> 440 = 315 > 262.5 >> 208 
 
Legend 
>> Significantly Different P < 0.05 
> Not Significantly Different 0.05 < P < 0.9 
= Statistically Equivalent P > 0.9 
 
 
Figure 6.11: DEQC head phantom results for uniformity sorted primarily by mAs and 
secondarily by rotation time for 50, 70, 110 and 140 keV monoenergetic reconstructions. 
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 Monoenergetic HU Stability using the DEQC body phantom was found to be affected 
primarily by mAs and secondarily by CTDIvol for all monoenergetic reconstructions 
investigated (Figure 6.12).  All visualizations are shown over a 30 HU range, however the 
minimum and maximum attenuation shown is specific to the reconstruction.  Using vendor-
provided elemental composition for the soft tissue rods and acquired NIST attenuation 
values, the predicted attenuation assuming a true monoenergetic acquisition was 
calculated.  These values, shown as black lines, demonstrate the varied attenuations, and 
thus varied contrasts, supplied by monoenergetic imaging.  For 110 and 140 keV 
reconstructions, the accuracy of the attenuation is improved with increased mAs.  In this 
case, low mAs protocols overestimate the attenuation in the soft tissue rods.  For 50 keV, 
protocols with increased mAs do increase the attenuation, however none of the protocols 
investigated provides an accurate attenuation.  70 keV monoenergetic reconstruction was 
invariant to changes in protocol and in general was within 5 HU of the predicted attenuation.  
Based on protocol and scanner variation, the range of possible attenuations provided by 
50, 70, 110 and 140 keV reconstructions was 26 HU, 6 HU, 12 HU and 15 HU, respectively.  
Intra-scanner variance was primarily affected by CTDIvol and secondarily affected by mAs.  
Inter-scanner variance appeared to be equally affected by both parameters.  In general, 
inter- and intra-scanner variances were on the same order of magnitude, however inter-
scanner variance was occasionally greater than intra-scanner variance for 50 keV 
monoenergetic reconstruction.   
 Results of the linear mixed model analysis for the effect of the primary acquisition 
parameter, mAs, on monoenergetic HU stability in the DEQC body phantom can be seen in 
Table 6.17.  Increasing mAs had a statistically significant effect on improving 
monoenergetic HU stability for both 110 and 140 keV.  Results for 70 keV seem to indicate 
an optimal mAs of 182, however given the limited variability of the result with mAs, it is 
unlikely that this is clinically significant.   
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Figure 6.12:  DEQC body phantom results for monoenergetic HU stability.  Left: 
Monoenergetic HU stability trends sorted primarily by mAs and secondarily by CTDIvol for 50, 
70, 110 and 140 keV monoenergetic reconstructions and displayed by scanner.  Calculated 
attenuations (using NIST values) based on vendor-provided elemental composition and true 
monoenergetic acquisition are shown in black.  Right: Monoenergetic HU stability inter- and 
intra-scanner variance trends sorted primarily by CTDIvol and secondarily by mAs for 50, 70, 
110, and 140 keV monoenergetic reconstructions. 
 
Table 6.17: DEQC body phantom results for the effect of mAs on monoenergetic HU stability 
based on linear mixed model analysis. 
Dual-Energy Reconstruction mAs effect on Monoenergetic HU Stability 
50 keV 600 >> 480 >> 315 >> 180 >> 182 = 208 >> 165 
70 keV 600 >> 315 >> 480 >> 180 >> 165 = 208 > 182 
110 keV 165 >> 180 > 208 > 182 >> 315 >> 480 >600 
140 keV 165 >> 180 > 208 = 182 >> 315  >> 480 >> 600 
 
Legend 
>> Significantly Different P < 0.05 
> Not Significantly Different 0.05 < P < 0.9 
= Statistically Equivalent P > 0.9 
 
Investigation of trends in monoenergetic HU stability by mAs and monoenergetic 
keV show the effect of lower mAs protocols on the utility of monoenergetic imaging.  
Protocols using 208mAs and below result in monoenergetic images with fixed attenuation, 
and thus fixed contrast, across all monoenergetic energies.  Protocols using 315mAs and 
above provide variable attenuation, and thus variable contrast, across monoenergetic 
energy values.  This variable contrast is one of the added benefits provided by DECT.  By 
altering the keV of the monoenergetic reconstruction, the relative influence of photoelectric 
and Compton processes is modulated and the relative contrast of high-Z materials can be 
either enhanced or diminished.  This ability has been shown to be particularly useful in the 
improvement of iodine contrast compared to SECT (41,62,107). 
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Figure 6.13:  DEQC body phantom results for monoenergetic HU stability trends sorted 
primarily by mAs and secondarily by CTDIvol for 50, 70, 110 and 140 keV monoenergetic 
reconstructions.  The dashed red line indicates a potential mAs cutoff for optimum efficiency 
of monoenergetic visualizations. 
 
DEQC Head Phantom: 
 Monoenergetic HU Stability using the DEQC head phantom was found to be affected 
primarily by mA and secondarily by CTDIvol for all monoenergetic reconstructions 
investigated (Figure 6.14).  Similar to uniformity results from the DEQC phantom, CT 6 
appears to deviate from the rest of the scanner population.  All visualizations are shown 
using a 16 HU range, however the minimum and maximum attenuation shown is specific to 
the reconstruction.  Using vendor-provided elemental composition for the soft tissue rods 
and acquired NIST attenuation values, the predicted attenuation assuming a true 
monoenergetic acquisition was calculated.  These values, shown as black lines, 
demonstrate the variable attenuation, and thus variable contrast, supplied by 
monoenergetic imaging.  For 110 and 140 keV reconstructions, the reconstruction 
attenuation decreases as mA increases.  This trend is reversed at the highest mA value 
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investigated.  Tube current (mA) values under 630mA appear to be fairly invariant to mA 
changes.  Two potential explanations for this pattern include: 1) attenuation does in fact 
decrease with increasing mA, and the 640mA acquisition represents an unexpected change 
in this pattern; 2) attenuation is stable as mA changes, and that the 630mA acquisitions 
represent an unexpected change in this pattern.  The correct interpretation of these results 
is unclear at this point.  70 keV monoenergetic reconstruction follows a similar pattern to 
110 and 140 keV, however to a much lesser extent with all results falling between 31 and 
36 HU.  50 keV monoenergetic reconstructions show a similar pattern but inverted, with the 
630mA acquisitions resulting in higher attenuations than expected and the 640mA protocol 
resulting in lower attenuations.  Based on protocol and scanner variation, the range of 
possible attenuations provided by 50, 70, 110 and 140 keV reconstructions was 9 HU, 5 
HU, 7 HU and 8 HU, respectively.   
Inter- and intra-scanner variance were primarily affected by mA and secondarily 
affected by CTDIvol.  Variance for 50 keV monoenergetic reconstructions decreased with 
increasing mA while variance for 110 and 140 keV increased with increasing mA.  Variance 
for 70 keV monoenergetic reconstructions was fairly stable across all mA values 
investigated.  Inter-scanner variance was considerably higher than intra-scanner variance 
for 50 keV monoenergetic reconstructions acquired using protocols with lower than 630mA. 
 Results of the linear mixed model analysis for the effect of the primary acquisition 
parameter, mA, on monoenergetic HU stability in the DEQC head phantom can be seen in 
Table 6.18.  Attenuation was found to be statistically significantly different for all mA values 
investigated using 110 or 140 keV reconstructions.   
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Figure 6.14: DEQC head phantom results for monoenergetic HU stability.  Left: 
Monoenergetic HU stability trends sorted primarily by mA and secondarily by CTDIvol for 50, 
70, 110 and 140 keV monoenergetic reconstructions and displayed by scanner.  Calculated 
attenuations (using NIST values) based on vendor-provided elemental composition and true 
monoenergetic acquisition are shown in black.  Right: Monoenergetic HU stability inter- and 
intra-scanner variance trends sorted primarily by mA and secondarily by CTDIvol for 50, 70, 
110, and 140 keV monoenergetic reconstructions. 
 
Table 6.18: DEQC head phantom results for the effect of mA on monoenergetic HU stability 
based on linear mixed model analysis. 
Dual-Energy Reconstruction mA effect on Iodine Accuracy 
50 keV 630 >> 640 > 550 > 375 >> 260 
70 keV 375 >> 640 = 260 >> 550 >> 630 
110 keV 260 >> 375 >> 640 >> 550 >> 630 
140 keV 260 >> 375 >> 640 >> 550 >> 630 
 
Legend 
>> Significantly Different P < 0.05 
> Not Significantly Different 0.05 < P < 0.9 
= Statistically Equivalent P > 0.9 
 
Investigation of trends in monoenergetic HU stability by mA and monoenergetic keV 
show relatively stable attenuation response compared to the dramatic effect seen in the 
DEQC body phantom.  Attenuation with respect to keV of the monoenergetic reconstruction 
was most variable (largest range) for 630mA protocols.   
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Figure 6.15: DEQC head phantom results for monoenergetic HU stability trends sorted 
primarily by mA and secondarily by CTDIvol for 50, 70, 110 and 140 keV monoenergetic 
reconstructions.   
 
6.3.2.4 Noise 
DEQC Body Phantom: 
 Noise using the DEQC body phantom was found to be affected solely by CTDIvol for all 
dual-energy reconstructions investigated (Figure 6.16, Figure 6.17).  As expected, noise 
was greatest for 50 keV monoenergetic reconstructions.  Unexpectedly, 110 and 140 keV 
reconstructions resulted in lower noise values than 70 keV for all CTDIvol values 
investigated.  This effect is likely due to reduction in beam hardening artifacts at the higher 
monoenergetic reconstructions.  Water(Iodine) reconstruction noise was higher than 
Iodine(Water) noise at all CTDIvol values investigated, however, direct comparison of these 
two noise values is inappropriate due to the large differences in the relative dynamic range 
of the two image types.  In general, voxel values from water density images tend to span 
approximately 100 mg/mL, while voxel values from iodine density images tend to span 
approximately 20-25 mg/mL. 
20
25
30
35
40
45
50
44.6 81.4 54.7 36.7 67 26.2 47.8 105.6
0.5 0.6 0.7 0.8
Av
g 
of
 S
of
t T
is
su
e 
Vo
xe
ls
 (H
U
) 
CTDIvol (mGy)  
 
mA 
Monoenergetic HU by keV 
 50keV
 70keV
110keV
208 
 
 Results of the linear mixed model analysis for the effect of the primary acquisition 
parameter, CTDIvol, on noise in the DEQC body phantom can be seen in Table 6.19.  A 
statistically significant change in noise was seen for all incremental CTDIvol increases over 2 
mGy for all dual-energy reconstructions.   
 
 
Figure 6.16: DEQC body phantom results for noise trends sorted by CTDIvol for 50, 70, 110 and 
140 keV monoenergetic reconstructions.   
 
 
Figure 6.17: DEQC body phantom results for noise trends sorted by CTDIvol for Water(Iodine) 
and Iodine(Water) material density reconstructions.   
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Table 6.19:  DEQC body phantom results for the effect of CTDIvol on noise based on linear 
mixed model analysis. 
Dual-Energy Reconstruction CTDIvol effect on Noise 
50 keV 10.3 >> 17.4 > 17.8 = 17.2 >> 25.5 >> 32.5 >> 33.9 >> 48.6 >> 62 
70 keV 10.3 >> 17.8 >> 17.4 > 17.2 >> 25.5 >> 32.5 >> 33.9 >> 48.6 >> 62 
110 keV 10.3 >> 17.4 = 17.8 > 17.2 >> 25.5 >> 32.5 >> 33.9 >> 48.6 >> 62 
140 keV 10.3 >> 17.4 >> 17.8 = 17.2 >> 25.5 >> 33.9 = 32.5 >> 48.6 >> 62 
Water (Iodine) 10.3 >> 17.4 >> 17.8 = 17.2 >> 33.9 >> 32.5 >> 48.6 >> 62 
Iodine (Water) 10.3 >> 17.4 >> 17.2 > 17.8 >> 25.5 >> 33.9 >> 32.5 >> 48.6 >> 62 
 
Legend 
>> Significantly Different P < 0.05 
> Not Significantly Different 0.05 < P < 0.9 
= Statistically Equivalent P > 0.9 
 
DEQC Head Phantom: 
 Noise using the DEQC head phantom was found to be affected solely by CTDIvol for all 
dual-energy reconstructions investigated (Figure 6.18, Figure 6.19).  As expected based on 
the literature, noise was lowest for 70 keV monoenergetic reconstructions with higher keV 
reconstructions resulting in slightly higher noise and 50 keV reconstructions resulting in the 
greatest amount of noise.  This represents a change in the noise pattern for higher keV 
reconstructions relative to the DEQC body phantom, where the reduction in beam 
hardening likely played a larger role due to the greater size of the phantom.  Water(Iodine) 
reconstruction noise was higher than Iodine(Water) noise at all CTDIvol values investigated, 
however, given the large differences in the relative dynamic range of the two image types, 
direct comparison of these two noise values is inappropriate.   
 Results of the linear mixed model analysis for the effect of the primary acquisition 
parameter, CTDIvol, on noise in the DEQC body phantom can be seen in Table 6.20.  
Statistically significant changes in noise were found across all dual-energy reconstructions 
for each CTDIvol investigated except the 36.7 and 47.8 mGy protocols.   
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Figure 6.18: DEQC head phantom results for noise trends sorted by CTDIvol for 50, 70, 110 and 
140 keV monoenergetic reconstructions.   
 
 
Figure 6.19: DEQC head phantom results for noise trends sorted by CTDIvol for Water(Iodine) 
and Iodine(Water) material density reconstructions.   
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Table 6.20: DEQC head phantom results for the effect of CTDIvol on noise based on linear 
mixed model analysis. 
Dual-Energy Reconstruction CTDIvol effect on Noise 
50 keV 26.2 >> 36.7 >> 47.8 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6 
70 keV 26.2 >> 36.7 > 47.8 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6 
110 keV 26.2 >> 47.8 > 36.7 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6 
140 keV 26.2 >> 47.8 > 36.7 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6 
Water (Iodine) 26.2 >> 36.7 = 47.8 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6 
Iodine (Water) 26.2 >> 36.7 >> 47.8 > 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6 
 
Legend 
>> Significantly Different P < 0.05 
> Not Significantly Different 0.05 < P < 0.9 
= Statistically Equivalent P > 0.9 
 
 
6.3.3 Recommendations on Clinical Implementation of DEQC Program 
Although a scan protocol covering the full ranges of multiple parameters is vital for 
the full characterization of a system, long term collection of such data for QC purposes is 
impractical.  In order to develop a long-term quality control program suitable for clinical 
implementation, a streamlined protocol was developed based on the results from the first 
13 weeks of analysis (Table 6.21).  Given the similarity of the DEQC head and DEQC body 
results, and the time required to setup and scan both phantoms, the finalized DEQC 
program limited data collection and analysis to only the DEQC body phantom.  Protocol 
acquisitions were limited to a more clinical CTDIvol range of 17.2 to 33.9 mGy, while 
maintaining those acquisitions necessary to separate out effects due to CTDIvol and rotation 
time.  Two such groups remained: approximately 33 mGy at 0.5 and 1.0sec rotation times, 
and approximately 17.5 mGy at 0.5, 0.6 and 0.7sec rotation times. 
A large dataset will be needed in order to determine the baseline values and 
tolerances necessary for the establishment of a true DECT quality control program.  
Streamlining the DEQC program from two phantoms with a combined 18 acquisitions to 
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one phantom with 6 acquisitions allowed more consistent and frequent data collection. In 
addition, by sampling only the data sets previously acquired from the earlier version, data 
collection prior to the implementation of this finalized DEQC program could also contribute 
to future analysis, increasing the size and scope of the data set.  This finalized DEQC 
program is currently established in the clinic and at the point of this publication has 
collected 35 weekly or bi-weekly DEQC exams on 10 dual-energy CT systems, for a total of 
350 DEQC exams. 
 
Table 6.21: Final recommendations for the clinically implementable dual-energy quality 
control protocol.  All acquisitions performed in helical mode, using a 40 mm beam width, 
Large Body SFOV, 42 cm DFOV and standard reconstruction filter. 
Group GSI-Preset Pitch Rot (s) mA 
Img Thk 
(mm) Interval CTDIvol Extent # Imgs 
1 GSI-1 0.516 0.5 630 5 5 33.9 S10-I10 5 
2 GSI-5 0.984 1 600 5 5 32.5 S10-I10 5 
3 GSI-10 0.984 0.8 600 5 5 25.5 S10-I10 5 
4 GSI-1 0.984 0.5 630 5 5 17.8 S10-I10 5 
5 GSI-54 0.516 0.6 275 5 5 17.4 S10-I10 5 
6 GSI-48 0.516 0.7 260 5 5 17.2 S10-I10 5 
 
6.4 Discussion 
While many studies have been performed to evaluate the effect of dual-energy 
acquisition and processing on noise (41,42,48,63,107), iodine accuracy (42,56,106,114–
118) and the stability and accuracy of the attenuations derived from the monoenergetic 
reconstructions (61), few have investigated the impact of acquisition parameters and none 
have investigated long term trends in these values.  This study sought to investigate the 
relationship of various acquisition parameters to values important to the quantitative clinical 
use of dual-energy CT such as iodine accuracy, uniformity, noise and the stability of the 
attenuations derived from monoenergetic reconstructions.  The end goal was to create an 
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efficient and pertinent DEQC program for clinical implementation and long term data 
collection.  
 
6.4.1 Iodine Accuracy 
Iodine accuracy was found to be primarily affected by protocol mAs with increasing 
values leading to improved iodine accuracy and decreased intra- and inter-scanner 
variances. At low mAs values in the DEQC body phantom, iodine accuracy was found to be 
overestimated for the 2 mg/mL rod, underestimated for the 5 mg/mL rod, and the 15 mg/mL 
rod remained generally unaffected by protocol variation.  While the differences in iodine 
concentration could certainly play a role, this effect is likely also influenced by differences in 
location and local environment between the three iodine rods.  For both the DEQC body 
and DEQC head phantom, iodine accuracies converged to a -5% measurement error.  
Given that independent verification of the concentration of iodine within the rods could not 
be performed, it is possible that the error is due to incorrect fabrication.  The iodine rods are 
also based on a 0 HU epoxy resin solid water containing a range of elements not limited to 
hydrogen and oxygen, which may affect the results of the water/iodine material 
decomposition.   
 
6.4.2 Uniformity 
Uniformity measures using the DEQC body phantom were primarily affected by 
rotation time, however the direction of the effect was dependent on the dual-energy 
reconstruction.  For 50 keV and Iodine(Water) reconstructions, increased rotation time led 
to lower and improved uniformity values, while in 110 keV, 140 keV and Water(Iodine) 
reconstructions it led to higher and degraded uniformity.  70 keV uniformity was not affected 
by increased rotation time, however, it was consistently elevated.  Given that these data 
were collected using a fast-kVp switching technique, one might assume that faster rotation 
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times would affect the efficiency of the kVp waveform and lead to reduced spectral 
separation.  However, longer rotation times seem to adversely affect uniformity in both the 
110 and 140 keV reconstructions.  Given the consistently elevated uniformity result for the 
70 keV reconstruction, it is likely that some factor outside protocol variation is in play.  If an 
offset were applied to the data to correct for the elevated 70 keV results, 110 and 140 keV 
uniformity would improve with increasing rotation time and 50 keV would initially improve 
but then worsen as it overshoots the 0 HU goal.  This result would be more consistent with 
current understanding of the potential effect of rotation time on uniformity measures.  This 
“offset” in the uniformity results could be due to a number of outside factors, however, the 
most likely factor is phantom design.  Based on the local environment of the central soft 
tissue rod used to evaluate uniformity, it is likely that these measurements might be 
affected by beam hardening or photon starvation caused by the influence of the 198 and 
334 HU calcium rods.  This would cause a consistent reduction in the CT number of the 
central soft tissue rod and thus an elevation in the uniformity value.  This hypothesis could 
be evaluated by replacing all non-soft tissue rods by solid water rods and repeating the 
measurement.  For all dual-energy reconstructions investigated, intra-scanner variance was 
always equal to or greater than inter-scanner variance, which indicated that uniformity 
would not be a concern for repeat scanning on varied scanners. 
Uniformity measures using the DEQC head phantom were primarily affected by mAs 
rather than rotation time.  This reduced dependence on rotation time is likely due to the 
reduction in phantom size from the DEQC body phantom to the DEQC head phantom.  For 
all dual-energy reconstructions, increased mAs led to similar or improved uniformity.  
Uniformity measures for 50 keV reconstructions were much improved from the DEQC body 
phantom with a reduction in maximum uniformity value from 18 HU for the DEQC body to 
5.2 HU for the DEQC head phantom.  Of note in the DEQC head phantom uniformity data is 
the consistently higher uniformity values at 50 keV for CT6 compared to the rest of the 
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scanner population.  Daily single-energy quality control data, which is based on an in-house 
QC program and measures uniformity in a similarly sized 22 cm diameter phantom (123), 
showed passing values for uniformity over the complete duration of this study. This finding 
highlights the serious need for a quality control program designed specifically to monitor the 
dual-energy capabilities and specific reconstructions available on these scanners.   
 
6.4.3 Monoenergetic HU Stability 
Monoenergetic attenuation (HU) results using the DEQC body phantom were 
dramatically affected by mAs.  Protocols with less than 315mAs resulted in similar 
attenuation measures across all monoenergetic reconstructions investigated.  One of the 
greatest advantages of dual-energy CT over single-energy CT is the variable contrast 
based on reconstructed keV that is derived from the dual-energy data.  In order to acquire 
dual-energy data, both the 80kVp and 140kVp beams must penetrate through the patient in 
sufficient quantities to be reconstructed into an image.  In the case of the DEQC body 
phantom, protocols below 315mAs did not provide sufficient tube output to result in 
adequate photon collection at the detector.  Having limited 80kVp data to draw from, the 
material decomposition process is highly affected, resulting in fixed attenuation across all 
monoenergetic reconstructions.  Since this fixed attenuation is tied to over-attenuation of 
the 80kVp beam, the mAs limit for this effect will be phantom (or patient) size dependent.   
Due to this fixed attenuation at low mAs values, attenuation results varied widely 
with acquisition protocol resulting in attenuation ranges of 25 HU, 6 HU, 12 HU and 17 HU 
for 50, 70, 110 and 140 keV reconstructions, respectively.  By constraining protocols to only 
those with mAs of 315 and above, the attenuation ranges were reduced to 10 HU (61% 
reduction), 5 HU (20% reduction), 6 HU (53% reduction) and 7 HU (54% reduction).  These 
results are within 1 HU of the attenuation ranges found using the DEQC head phantom 
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where no attenuation discontinuity was identified, potentially indicating stable response due 
to adequate 80kVp penetration.   
Inter-scanner variance was greater than intra-scanner variance for measures of 
monoenergetic HU stability for 50 keV reconstructions using both the DEQC body and 
DEQC head phantoms.  50 keV monoenergetic reconstructions are routinely used to 
increase the conspicuity of iodine (62).  Given the high inter-scanner variance relative to the 
intra-scanner variance, it is recommended that patients requiring repeat measures be 
limited to a single scanner or imaged using a higher mAs protocol for increased 
repeatability. 
 
6.4.4 Noise 
Noise values improved with increasing selected CTDIvol for both the DEQC body 
and DEQC head phantom, as expected.  Although several papers have shown optimal 
noise values at 65-77 keV (41,42,48,63,107), data for the DEQC body phantom resulted in 
lowest noise in the 110 and 140 keV reconstructions.  Given the large size of the phantom 
and the highly heterogeneous environment, it is likely this effect is due to enhanced 
correction of beam hardening artifacts at the higher keV reconstructions.  Data for the 
DEQC head phantom does not show improved noise values for the 110 and 140 keV 
reconstructions relative to 70 keV, likely due to the lesser extent of beam hardening in a 
smaller phantom. 
 
6.4.5 Differences in DEQC Body and DEQC Head Phantom Results 
In general, the DEQC head phantom provided more stable and improved results 
over the DEQC body phantom.  Iodine accuracy results for the DEQC head phantom 
showed 60% improvement in iodine accuracy relative to the DEQC body phantom.  While 
the DEQC body phantom provided inconsistent results on the effect of protocol mAs on 
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uniformity, the DEQC head phantom provided consistent improvement in measured 
uniformity with increasing protocol mAs.  In addition, the uniformity for 50 keV 
monoenergetic reconstructions was vastly improved from a maximum value of 18 HU in the 
DEQC body phantom to 5 HU in the DEQC head phantom.  Monoenergetic HU stability 
results were dramatically improved in the DEQC head phantom due to the lack of over-
attenuation of the 80kVp beam.  After eliminating those protocols with inadequate 
transmission, the results for attenuation (HU) range across protocols were similar for both 
phantoms.   
In general, both inter- and intra-scanner variances for all test metrics evaluated were 
lower in the DEQC head phantom than in the DEQC body phantom.  Comparing the DEQC 
head phantom results to those of the DEQC body phantom, there was a reduction in the 
dependence on rotation time for both the uniformity and monoenergetic HU stability metrics.  
Given the smaller size and uniform shape of the DEQC head phantom, the effect on the 
fast-kVp switching waveform, and thus the material decomposition process is likely less 
pronounced. 
  
6.4.6 Impact of Results on Intracranial Lesion Characterization 
While this project’s primary aim was to characterize the response of the DECT 
scanner and develop a long-term, clinically-implementable quality control program, it also 
served as validation for the comparison of data collected over time as part of the 
intracranial lesion research projects.  Iodine accuracy for the DEQC head phantom was 
measured used two iodine rods; one at 2 mg/mL and a second at 5 mg/mL.  When imaged 
using a 120kVp single-energy protocol, these rods have attenuations of 51 HU and 128 HU. 
This attenuation range is very similar to the attenuation range of intracranial lesions 
investigated in Chapters 4 and 5.  Iodine accuracy for these rods resulted in maximum 
percent errors of 8 and 6% for the 2 mg/mL and 5 mg/mL rods respectively (Figure 6.5).  
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Presented as a difference measure instead of a percentage, this translates to maximum 
errors of 0.15 and 0.3 mg/mL.  This, coupled with inter- and intra-scanner variances of 
under 0.05 mg/mL indicates that iodine concentration measurements are consistent among 
scanners and over time (at least for several months).  Given that all basis material 
reconstructions are linearly correlated (a calcium/water material density pair is derived from 
an iodine/water material density pair), these iodine density data also validate the 
comparison of calcium and water density data collected over time.  Direct measure of the 
calcium and iron rods included in the DEQC head phantom was initially pursued, however 
use of a non-standard background material for these rods due to material engineering 
requirements made accuracy measures less straightforward. 
Monoenergetic HU stability measurements for the DEQC head phantom resulted in 
relatively stable attenuation regardless of protocol for 70 keV reconstructions (Figure 6.14).  
The maximum attenuation range, based on either protocol variation on a single scanner, or 
scanner variation given a single protocol, was 2.9 HU, within the 3 HU matching of the 
matched model pairs in Chapter 4.  Inter- and intra-scanner variances were found to be 
under 1 HU.  These results support the comparison of the 68 keV monoenergetic data 
collected over several months as part of the intracranial lesion work. 
Uniformity data collected using the DEQC head phantom resulted in uniformities of 
2 HU, 2 mg/mL and 6 mg/mL for 70 keV, Iodine(Water) and Water(Iodine) reconstructions 
respectively (Figure 6.9, Figure 6.10).  Results for the Water(Iodine) reconstruction were 
higher than that of the Iodine(Water) reconstruction, though given the difference in the 
dynamic range of these image types, the higher value for the Water(Iodine) reconstruction 
is reasonable.  Inter- and intra-scanner variances were found to be below 0.3 HU, 0.2 
mg/mL and 1.8 mg/mL for 70 keV, Iodine(Water) and Water(Iodine) respectively.  Given 
that these uniformity errors are minimal, it is unlikely that uniformity errors would affect 
lesion model data.  This is especially likely given that none of the lesion models were 
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evaluated close to the center of the phantom and instead were positioned midway between 
the phantom center and periphery (Figure 4.2). 
The DEQC head phantom results for iodine accuracy, uniformity and monoenergetic 
HU stability all resulted in low inter- and intra-scanner variance for the 70 keV, 
Iodine(Water) and Water(Iodine) reconstructions.  This provides independent support for 
the high inter- and intra-canner correlations found in Chapter 4.  Coefficients of variation 
(CV) were found to be approximately 5% for inter-scanner and 4% for intra-scanner 
correlations, respectively (Table 4.23), supporting the comparison of results from both 
different time points and different scanners. 
While rod size was not varied as part of the DEQC head phantom, rotation time and 
selected CTDIvol were identified as sources of variability, similar to the results of inter-
method, inter-scanner and intra-scanner correlations investigated in Chapter 4.  Results of 
the DEQC head phantom also indicated mAs as a major parameter affecting multiple test 
metrics.  No analysis was performed based on variation in protocol mAs for the intracranial 
lesion work, however for the protocols investigated, mAs monotonically increased with 
selected CTDIvol for a given pitch.  This would indicate that analysis by mAs would provide 
similar results to analysis by selected CTDIvol.  Given that the use of fixed GSI-presets does 
not allow for independent investigation of these two parameters, it is possible that variation 
in mAs may explain the relatively low success of the power fits for determining the 
appropriate CTDIvol for 90% differentiation accuracy based on lesion attenuation. 
In all cases, results of the DEQC head phantom support the comparison of 
intracranial lesion data collected over the course of several months.  The results show low 
inter- and intra-scanner variability, potentially opening this method for intracranial 
differentiation and classification to repeat measures on separate scanners.  Iodine 
accuracy, uniformity and monoenergetic HU stability measures using the DEQC head 
phantom were all significantly improved compared to DEQC body phantom results.  Given 
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the difference in effective diameter of the DEQC head phantom (22 cm diameter) and the 
biologically relevant brain phantom used in Chapters 4 and 5 (14 cm by 18 cm for an 
effective diameter of 16 cm), it is likely that the smaller phantom size would lead to even 
more stable results than those of the DEQC head phantom. 
 
 
6.4.7 Limitations 
Phantom design was heavily influenced by the desire to include the evaluation of a 
wide range of material rods and test metrics.  As a consequence, several aspects of the 
phantom design may impact the results.  First, in order to include relevant material rods, the 
size of the DEQC head phantom was increased to 22 cm, larger than the approximately 17 
cm diameter of the typical human head (124).  Second, the profile of the DEQC head 
phantom was simplified to a circle, enabling easy insertion and removal from the DEQC 
body phantom.  Third, the DEQC head phantom was not designed with anthropomorphic 
features like a skull, which would influence its applicability to patient scans.  Due to its size 
and shape, the DEQC head phantom was imaged on a stand on the CT table instead of in 
a head holder, which would better approximate clinical imaging.  For both the DEQC head 
and DEQC body phantoms, material rods were fixed to a single location.  Although an 
attempt was made to optimize the rod layout to minimize the effect of beam hardening on 
the evaluation of test metrics, it is likely that test metric results were influenced by both a 
rod’s location and local environment.  This is especially true for noise, which was evaluated 
within a single centrally located rod and not over a larger or more representative portion of 
the phantom.  Iodine accuracy was assessed using a material decomposition of pure iodine 
and water, although the rods were fabricated by adding iodobenzene (C6H5I) to a 0 HU 
epoxy resin material. This discrepancy between the fabrication materials and the basis 
materials for the material decomposition may influence the accuracy of the iodine 
concentration results.   
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In addition to the phantoms, analysis was heavily limited due to the inability to 
independently investigate acquisition parameters due to the use of fixed GSI-presets.  This 
is the current reality of dual-energy acquisition using the GE DECT system and while 
complicating advanced analysis, it does force the quality control program to mimic clinical 
care.  The method to determine primary and secondary trends in test metrics was primarily 
based on visual assessment and would benefit from more rigorous statistical analysis.  
Finally, evaluation of iodine accuracy and monoenergetic HU stability both used nominal 
values that could not be independently validated.  In the case of iodine accuracy, the true 
accuracy was derived from the stated iodine concentration by the rod manufacturer.  
Without some way to independently verify this, errors in iodine accuracy could potentially be 
due to errors in rod fabrication.  In the case of monoenergetic HU stability, the predicted 
attenuation added to the graphs was calculated assuming a true monoenergetic beam while 
DECT reconstructions represent virtual monoenergetic values based on the material 
decomposition results. 
 
6.4.8 Future Work 
Future work includes development of a dual-energy quality control process for dual-
source dual-energy systems.  In addition, investigation will continue into the effect of 
phantom (or patient) size on the mAs cutoff for static attenuation across monoenergetic 
reconstructions, as well as the creation of a more advanced and rigorous noise metric.  A 
multivariate logistic model will be pursued to determine major sources of variability for test 
metrics based on all available acquisition parameters.  Data will continue to be collected in 
order to determine baseline values and failure threshold criteria for the validation of long-
term DECT scanner performance. 
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Chapter 7 
7 Conclusions 
 
7.1 Summary of Major Findings 
In this dissertation we have explored the application of dual-energy CT to the 
differentiation of intracranial calcification and hemorrhage.  Currently, single-energy CT is 
able to positively identify intracranial lesions of over 100 HU as calcification, however, 
lesions below this cut off are impossible to identify using this technique.  We have shown 
using a basic agar-gel based physics model (Chapter 3) that calcium, present in 
calcification, and iron, present in hemorrhage have distinct enough spectral attenuation 
curves to be differentiable using dual-energy CT over the attenuation range of interest.   
Next, this method was expanded to better replicate the imaging environment of the 
head and to evaluate a range of lesion sizes and locations (Chapter 4).  A spectrally 
equivalent brain material was created to mimic the spectral attenuation properties of brain 
matter and an anthropomorphic phantom was used to mimic the shape and attenuation of 
the skull.  A range of protocol variations (CTDIvol, image thickness and reconstruction filter) 
were used to elucidate the optimal acquisition and reconstruction parameters for this 
method.  While the initial goal was to create optimized protocols for each lesion size and 
location, general trends were identified that influenced differentiation accuracy regardless of 
these lesion specific parameters.  Based on the protocol variations investigated, 
differentiation accuracy increased with selected CTDIvol and image thickness.  No effect 
was observed based on changes in reconstruction filter.  Although these factors were the 
only parameters varied directly, due to the fixed nature of the GSI-presets available on the 
GE 750HD scanner, a further parameter, rotation time, was found to affect differentiation 
accuracy based on inter-method and inter-study correlation measurements.  Rotation times 
223 
 
of 0.5sec, in particular, were found to adversely affect both inter- and intra-scanner 
correlation and should therefore be avoided.   
 
 
Figure 7.1: Graphical representation of lesion attenuation (HU) necessary for 90% GB 
differentiation accuracy by acquisition parameters (Table 4.15).  The un-shaded region 
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the 
current clinical limit of 100 HU imposed by SECT. 
 
The effect of selected CTDIvol and image thickness on differentiation accuracy can 
be seen in Figure 7.1 (reproduction of Figure 4.33 for convenience) which shows the SECT 
attenuation (HU) necessary to achieve 90% differentiation accuracy using geometric 
bisector analysis.  The shaded region represents differentiation currently available using 
single-energy CT, while the un-shaded region represents additional differentiation ability 
using dual-energy CT.  Assuming a 132.6 mGy CTDIvol, a standard filter and 5 mm thick 
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images, 90% differentiation accuracy using the geometric bisector method would be 
possible down to approximately 60 HU, 55 HU and 70 HU for 1.0 cm cerebrum, 1.5 cm 
cerebrum and 1.5 cm skull base lesions respectively (Figure 7.2).   
 
 
Figure 7.2: Accuracy of intracranial lesion differentiation using geometric bisector method 
with 132.6 mGy CTDIvol, 5 mm image thickness and standard filter.  Error bars represent one 
SD of the variation over the three studies collected. 
 
Based on these differentiation results, an experiment was pursued to assess the 
ability of dual-energy CT to classify unknown intracranial lesions using the geometric 
bisector method (Chapter 5).  Based on the results of the earlier differentiation project, and 
current clinical parameters, a three tier protocol with fixed image thickness, fixed filter and 
three separate CTDIvol values was designed.  The CTDIvol values represented the current 
routine brain protocol CTDIvol value, the maximum value available on the CT scanner, and a 
midpoint value.  All lesion models, except for 0.5 cm calcifications in the cerebrum, resulted 
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in increased classification ability beyond that of single-energy CT.  These results support 
our hypothesis that DECT could be used to differentiate (and subsequently classify) 
intracranial calcification and hemorrhage below the attenuation level possible using SECT.   
 
7.2 Comments on Clinical Implementation  
Several methods were investigated based on their ability to differentiate, and later 
classify, intracranial hemorrhage and calcification.  Although more simplistic, the geometric 
bisector method was found to be as effective, if not more so, than the competing advanced 
statistical methods (Gaussian mixture model method, support vector machine method, and 
probability distribution method).  This effect was seen for both differentiation and 
classification studies.  Analysis of the generalizability of the original lesion and acquisition 
specific geometric bisector plane solution (Chapter 4.2.5.5), identified two major sources of 
variability: small lesions under 0.5 cm diameter and lesions in the skull base.  The ability to 
use a generalized geometric bisector plane solution that has no dependence on acquisition 
and reconstruction parameters will allow the radiologist more freedom to prescribe protocol 
parameters on a case by case basis.    
In addition, high correlation was seen between 68 keV attenuation and single-
energy CT attenuation for all lesion models investigated.  Correlation was less optimal in 
the skull base, likely due to increased beam hardening in that region of the brain.  These 
results indicate that a 68 keV reconstruction could be used for lesion attenuation measures 
instead of a separate single-energy acquisition.  By removing the necessity for a separate 
single-energy acquisition, the total dose to the patient may be reduced by limiting the exam 
to the dual-energy acquisition, or the dose of the dual-energy acquisition could be 
increased, thus increasing the quality and accuracy of the exam. 
While inter- and intra-scanner correlations were not assessed for intracranial 
classification, results for the intracranial differentiation studies yielded coefficients of 
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variation (CV) under 5% in both cases once major sources of variability were removed.  For 
the geometric bisector method, inter-scanner variance was higher than intra-scanner 
variance, potentially indicating that repeat measures should be performed on the same 
scanner.  Since the difference between inter-scanner and intra-scanner correlation was 
approximately 1.3%, the clinical impact of this effect would likely be minimal.  These 
conclusions are supported by the dual-energy quality control program results (Chapter 6), 
indicating low inter- and intra-scanner variances in the DEQC head phantom across all test 
metrics.  Accurate and consistent quantitative results were observed for iodine accuracy, 
uniformity and monoenergetic HU across a wide range of GSI-presets, further supporting 
the inter-comparability of collected project data.   
 
7.3 Limitations and Future Directions 
The investigation of intracranial lesion classification using dual-energy CT has led to 
several unresolved questions.  First, lesion classification results for 0.5 cm and 1.0 cm 
cerebrum lesions do not provide sufficient information to state the lesion size limitations of 
this method.  Further investigation would require the creation of intermediate size models, 
the evaluation of which would not be possible without modification of this phantom.  
Furthermore, since neither heterogeneity nor cross contamination between the lesion types 
were investigated as part of our phantom model, the usefulness of this method for 
heterogeneous or mixed lesions cannot currently be confirmed.  Further investigation using 
various levels of heterogeneity or differing mixture ratios of calcification and hemorrhage 
may provide further insight.  Finally, display field of view remained constant throughout this 
study.  Reduction in DFOV from 25 cm to 12 cm may improve classification confidence for 
smaller lesions by increasing sample size, reducing partial volume effect and increasing 
ease of ROI placement. 
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The dual-energy quality control program will be generalized to include dual-source 
dual-energy CT systems.  In addition, further investigation of the effect of phantom size on 
the mAs required for variable attenuation and contrast (when using variable keV 
monoenergetic reconstruction options) is warranted.  A multivariate logistic model will be 
pursued to statistically determine major sources of variability in DEQC test metrics based 
on all acquisition parameters investigated.  DEQC data collection will continue in order to 
determine the baseline and failure threshold criteria necessary for validation of long-term 
DECT scanner performance. 
In conclusion, these studies into the characterization of intracranial lesions have 
supported the hypothesis that DECT could be used to differentiate, and further classify, 
intracranial calcification and hemorrhage below the attenuation level possible using SECT.  
Chapter 3 (Specific Aim 1) supports the idea that calcium, associated with calcification, and 
the iron, associated with hemorrhage, have distinct enough attenuation curves to allow for 
differentiation of these two lesion types using dual-energy CT.  Chapter 4 (Specific Aim 2) 
verified these differentiation results for various size and location lesions using a more 
biologically relevant and spectrally equivalent phantom model resulting in recommended 
acquisition parameters and analysis models for optimal differentiation accuracy.  Chapter 5 
(Specific Aim 3) validated the protocol recommendations and analysis methods developed 
in Chapter 4 by showing dual-energy CT’s ability to classify unknown lesions below the 100 
HU cutoff imposed by SECT.  Finally, Chapter 6 (Specific Aim 4) established the effect of 
protocol acquisition parameters on a number of DEQC test metrics, as well as the inter- and 
intra-scanner variance in these metrics, allowing both validation of the collected research 
data and assessment of the validity of repeat measures in patients.  Together these 
findings establish the added benefit of dual-energy CT evaluation for intracranial lesion 
characterization and provide justification for future clinical evaluation in patients.   
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Chapter 8 
8 Appendix 
 
This chapter is based upon: 
JL Nute, LG Le Roux, AG Chandler, V Baladandayuthapani, D Schellingerhout, DD Cody.  
Differentiation of low-attenuation intracranial hemorrhage and calcification using dual-
energy computed tomography in a phantom system. Invest Radiol. 2015; 50(1): 9-16.  doi: 
10.1097/RLI.0000000000000089 
Written permission has been obtained from the journal for use of these materials in 
this dissertation.  Wolters Kluwer Health Lippincott Williams & Wilkins © No modifications 
will be permitted. 
 
8.1 Gaussian Mixture Model Formulation 
The basic data collected from our experiments had a three dimensional structure 
with the x-axis defined as the dual-energy CT water density, the y-axis defined as the dual-
energy CT calcium density, and the z-axis defined as the SECT attenuation (HU). Our basic 
scientific question of characterizing this three-dimensional data cloud into distinct (sub-) 
populations corresponding to water and calcium can be construed as a clustering problem 
i.e. at each HU we wish to identify how well these distinct clusters are separated. Visually 
inspecting the data we found that at lower HU these clusters are not very well separated but 
the distinction increases with SECT attenuation (HU) levels and we would like accurately 
quantify the uncertainty of this process. The most commonly used clustering algorithms are 
mixture models (125).  Mixture models are a common statistical tool for clustering and allow 
properties of multiple subpopulations (distributions) to be statistically inferred from pooled-
population data. Gassuian mixture models (GMM) are a special case of mixture models and 
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was chosen for this study because of its ease of interpretation and to take advantage of the 
3D and potentially overlapping nature of the data collected. The basic GMM can be 
expressed concisely as: 
 
Equation 15  ???? ? ? ??
?
???
???? ? ???   
where P(X) represents the joint distribution of the 3-D water/calcium/HU data, K is 
number of mixture components, ?? is the mixture weights/prior probability and ????? ??) 
represents the Gaussian (normal) density with mean ?? and variance-covariance matrix ?? 
corresponding to the cluster k respectively. All of these quantities are treated as unknown 
parameters and are estimated by the data as detailed below.  
 
8.2 GMM Fitting and Analysis 
We used MATLAB Statistics Toolbox™ software, and specifically 
the gmdistribution class to fit an unsupervised GMM analysis using a 50% training set, 50% 
validation set approach. GMM analysis uses an expectation maximization(EM) algorithm 
(126) to iteratively fit two potentially overlapping Gaussian distributions to the combined 
hemorrhage-calcification model pair data and consists of two steps: the Expectation (E) 
step which calculates the expected values for the membership weights of each data point 
as functions of the mixture weights ?? and the maximization (M) step which uses the 
membership weights obtained from the E step, and recomputes the distribution of the 
Gaussian distributions ?? and  ??respectively (127). This procedure is repeated iteratively 
until convergence is achieved.  
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Posterior probability calculations 
Once these distributions are optimally estimated using the EM algorithm, the 
analysis provides for each voxel the probability that the voxel belongs to the hemorrhage 
cluster and (vice-versa) the probability that the voxel belongs to the calcification cluster 
which is calculated using the Bayes theorem as: 
 
Equation 16 ? ? ???????????????????? ? ????????????????????????????????       
 
where the probabilities on the right-hand side are calculated using the (weighted) 
ratio of the Gaussian densities corresponding to each cluster estimated via the EM 
algorithm. An example plot of these posterior probabilities for one HU pair is show in Figure 
8.1.  Voxels were assigned to a cluster if their probability of belonging to a cluster (P) 
exceeded a median probability threshold of 50%. The voxel identities predicted by the GMM 
were then compared to the true voxel identities and the true hemorrhage and true 
calcification values were calculated.  The accuracy with which the GMM differentiated the 
calcification gel model from the hemorrhage gel model was then calculated as the sum of 
the true hemorrhage and calcification values divided by the total number of voxels in the 
two gel model data sets. Because of the stochastic nature of iterative approaches such as 
GMM analysis, the method was repeated over 1,000 runs for each matched model pair to 
assess the stability of model configurations.  Each run used a different starting point 
randomly selected as part of the gmdistribution.fit function.  Any runs whose final log 
likelihood value differed from that of the median results by my more than 3 standard 
deviations were presumed to be influenced by local minima (128), and were removed from 
the results.  The analysis was repeated with new initial values until there were 1,000 
successful runs for each matched model pair.  The accuracy was calculated for each 
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successful run, and then the mean and standard deviation of the accuracy was calculated 
for the 1,000 runs of each attenuation matched model pair.   
To determine whether the initial random separation of data into training and validation 
sets affected the accuracy results, the random selection, as well as the 1,000-GMM-run 
analysis, was repeated 10 times for each SECT attenuation-matched model pair.  For each 
matched model pair, the 10 random splits were found to yield identical results (data not 
shown), indicating the random separation of the data into training and validation data sets 
did not affect the final GMM accuracy results. 
 
 
Figure 8.1:  Posterior probabilities for the calcification cluster based on the GMM results of 
the 50 HU matched model pair. Red indicates a very high probability the voxel is calcification, 
while blue indicates a very low probability.   
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